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1 Abstract
To understand the role of epigenetic mechanisms involved in neural stem cells dur-
ing development and adulthood, I examined the localisation and function of the
histone deacetylase (HDAC) 2 that aﬀects transcriptional regulation by modifying
the N-terminal ends of the histone tails resulting in decreased transcriptional activity.
HDAC2 protein was detected at high levels in postmitotic neurons in the developing
and adult brain. Interestingly, neuronal precursors in the developing brain did not
contain HDAC2 protein, while it increased in neuronal precursors in postnatal and
adult forebrain. In the two regions of adult neurogenesis, HDAC2 was contained
in doublecortin-positive neuroblasts and in transit-amplifying progenitors, but not
in the adult neural stem cells. In order to understand the function of HDAC2 in
neurogenesis, I examined an HDAC2 deﬁcient mouse line lacking the catalytic ac-
tivity of HDAC2. While embryonic neurogenesis occurs normal in these mice, the
proliferation of adult neural progenitors is increased and neurons derived from both
zones of adult neurogenesis, the subependymal zone (SEZ) and dentate gyrus (DG)
die at a speciﬁc maturation stage in the absence of functional HDAC2. In vitro cul-
tures of neural stem cells from the adult HDAC2 deﬁcient SEZ also showed defects
in neuronal maturation while proliferation and the self-renewal capacity remained
unaltered. Interestingly, these neuronal maturation deﬁcits were not observed in
neural stem cell cultures isolated from the embryonic brain. These defects in neu-
ronal maturation from isolated neural stem cells therefore imply a cell-autonomous
function of HDAC2 and transplantation experiments of WT cells into mutant mice
further rule out the possibility that additional niche-dependent defects in HDAC2
deﬁcient mice might contribute to the phenotype. Thus, the absence of functional
HDAC2 reveals a rather speciﬁc function in adult neurogenesis and the maturation
of adult generated neurons. As transcription is regulated by histone modiﬁcations
in cooperation with the chromatin remodeling machinery, I also examined the role
of the brahma-related gene (Brg) 1 that acts as the ATPase subunit in the chro-
matin remodeling complex SWI/SNF. Brg1 and HDAC2 were coexpressed in most
brain cells, prompting the question whether deletion of Brg1 would result in a sim-
ilar phenotype than loss of HDAC2-function. To examine the role of Brg1 in adult
neurogenesis, I took advantage of a mouse line expressing the inducible form of
Cre in adult neural stem cells. Brg1 deletion in adult neural stem cells resulted in
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defects in neuronal fate acquisition and apparent fate conversion into the oligoden-
drocyte lineage. Furthermore, the lack of Brg1 reduces self-renewing adult neural
stem cells in vitro. These data therefore identify for the ﬁrst time a speciﬁc role of
two epigenetic factors in the central nervous system, HDAC2 and Brg1, revealing
their distinct functions in adult neurogenesis. HDAC2 is involved in the regulation
of neuronal maturation in the adult, but not the embryonic brain. Conversely, Brg1
regulates neural stem cell maintenance and neuronal cell fate in both embryonic and
adult neurogenesis. Thus, the functions of HDAC2 and Brg1 reveal the speciﬁcity
by which epigenetic regulators aﬀect key aspects of adult neurogenesis with the later
regulating fate and the former regulating neuronal maturation.
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2 Introduction
Neural stem cells have the ability to generate distinct cell types for the formation
of the nervous system and cell replacement during development and throughout
adulthood. Neural development and plasticity are determined by both extrinsic and
intrinsic factors that interface to regulate gene programs controlling neural cell fate
and function. The molecular mechanisms of complex processes such as prolifera-
tion and diﬀerentiation are not yet well understood. Recent reports have shown
that chromatin remodeling and epigenetic gene regulation play an important role
in diverse areas such as neural cell fate speciﬁcation and synaptic development and
function. Epigenetic mechanisms include cell-type speciﬁc transcriptional regula-
tion, histone modiﬁcations and chromatin remodeling enzymes. In this study two
epigenetic regulators and their role in neural stem cells will be introduced. First, the
histone deacetylase (HDAC) 2, a small enzyme capable of deacetylating histones as
well as proteins known to act as transcriptional repressors. Second, brahma-related
gene (Brg) 1, an ATPase catalytically active in a chromatin remodeling complex
SWI/SNF (mating type switching/sucrose nonfermenting) and known to act pre-
dominantly as a transcriptional activator. The expression analysis from embryonic
to adult stages for both proteins will be presented followed by a functional study of
transgenic mouse lines deﬁcient for HDAC2 and Brg1 to examine their role in adult
neural stem cells and their diﬀerentiation toward the neuronal lineage generating
constantly new neurons in the adult mouse brain.
2.1 Neural stem cells
The mammalian central nervous system (CNS) is a complex structure that ﬁrst
arises by folding in the neural plate to become the neural tube, which comprises
neuroepithelial stem cells. These cells were historically believed to produce two
separate pools of committed neuronal and glial progenitors [His, 1889], which then
generate neurons and glia, respectively, in the brain. Other studies support a dif-
ferent model in which neuroepithelial cells either produce or transform into radial
glia that divide asymmetrically to give rise to neurons and glia [Schaper, 1897]. Re-
cent data have shown that neuroepithelial cells divide symmetrically and thereby
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generate two stem cells [Gotz and Huttner, 2005] followed by many asymmetric cell
divisions generating a more restricted progenitor and a neuron. In the primitive
neural tube neuroepithelial cells contact both the ventricular and pial surface as de-
picted in Figure 2.1. They then form the neuroepithelium and undergo interkinetic
nuclear migration where the distinct area of one single layer of neuroepithelial cells
forming the neuroepithelium appears as layered. As development progresses, the
wall of the neural tube thickens and neuroepithelial cells transform into elongated
radial glia by maintaining their ventricular and pial contacts.
Figure 2.1: Schematic illustration of neural stem cell development
Left panel: Neuroepithelial stem cells (purple) extend from the ventricle to the pia. Middle panel:
Radial glia (purple) also contact the pia and ventricular surface. These cells are known to divide
either symmetrically or asymmetrically (arrows) to produce neurons that migrate into the cortex
along the ﬁber of the radial glia. Radial glia produce neurons directly or indirectly via
intermediate precursors (green). Right panel: Radial glia transform into cortical astrocytes later
in development. Picture taken from Alvarez-Buylla et al., 2001
Radial glia are more fate-restricted than neuroepithelial cells [Williams and Price,
1995; Malatesta et al., 2003] but they maintain epithelial properties such as the
interkinetic nuclear migration [Frederiksen and McKay, 1988; Misson et al., 1988],
expression of the intermediate ﬁlament nestin [Lendahl et al., 1990; Hendry et al.,
1988] and their contact to the pial and ventricular surface. Most radial glia disap-
pear within several days to some weeks after birth. In many non-mammalian species,
however, radial glia persist into adult life [Garcia-Verdugo et al., 2002; Grandel et al.,
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2006]. In birds radial glia have been studied extensively, where they proved to con-
tinue to divide lifelong [Alvarez-Buylla et al., 1990], leading to the proposition that
these radial glia are neuronal precursors. With the appearance of radial glial cell
properties such as the expression of characteristic astrocyte molecules during neuro-
genesis [Kriegstein and Gotz, 2003; Campbell and Gotz, 2002; Gotz, 2003] radial glia
become more fate-restricted than neuroepithelial cells. This has been supported by
several studies using recombination-mediated fate mapping [Malatesta et al., 2003;
Anthony et al., 2004] and retrovirus-mediated cell lineage experiments [McCarthy
et al., 2000]. In vitro studies were also in line with the in vivo observations. By
dissecting embryonic cortical tissue at the peak of cortical neurogenesis (E14-E16)
and culturing those cells, radial glia generate primarily neuronal colonies, whereas
later, when embryonic neurogenesis ends (E18), very few neuronal clones were ob-
served [Malatesta et al., 2000]. In the adult CNS only two regions exist where
neurogenesis occurs, the subgranular layer (SGL) in the dentate gyrus (DG) [Ka-
plan and Bell, 1984; Cameron et al., 1993; Gage et al., 1998; Seri et al., 2001, 2004]
and the subependymal zone (SEZ) [Doetsch et al., 1999]. Cells that behave in vitro
like neural stem cells were isolated from these two regions [Morshead et al., 1994;
Gage et al., 1995; Palmer et al., 1997]. The identiﬁed neural stem cells in these re-
gions possess characteristics previously attributed to fully diﬀerentiated astrocytes
[Doetsch et al., 1999; Alvarez-Buylla et al., 2002]. These astrocytes have lost their
connection to the pial surface and only contact the ventricular lumen by extending
a thin cellular process between ependymal cells at the SEZ [Doetsch et al., 1999].
SEZ astrocytes also show several characteristics similar to neuroepithelial stem cells
in the embryonic neural tube such as the expression of nestin [Filippov et al., 2003],
an intermediate ﬁlament protein found in neuroepithelial stem cells [Lendahl et al.,
1990]. In particular, radial glia in the adult DG have also been shown to divide
in the SGL and hilus and to generate small dark cells corresponding to a transient
cell type in the generation of new granular neurons, the so-called Type D cells [Seri
et al., 2001].
2.1.1 Classiﬁcation of adult neural stem cells
During development the potential of a neural stem cell gets more and more restricted.
Neuroepithelial stem cells are multipotent and can generate undiﬀerentiated precur-
sors, astrocytes, oligodendrocytes and neurons [McCarthy et al., 2001]. During
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brain development, neural stem cells do not generate these 3 diﬀerent postmitotic
cell types directly but rather indirectly via intermediate precursors that are more
restricted in their potential generating only a single cell type. Adult neural stem
cells in the two neurogenic niches, SEZ and SGZ, are described as Type B stem cells
that show all characteristics of a stem cell: Multipotency, self-renewal capacity with
the theoretically unlimited ability to produce progeny indistinguishable from them-
selves, and a slow division. They can be identiﬁed via their position and morphology
expressing GFAP and nestin [Lendahl et al., 1990] but their identiﬁcation is mainly
based on morphological analysis by electron microscopy [Doetsch et al., 1999]. So
far, no marker that is exclusive to stemlike cells has been identiﬁed. Lineage tracing
studies in adult mice have demonstrated that newly born neurons, astrocytes and
sometimes oligodendrocytes can be derived from heterogeneous populations of cells
expressing a given molecular marker such as nestin, Sox2 and glutamate-aspartate
transporter (GLAST) (reviewed by Breunig et al., 2007).
Figure 2.2: Classiﬁcation of neural stem cells in the adult brain
A neural stem cell gives rise to a pool of transit-amplifying progenitors that generate
lineage-restricted progenitor cells which then give rise to the three distinct cell types existing in
the brain, oligodendrocytes (blue), astrocytes (yellow) and neurons (red). Picture taken from Lie,
C. et al., 2004
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Speciﬁc targeting of a distinct cell population is achieved by an inducible trans-
genic mouse line, where a gene of interest will be deleted only in cells expressing
GLAST [Mori et al., 2006] after tamoxifen induction. As GLAST is expressed in
SEZ astrocytes also neural stem cells will be included in the target cell population.
In this study this technique will be described in more detail and the speciﬁcity
of using it with regard to examining functional aspects of adult neurogenesis will
be shown. The progeny of the type B stem cells are the intermediate precursors
that are fast dividing and are therefore called transit-amplifying precursors or type
C cells [Capela and Temple, 2002; Doetsch et al., 1999, 2002]. They can be iden-
tiﬁed by bromodeoxyuridine (BrdU) and 3H-thymidine (3HT) labeling, DNA-base
analogues that incorporate during mitosis into the DNA. Type C cells give rise to
lineage-restricted progenitor cells (Figure 2.2), the so-called Type A cells, either
neuroblasts or glioblasts, subdivided in astroglio- or oligodendroglioblasts. Type A
cells then generate postmitotitc neurons, astrocytes or oligodendrocytes [Lie et al.,
2004]. For the neuronal lineage, neuroblasts of the SEZ already express neuronal
traits (PSANCAM or doublecortin) and migrate via the rostral migratory stream
(RMS) toward the olfactory bulb (OB). After reaching the OB, the newly born neu-
rons detach from their chain formation, migrate radially, and progress into one of
the cell layers where they undergo terminal diﬀerentiation to then become integrated
into the existing network (Figure 2.3).
2.1.2 Regulation and maintenance of the neural stem cell fate
The expression of several key transcription factors such as the basic-helix-loop-helix
(bHLH) becomes important for the transition from neuroepithelial cells to radial glia
cells and the maintenance of this cell fate. For the latter, Hes genes were shown to
play a crucial role [Kageyama et al., 2005]. Radial glia are still present in the neona-
tal mouse brain [Merkle et al., 2004; Noctor et al., 2002] and adult neural stem cells
arise from these radial glia cells. The maintenance of stem cells in the adult mouse
brain is based on the homeostasis between self-renewal and diﬀerentiation of these
cells toward certain cell types. This balance is established by several mechanisms
such as the Notch signaling pathway [Ninkovic and Gotz, 2007]. Proliferating cells
and putative neural progenitors in both the SGZ and SEZ are closely associated with
the vasculature, indicating that factors released from the blood vessels may have di-
rect impact on adult neural progenitors [Palmer et al., 2000; Alvarez-Buylla and Lim,
10
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Figure 2.3: Neurogenesis in the SVZ
Progenitor cells (A-C) lining the lateral ventricle adjacent to the ependymal cells (E). Type B
stem cells have contact to the ventricular lumen over a thin cellular process. Newborn neurons
reach the OB through chain migrations along the RMS and integrate as granule neurons in the
granular cell layer (GCL) or as periglomerular neurons in the glomerular layer (GL) after
morphological and physiological development. EPL= external plexiform layer, GCL= granule cell
layer, GL= glomerular layer, Mi= mitral cell layer, OB= olfactory bulb, RMS= rostral migratory
stream, SVZ= subventricular zone. Picture taken from Zhao et al., 2008
2004]. The infusion of the vascular endothelial growth factor (VEGF) promotes cell
proliferation in both neurogenic areas, which can be blocked by a dominant-negative
VEGF receptor 2 [Cao et al., 2004]. Not only the contact between neural stem cells
and blood vessels but also that between stem cells and ependymal cells proved cru-
cial for the maintenance of the stem cell fate. Ependymal cells secrete the pigment
epithelium-derived factor (PEDF) which could be shown to promote a self-renewing
stem cell fate [Ramirez-Castillejo et al., 2006]. Furthermore, growth factors, in
particular the epidermal growth factor (EGF) and the ﬁbroblast growth factor 2
(FGF2), are potent factors for the maintenance of adult neural stem cells [Doetsch
et al., 2002; Jin et al., 2003]. Adult neural progenitors are also regulated by a vari-
ety of other extrinsic factors that act as positive key regulators, e.g. through sonic
hedgehog signaling or the neurotrophin brain-derived neurotrophic factor (BDNF)
[Zhao et al., 2008; Henry et al., 2007]. The targets of many of the extrinsic factors
are yet unknown. One might assume that these extracellular regulators could cause
changes in other cell types within the neurogenic niches and exert an indirect eﬀect
on adult neural stem cells. Besides intracellular signaling pathways downstream of
the growth factors as well as neurotrophins and morphogens, a variety of other in-
tracellular mechanisms have been implicated in the regulation of adult neurogenesis.
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The transcription factor Bmi-1, for example, is required for the maintenance of adult
neural stem cells [Molofsky et al., 2005]. Pax6 promotes neuronal diﬀerentiation of
SVZ progenitors, whereas Olig2 has an opposite eﬀect [Hack et al., 2005] although
these factors act similarly during embryogenesis generating diﬀerent types of neurons
[Gotz et al., 1998; Ono et al., 2008]. Recently it has become more and more clear
that epigenetic regulation also plays an important role in adult neurogenesis. It was
shown, for example, that neural stem cells lacking the methyl-CpG binding protein
1 (MBD1), which is important for the methylation of the DNA, exhibit increased ge-
nomic instability and a reduced neuronal diﬀerentiation [Zhao et al., 2003]. Histone
deacetylases were shown, together with TLX, an orphan nuclear receptor essential
for neural stem cell proliferation and self-renewal, to be important for neuronal dif-
ferentiation [Hsieh and Gage, 2004; Sun et al., 2007]. All these studies support the
notion that numerous extrinsic factors and intracellular pathways are involved in
the regulation of adult neurogenesis.
2.2 Epigenetic factors involved in adult
neurogenesis
Little is known about the functional role of speciﬁc epigenetic factors in molecular
processes such as the proliferation or diﬀerentiation of neural stem cells to generate
constantly new cells in the adult brain, respectively. Epigenetic mechanisms refer
to eﬀects that promote cellular speciﬁcation by imposing a speciﬁc and heritable
pattern of gene expression on the progeny of diﬀerentiating cells without altering
the DNA sequence. Major epigenetic mechanisms include posttranslational histone
modiﬁcation such as acetylation, methylation and phosphorylation. The ability of
transcription factors to access nucleosome-bound DNA is dependent upon DNA pack-
aging [Wade, 2001] (Figure 2.4). Modiﬁcations of histones and/or DNA can alter
the strength of their packaging and thus can modulate transcriptional activity [Strahl
and Allis, 2000]. In contrast to methylation and phosphorylation, the acetylation of
the core histones is probably the best understood type of modiﬁcation. Interestingly,
speciﬁcally this chromatin modiﬁcation has also shown to play important roles in
neurogenesis per se. Most of the studies designed in the ﬁeld of neurogenesis were
based on treatment with HDAC inhibitors, but the results were very controversial
[Hsieh et al., 2004; Salminen et al., 1998]. In general, the maintenance of histone
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acetylation has been shown to positively aﬀect neuronal diﬀerentiation [Hsieh et al.,
2004], whereas HDAC activity and hence deacetylation was shown to play a role in
the progression toward the oligodendrocytic lineage [Marin-Husstege et al., 2002].
However, besides the use of general pharmacological HDAC inhibitors, the role of
individual HDACs has not been examined in the central nervous system (CNS). Fur-
thermore, the application of HDAC inhibitors in the ﬁeld of cancer treatment makes
it much more attractive to study their role as opposed to that of their counterplayers,
the histone acetyltransferases (HATs). Therefore, the characterization and function
of single HDACs selectively in a complex tissue such as the brain is of great interest,
given that a single HDACs contribute to the regulation of neuronal diﬀerentiation
and survival in a time-dependent manner, as it will be shown here.
Figure 2.4: Histone modiﬁcations
Schematic illustration of changes in histone modiﬁcations results in either transcriptional
repression or activation. Histone deacetylation and methylation are involved in the formation of
condensed chromatin leading to an inactive chromatin state. Histone acetylation and
demethylation allow relaxation of chromatin resulting in an active state. Ac= acetylation, K4=
lysine 4, K9= lysine 9, HAT= histone acetyltransferases, HDAC= histone deacetylases, HDMT=
histone demethylase, HMT= histone methyltransferase, TAF= TBP-associated factor, TBP=
TATA-binding protein. Picture taken from Hsieh and Gage, 2005
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2.2.1 Histone deacetylases (HDACs)
In order to understand the potent eﬀects of broad-range HDAC inhibitors by phar-
macological tools and the fact that the use of HDAC inhibitors brought contradictory
ﬁndings in diﬀerent contexts regarding neurogenesis, the analysis should be concen-
trated on single HDACs. The treatment of p25 overexpressing mice, for example,
showed severe neuronal degeneration with a class I histone deacetylase inhibitor re-
sulting in remarkable improvements in synaptic connections and behavior [Fischer
et al., 2007]. However, several reports suggesting that HDAC inhibitors actually
promote neuronal cell death stand in direct contrast to this [Salminen et al., 1998;
Morrison et al., 2007]. Before examining single HDACs, the classical family of
HDACs and their original requirements will be described in the following.
2.2.1.1 Classiﬁcation of HDACs
The classical HDAC families are composed of two phylogenetic classes, namely class
I and class II (Figure 2.5). Class I HDACs (HDAC1, 2, 3 and 8) are most closely
related to the yeast (Saccharomyces cerevisiae) homologue RPD3. Class II HDACs
are HDAC4, 5, 6, 7, 9 and 10. They share similarities with the yeast deacetylase,
HDA1. The recently found HDAC11 [Gao et al., 2002] could not be ascribed to
any of the existing classes as it does not show suﬃcient basic similarity with any
of the members of class I and II. Therefore, it has been proposed that HDAC11
may belong to a separate subclass [Gregoretti et al., 2004]. Another class of NAD+
dependent HDACs is the sirtuin (Sir) family. These are homologues of the yeast
Sir2 gene, which has been implicated in chromatin silencing, cellular metabolism
and aging [Guarente, 2000].
2.2.1.2 Function and localization of HDACs
As the general function of HDACs is to deacetylate histones, they have to be lo-
calized in the nucleus. This nuclear localization of HDACs occur via a nuclear
localization signal (NLS) or via transport and stabilization together with other pro-
teins/complexes. Class I HDACs are found almost exclusively in the nucleus, with
the exception of HDAC3, which can also be localized in the cytoplasm, suggesting
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Figure 2.5: Evolutionary relationship between the HDACs
Class I HDACs contain HDAC 1,2,3 and 8, while HDAC 4,5,6,7,9 and 10 are categorized under
class II. HDAC11 does not show enough identity with class I or class II to be placed in either
class. Picture taken from de Ruijter, A. J. et al., 2003
that it also contains a nuclear export signal (NES) [de Ruijter et al., 2003]. Class
II HDACs are able to shuttle in and out of the nucleus in response to certain cellu-
lar signals. The mechanism of action of HDAC enzymes as mentioned above is to
remove acetyl groups from the N-terminal histone ends, thereby leading to a tighter
wrapping of the DNA. This compaction reduces accessibility for transcription fac-
tors, resulting ﬁnally in a transcriptional repression. This function is mediated via
the catalytic domain of each HDAC consisting of ≈ 390 amino acids. Crucial for the
functional activity of the HDAC enzyme are two adjacent histidine residues, two
aspartic residues and one tyrosine residue [Buggy et al., 2000; Finnin et al., 1999].
An essential component is a Zn2+ ion in the catalytic domain of the HDACs, which
is the target for most HDAC inhibitors displacing it [Finnin et al., 1999]. Class I
HDACs have been shown to be part of multicomponent protein complexes, which
are recruited by DNA binding proteins. Three complexes containing HDAC1 and/or
HDAC2 have been characterized so far: the Sin3 , NuRD (nucleosomal remodeling
and deacetylation) and CoREST (Co-RE1 silencing transcription factor) complexes
[Ayer, 1999; Zhang et al., 1999]. Indeed, HDAC1 and HDAC2 only display activity
within a complex of proteins in vivo.
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2.2.1.3 HDAC2
The above described discrepancy of eﬀects observed by HDAC inhibitor treatment
may also be based on diﬀerences in the expression proﬁle of individual HDACs. In
this regard HDAC expression was studied in the brain. An interesting expression
pattern was observed for HDAC2 present in adult, but not embryonic neuronal
precursors, besides its strong expression in postmitotic neurons in all diﬀerent stages
of brain development. HDAC1 showed a complementary expression pattern as it
could be detected in embryonic neuronal precursors and predominantly in glial cells
at later stages in brain development.
The structure of HDAC2 is very similar to that of HDAC1, in fact, they show 82%
sequence homology. As mentioned above, HDAC1 and HDAC2 are often found
together in complexes [de Ruijter et al., 2003]. Several studies dealing with the
function of HDAC1 in the neuronal development have been conducted. Based on
these experiments it has been suggested that HDAC1 induces diﬀerentiation of reti-
nal progenitors as well as motoneurons in the zebraﬁsh as a result of the repression
of Wnt and Notch signaling [Yamaguchi et al., 2005; Cunliﬀe, 2004]. Concerning
HDAC2 less is known about its role in the CNS. However, it has been demonstrated
that HDAC2 is involved in REST (RE1 silencing transcription factor) -mediated
repression of neuronal cell fate in non-neuronal cells [Ballas et al., 2001]. The tran-
scriptional repressor REST is a key regulator of many neuronal genes.
In this work an expressional and functional analysis of HDAC2 will be demonstrated
in the developing and adult brain. The functional study was mainly performed on a
HDAC2 gene trap mouse line in which the catalytic domain of HDAC2 is disrupted
and, therefore, its function disappears. This construct will be explained in more
detail further on. Studies that have been conducted on these HDAC2 mutant mice
elucidated a role of HDAC2 in cardiac development [Trivedi et al., 2007]. This
work revealed that HDAC2 regulates cardiac hypertrophy by inhibiting the (PI3K)-
Akt pathway, which is important for growth control and implicated in hypertrophic
signaling [Dorn and Force, 2005]. The group of Montgomery et al. (2007) generated
a full HDAC2 knock-out (KO) that show a 100% postnatal lethality within the
ﬁrst 24 hours after birth, while HDAC2−/− oﬀspring were indistinguishable from
wildtype (WT) littermates [Montgomery et al., 2007]. This suggests a potent role
for HDAC2 in the early postnatal development and, moreover, a possible role of
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HDAC2 in adult neurogenesis as HDAC2 immunoreactivity was found in adult but
not embryonic neuronal precursors will be shown in this study.
2.2.2 Chromatin remodeling complexes
Chromatin modiﬁcations are not only important to promote cellular speciﬁcations
but also insofar as the remodeling of the chromatin structure can make the DNA
more accessible for the transcriptional machinery to enter regulatory sequences in
the promoter region of certain genes. DNA together with histone proteins H2A,
H2B, H3, and H4 form nucleosomes, comprising the basic structure of chromatin.
Chromatin not only functions as DNA compaction but also contributes to the regula-
tion of nuclear processes such as transcription. ATP-powered molecular machineries
known as chromatin remodeling factors serve to modify the chromatin structure
by changing histone-DNA contacts [Morettini et al., 2008]. These ATP-dependent
chromatin remodeling factors are typically organized in multiprotein complexes, e.g.
SWI/SNF complex, NuRD or CHRAC (Chromatin accessibility complex) complex
[Vignali et al., 2000]. The most extensively studied proteins involved in chromatin
remodeling are Brm (brahma) and Brg (brahma-related gene) 1. These proteins func-
tion as ATP-subunits of complexes, which are highly related to the SWI/SNF family
of ATPases that are structurally related to the Saccharomyces cerevisiae Swi2/Snf2
protein [Eisen et al., 1995]. Brm or Brg1 either remove, reposition or assemble nu-
cleosomes, resulting in an altered structure or positioning of nucleosomes. Thus,
SWI/SNF complexes appear to function at every step in the process of transcrip-
tional activation but can also facilitate the repression of speciﬁc genes [Sudarsanam
and Winston, 2000].
2.2.2.1 Brg1
The ATPase subunits of SWI/SNF complexes Brg1 or its analogue Brm contain a
single bromodomain (a protein motif associated with the binding of certain acety-
lated proteins) and both act as the ATPase in SWI/SNF complexes. It was sug-
gested therefore that Brm and Brg1 are functionally redundant, as mice lacking
Brm are viable and fertile [Muchardt et al., 1998]. However, in vitro studies have
suggested that they regulate diﬀerent sets of genes [Kadam and Emerson, 2003].
17
2 Introduction
Moreover, Brg1-null mice die before implantation [Bultman et al., 2000], showing
that Brg1 exerts speciﬁc functions early in development. Studies in Xenopus lae-
vis have indicated that Brg1 is required for neuronal diﬀerentiation by mediating
the transcriptional activities of the proneural bHLH genes Neurogenin (Ngn) and
NeuroD [Seo et al., 2005b]. Moreover it was also shown in zebraﬁsh that Brg1 is
involved in neural crest induction, which is critical for the development of neurons,
glia and pigment cells [Eroglu et al., 2006]. Recently it was shown by Lessard et al.
(2007) that a switch of subunits occurs in ATP-chromatin remodeling complexes,
such as SWI/SNF, which is essential for neural development. They could also show
that Brg1 is essential for the self-renewal and maintenance of neural progenitor cells
as well as for neuronal diﬀerentiation processes later on. As Brg1 transcripts are
found to be expressed in neural stem cells in the VZ at E15 and later also at the
SEZ, it may play a role in the development of the nervous system. This question
was addressed by Matsumoto et al. (2006) where they used a Brg1 transgenic mouse
containing loxP sites [Sumi-Ichinose et al., 1997] and crossed it with mice express-
ing the cre recombinase (Cre) under the control of the nestin promoter [Kellendonk
et al., 1999]. By studying these mice lacking the Brg1 protein at E13-E14 they were
able to show that Brg1 is suﬃcient for neural stem cell maintenance and also seems
to be more important in astrocyte diﬀerentiation than in neuronal diﬀerentiation
as reported by other research groups. These contradictory results as well as the
fact that chromatin remodeling complexes, such as SWI/SNF interact with tran-
scriptional repressor complexes, in which HDAC2 is present, imply that they recruit
each other in an orchestratic manner. On the premise that the roles of HDAC2
and Brg1 in the adult neurogenic regions have, as yet, not been extensively studied
it was the aim of my PhD research to shed some light onto the speciﬁc functions
of the aforementioned two epigenetic regulatory elements. The expression data of
HDAC2 and Brg1 turned up results that indicate a strong similarity of the protein
expression patterns and a colocalization that is highly speciﬁc in both the embryonic
forebrain as well as the adult brain. The resulting implications set the foundation
for the further study of HDAC2 deﬁcient mice as well as Brg1 ﬂoxed mice in order
to identify the roles of HDAC2 and Brg1 in the processes of adult neurogenesis.
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3 Abbreviations
AB Antibody
aSEZ adult subependymal zone
APS Ammonium persulfate
bp Base pairs
bFGF Basic ﬁbroblast growth factor
BLBP Brain lipid binding protein
BrdU 5 -bromo-2 'deoxy-uridine
Brm Brahma
Brg Brahma-related gene
Calr Calretinin
CB Cerebellum
CHRAC Chromatin accessibility complex
cDNA Complementary DNA
CNS Central nervous system
CP Cortical plate
CPM Counts per minute
Casp3 Activated caspase 3
Cre causes recombination
Ctx Cortex
DAPI 4 '-6 -Diamidino-2 -phenylindole
DCX Doublecortin
dd1 Diﬀerentiated for 1 day
dd3 Diﬀerentiated for 3 days
DIV Days in vitro
DNA Desoxyribonucleic acid
DNAse Desoxyribonuclease
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3 Abbreviations
dNTP Deoxynucleotide triphosphate
E Embryonic day
EGF Epidermal growth factor
eGFP Enhanced green ﬂuorescent protein
EPL External plexiform layer
EtOH Ethanol
FACS Fluorescent activated cell sorting
FCS Fetal calf serum
FGF Fibroblast growth factor
GABA γ-aminobutyric acid
GAPDH Glyceraldehyde-3 -phosphate dehydrogenase
GCL Granule cell layer
GE Ganglionic eminence
GFAP Glial ﬁbrillary acid protein
GFP Green ﬂuorescent protein
GL Glomerular layer
GM Grey matter
Gsk3β Glycogen synthase kinase 3β
HDRP HDAC-related protein
HC Hippocampus
HDAC Histone deacetylase
HDAC2 def Histone deacetylase 2 deﬁcient
hGFAP human Glial ﬁbrillary acidic protein
HRP Horse radish peroxidase
kDa Kilo Dalton
KO Knock out
Ig Immunoglobulin
Inpp5f Inositol polyphosphate-5-phosphatase f
IP Intra peritoneal
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3 Abbreviations
IZ Intermediate zone
IRES Internal ribosomal entry side
MEF Mouse embryonic ﬁbroblasts
Mi Mitral cell layer
M-phase Mitosis phase of the cell cycle
mRNA messenger ribonucleic acid
n.d. not deﬁned
Ngn Neurogenin
NS neurospheres
OB Olfactory bulb
OPC Oligodendrocyte progenitor cell
P Postnatal day
PBS Phosphate buﬀered saline
PCR Polymerase chain reaction
PDL Poly-D-lysine
RMS Rostral migratory stream
RNA Ribonucleic acid
rpm Rounds per minute
RT Room temperature
RT-PCR Realtime- polymerase chain reaction
SCWM Subcortical white matter
SEM Standard error of the mean
SEZ Subependymal zone
STDV Standard deviation
SWI/SNF mating type switching/sucrose nonfermenting
TAP Transit-amplifying precursor
TSA Trichostatin A
ud undiﬀerentiated
VPA Valproic acid
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3 Abbreviations
VZ Ventricular zone
WM White matter
WT Wildtype
Zli Zona limithans intrathalamica
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4 Materials and Methods
4.1 Animals
4.1.1 Mouse lines
The inbred mouse strain C57BL/6J was used as wildtype (WT). The day of vaginal
plug was considered as embryonic day 0 (E0), the day of birth as postnatal day 0
(P0). Here we used an HDAC2 deﬁcient mouse line. The Hdac2 gene-trap clone
was obtained from the German Genetrap Consortium (ES clone no. W035F03).
The genomic locus of HDAC2 was interrupted by insertion of the pT1-βgeo vector,
which integrated into intron 8. Chimeric mice were produced by blastocyst injec-
tion according to standard protocols [Zimmermann et al., 2007] on a C57BL/6J
background. Additionally, a Brg1 ﬂoxed/ﬂoxed transgenic mouse line was gener-
ously provided by Pierre Chambon, Universitè Louis Pasteur, Strassbourg, France
was used [Sumi-Ichinose et al., 1997]. For the deletion of Brg1 in the adult brain
the inducible mouse line GLASTCreERT2 was used [Mori et al., 2006] and crossed
with Brg1 ﬂoxed/ﬂoxed mice. To follow the recombined cells over time a reporter
mouse line Z/EG was crossed in [Novak et al., 2000].
4.1.2 Genotyping of mutant and transgenic mice
Genotyping was performed by PCR on genomic DNA extracted from mouse tails.
DNA was obtained following the protocol by [Laird et al., 1991]: Tail biopsies of less
than 5mm length were transferred in 0,5ml lysis buﬀer and incubated rotating for
several hours or overnight at 55 ◦C in a modiﬁed hybridization oven. Following com-
plete lysis, hairs and tissue residues were removed by centrifugation in an Eppendorf
centrifuge at maximum speed (13,1 × 103 rpm ≈ 16.000 g) for 10 -20minutes. The
supernatant was transferred into 0,5ml isopropanol and mixed well. After precipi-
tation DNA pellets were transferred in 200µl TE-buﬀer. To solve the DNA, tubes
were again rotated at 55 ◦C for several hours.
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4.1.2.1 HDAC2 deﬁcient genotyping protocol
PCR was carried out using about 80 ng of genomic DNA (≈ 2µl) and 0,5µM of
the HDAC2 primers (Table 4.1) in a 20µl reaction containing 0,25mM dNTPs,
1,5U of Taq-DNA-polymerase, 2µl 10× PCR-buﬀer and 0,5µl Q-solution. Cycling
conditions were: preheat to 94 ◦C, 2 minutes at 94 ◦C, followed by 39 cycles at 94 ◦C
for 30 seconds, at 58 ◦C for 1 minute and at 72 ◦C for 2 minutes. Finally, amplicons
were extended at 72 ◦C for 7 minutes. 15µl of each PCR-product was analyzed on
a 2% agarose-TAE-gel. The amplicon obtained from normal WT DNA is 514 bp
long and the amplicon obtained from HDAC2 deﬁcient-DNA is 290 bp long (Figure
4.1).
Figure 4.1: Genotyping HDAC2
4.1.2.2 Brg1 ﬂoxed/ﬂoxed genotyping protocol
The PCR protocol for Brg1 ﬂoxed/ﬂoxed mice was adapted from [Sumi-Ichinose
et al., 1997]. PCR was designed by using about 80 ng of genomic DNA (≈ 2µl)
and 1µM of the primers TG57, TH185 and TB82 (Table 4.1) in a 20µl reaction
containing 0,25mM dNTPs, 1,5U of Taq-DNA-polymerase, 2µl 10× PCR-buﬀer
and 0,5µl Q-solution. Cycling conditions were: 5 minutes at 94 ◦C, followed by 35
cycles at 94 ◦C for 30 seconds, at 55 ◦C for 30 seconds and at 72 ◦C for another 30
seconds. Finally, amplicons were extended at 72 ◦C for 7 minutes. 15µl of each
PCR product was analyzed on a 2% agarose-TAE-gel. The various Brg1 alleles
were identiﬁed with the recommended primers TG57 and TH185 for the WT (+)
allel (241 bp), the L2-allel containing the loxP-sites (387 bp) (Figure 4.2).
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Figure 4.2: Genotyping Brg1
4.1.2.3 GLASTCreERT2 genotyping protocol
For detection of GLASTCreERT2 PCR was designed by using about 80 ng of ge-
nomic DNA (≈ 2µl) and 1µM of the primers Glast F8, Glast R3 and CER1 (Table
4.1) in a 30µl reaction containing 0,25mM dNTPs, 1,5U of Taq-DNA-polymerase,
3µl 10× PCR-buﬀer and additionally 3µl MgCl and 6µl Q-solution. Cycling con-
ditions were: 5 minutes at 94 ◦C, followed by 35 cycles at 94 ◦C for 30 seconds, at
55 ◦C for 30 seconds and at 72 ◦C for another 30 seconds. Finally, amplicons were
extended at 72 ◦C for 7 minutes. 15µl of each PCR product was analyzed on a
2% agarose-TAE-gel. The GLAST locus before recombination can be indentiﬁed
with the recommended primers GLAST F8 and R3 (700 bp) and the insertion of
the CreERT2 was detected with the primers GLAST F8 and CER1 (400 bp) (Table
4.1).
4.1.2.4 Z/EG genotyping protocol
PCR was carried out to detect eGFP in the Z/EG reporter mice by using about
80 ng of genomic DNA (≈ 2µl) and 0,5µM of the primers (Table 4.1) in a 25µl
reaction containing 0,25mM dNTPs, 1,5U of Taq-DNA-polymerase, 2,5µl 10× PCR-
buﬀer and additionally 0,5µl MgCl. To optimize the PCR result 1µl Glycerol and
1µl DMSO was added. Cycling conditions were: 9minutes at 95 ◦C, followed by
37 cycles at 95 ◦C for 20 seconds, at 56 ◦C for 30 seconds and at 72 ◦C for another
30 seconds. Finally, amplicons were extended at 72 ◦C for 10minutes. 15µl of each
PCR product was analyzed on a 2% agarose-TAE-gel. The PCR product has a size
of 400 bp and can be detected if mice are positive for the reporter.
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Table 4.1: PCR primers
Primer name Primer sequence
HDAC2 WT For 5'-TgATggAgATgTACCAgCCTAgCgCgg-3'
HDAC2 WT Rev 5'-gCgCTgACATgCAACAAACTACTCATgg-3'
HDAC2 Mut For 5'-CTggAgAAggCCCgACCATCC-3'
HDAC2 Mut Rev 5'-CATgCgCTgCCACATgCAACTTTgC-3'
TG57 5'-gCCTTgTCTCAAACTgATAAg- 3'
TH185 5'-gTCATACTTATgTCATAgCC-3'
TB82 5'-gATCAgCTCATgCCCTAAgg-3'
GLAST F8 5'-gAggCACTTggCTAggCTCTgAggA-3'
GLAST R3 5'-gAggAgATCCTgACCgATCAgTTgg-3'
CER1 5'-ggTgTACggTCAgTAAATTggACAT-3'
eGFP F2 5'-CTACggCAAgCTgACCCTgAAgTTC-3'
eGFP R2 5'-gCCgATgggggTgTTCTgCTggTAg-3'
4.2 Tamoxifen administration
Tamoxifen (SIGMA, T-5648 ) was dissolved in pre-warmed corn oil (SIGMA, C-
8267 ) at 20mg/ml concentration on a shaker at 37 ◦C overnight. 10mg tamoxifen
is required to achieve recombination eﬃciently. Following a previously established
protocol [Mori et al., 2006], 1mg tamoxifen was injected intraperitoneally (i.p.)
twice a day for 5 consecutive days. Each time an amount of 50µl was injected. The
solution was kept in darkness at 4 ◦C for maximum 1month to avoid precipitation.
4.3 Histology
Pregnant animals were sacriﬁced with diethylether or increasing CO2 concentrations
followed by cervical dislocation. Embryos (day 14 ) were removed by hysterectomy
and transferred to Hanks buﬀered salt solution (HBSS) with 10mM HEPES. Em-
bryonic brains were removed and ﬁxed for 2 hours in 4% paraformaldehyde (PFA)
in 0,1M phosphate-buﬀered saline (PBS), pH 7,5 . Postnatal day 0-5 old pups were
decapitated, brains removed and ﬁxed for 5-7 hours in 4% PFA. Adult animals were
ﬁrst anaesthetized with 5% chloralhydrate and then transcardially perfused with
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4% (PFA) and postﬁxed at 4 ◦C in the same ﬁxative overnight.
4.3.1 Cryosections
After post ﬁxation brains were incubated for 24 hours in 30% sucrose in PBS, em-
bedded in Tissue Tek and stored at −20 ◦C. Cryosections were cut sagitally at 12µm
(embryonic brains) and 20µm thickness (adult brains), mounted on glass slides and
processed for immunohistochemistry.
4.4 Immunostaining
The following primary antibodies were used in a PBS solution containing 0,5%
Triton X100 and 10% serum as listed in Table 4.2. Usually the antibody mix
was applied and incubated overnight at 4 ◦C in a humid chamber, but for some
antibodies special pretreatments were necessary. For the immunodetection of BrdU,
pretreatment with 2N HCl for 60minutes was required to denature double-stranded
DNA. This was followed by two washes with 0,1M sodium-tetraborate-buﬀer (pH
8,5 ) for 15minutes at RT. After three further washes in PBS the staining with
the mouse anti-BrdU or rat anti-BrdU was performed. Intermediate ﬁlament and
microtubuli stainings like anti-nestin-, anti-β-IIItubulin- and anti-GFAP-staining
required a special pre-treatment for better visualization of intermediate ﬁlaments
and microtubuli before the application of the primary antibodies. Therefore, cells
were incubated in ethanol (EtOH) glacial acetic acid for 15minutes at -20 ◦C followed
by three washes in PBS for 10minutes at RT. After the washing steps in PBS cells
were incubated in blocking solution (PBS+Triton+serum) with speciﬁc subclasses of
secondary antibodies coupled to FITC- or TRIC at a dilution of 1 :100 , Cy2- or Cy3-
coupled antisera at 1 :200 or Alexa 488 or Alexa 594 at 1 :400 for 45minutes at RT
(Table 4.3). For triple-stainings, biotinylated secondary antibodies (dilution 1 :100 )
followed by incubation in Streptavidin-AMCA at a 1 :100 dilution was used. After
three further washes in PBS, glass coverslips with cells or sections were mounted in
Aqua Poly/Mount, a glycerol-based mounting medium. To rule out any unspeciﬁc
binding of the secondary antisera, control experiments were performed by either
leaving out the primary antibody or by using a primary antibody against an antigen
that is not present in the representative tissue or at the respective developmental
27
4 Materials and Methods
stage. Nuclei were visualized with DAPI (4 ', 6 ' diamino-2 -phenylindole, Sigma) by
incubating cells or sections for 10minutes with a concentration of 0,1 g/ml DAPI in
PBS.
4.4.1 Tyramide signal ampliﬁcation
Some stainings were enhanced using the tyramide ampliﬁcation kit (Perkin Elmer)
as described in the tyramide signal ampliﬁcation (TSA) handbook (Perkin Elmer).
Brieﬂy, the TSA system uses horse radish peroxidase coupled to a secondary anti-
body to catalyze the deposition of ﬂuorescein or rhodamine labeled tyramide am-
pliﬁcation reagent onto tissue sections (Table 4.4). This reaction results in the
deposition of numerous ﬂuorescein or rhodamine labels immediately adjacent to the
immobilized horse-radish-peroxidase (HRP). Since this technique results in a signiﬁ-
cant enhancement of the signal it was used for weak signals in immunostainings (on
adult sections for HDAC2, Olig2 or GFP).
4.5 Quantitative analysis
Quantiﬁcations (absolute cell numbers, marker coexpression) were performed by
means of Neurolucida connected to an Axiophot Zeiss microscope (40× objective).
The analysis was performed on sagittal sections at medio-lateral levels from 0,6 to
1mm relative to midline (3-7 sections per animal) in 3 pairs of WT and HDAC2
deﬁcient mice, if it is not indicated diﬀerently in the ﬁgure legends. For all data
sets, the arithmetic average x = 1
n
n∑
i=1
xi standard deviation s =
√√√√√ n∑
i=1
(xi − x)2
n−1
and standard error of the mean SEM = s√
n
was calculated. The error bars in the
diagrams showing the SEM. To test the data for signiﬁcance the student's T-test
was used. The p-value (p) of this test declares the probability of the conclusion
being correct. There is a 95% chance of the means to be signiﬁcant diﬀerent if
p = 0,05 , a 99% chance of the means to be highly signiﬁcant diﬀerent for p =
0,01 and a 99,9% chance of the means to be very highly signiﬁcant diﬀerent for
p = 0,001 . The calculations and constructions of the diagramms were carried out
with GraphPadPrism 4,0 .
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Table 4.2: Primary antibodies
Name Host-animal Marker for Supplier
anti-Blbp Rabbit 1 :1500 Radial glia Nataniel Heintz
Rockefeller Univ.
New York, USA
anti-BrdU Rat 1 :10 S-phase Abcam
Mouse IgG1 1 :300 Bio-Science
anti-Brg1 Mouse IgG1 1 :100 ATPase of a chromatin Santa Cruz
remodelling complex
anti-Calretinin Mouse IgG1 1 :100 Subset of mature neurons Chemicon
anti-act. Rabbit 1 :100 Apoptosis Promega
caspase 3
anti-CC1 Mouse IgG2b 1 :200 Immature oligodendrocytes Calbiochem
anti-DCX Guineapig 1 :2000 Immature neurons Chemicon
Rabbit 1 :200 (Neuroblasts) Chemicon
anti-GFAP Rabbit 1 :1000 Precursor subtypes, DAKO
Mouse IgG1 1 :200 Astrocytes Sigma
anti-GFP Rabbit 1 :500 Reporter gene Clontech
Mouse IgG1 1 :200 Chemicon
anti-HDAC1 Rabbit 1 :100 HDAC1 Cell Signaling
anti-HDAC2 Rabbit 1 :100 HDAC2 Santa Cruz
anti-NeuN Mouse IgG1 1 :50 Postmitotic neurons Chemicon
anti-Ki67 Rat 1 :50 Precursor cells Dianova
(Tec-3) Immundiagnostics
anti-NG2 Rabbit 1 :300 Oligodendrocyte precursors Chemicon
anti-Olig2 Rabbit 1 :300 Immature Oligodendrocytes Chemicon
anti-PH3 Rabbit 1 :100 M-phase marker Upstate Biotech
anti-Prox1 Rabbit 1 :200 Immature neurons DG Santa Cruz
anti-Sox2 Rabbit 1 :1000 precursor-and postmitotic cells Santa Cruz
anti-β-IIItubulin Mouse IgG2b 1 :100 Young neurons Sigma
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Table 4.3: Secondary antibodies
Name Supplier
anti-rabbit Ig FITC/TRITC/biotinylated Boehringer Ingelheim (Vector Laboratories)
anti-rabbit Ig Cy2/Cy3 Dianova
anti-rabbit Alexa 488 / 564 Invitrogen
anti-rat Ig Cy3 Dianova
anti-rat Ig Alexa 488 Invitrogen
anti-mouse IgG1 FITC/TRITC /biotinylated Southern Biotech
anti-mouse IgG2b FITC/TRITC/biotinylated Southern Biotech
Streptavidin AMCA Boehringer Ingelheim (Vector Laboratories)
Table 4.4: Tyramid Signal Ampliﬁcation Reagents
Name Content
TN Buﬀer (pH 7,5 ) 0,1M Tris-HCl (pH 7,5 and 0,15M NaCl
TNT Buﬀer 0,1M Tris-HCl (pH 7,5 , 0,15M NaCl,
0,005% Tween 20
Blocking Reagent Milk Powder
TNB Buﬀer 0,1M Tris-HCl (pH 7,5 , 0,15M NaCl and
Blocking Reagent
SA-HRP Horseradish Peroxidase-labelled reagent
Amplﬁcation Diluent
Ampliﬁcation reagent Fluorophore
4.6 Tissue culture
4.6.1 Cultures of primary dissociated neural precursors
Embryos at day E14were removed by caesarean section from time-pregnant mice
plug positive at day EO and anaesthetized by an overdose of diethylether (Sigma).
The meninges of the embryonic brains were removed, the telencephalic hemispheres
separated, the hippocampi and the olfactoric bulbi removed. The cortex (Ctx) and
the ganglionic eminence (GE) were dissected and collected in separate tubes under
sterile conditions in HBSS (Invitrogen) containing 10mMHEPES (Invitrogen) on ice.
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To show the forebrain morphology with the separation into Ctx and GE a picture
of an E16 embryonic forebrain was used, what is also valid for E14 (Figure 4.3).
The tissue was then allowed to settle and HBSS medium was removed and replaced
by trypsin-EDTA and incubated for 15minutes at 37 ◦C. The enzyme activity was
stopped by the addition of twice the volume of Dulbecco's modiﬁed eagle medium
(DMEM; Invitrogen) supplemented with 10% fetal calf serum (FCS; Sigma) and
penicillin/streptomycin (100 units/ml streptomycin; Invitrogen). The tissues were
mechanically dissociated with a ﬁre-polished Pasteur pipette coated with serum,
twice pelleted for 5minutes at 172 g and resuspended in FCS containing medium.
Cells were plated at 106 cells/ml in DMEM/FCS (0,5ml/well) in a 24 -well plate in
poly-D-lysine (PDL) coated coverslips and incubated at 37 ◦C and 5% CO2. Acutely
dissociated cells were ﬁxed after 2 hours with 4% PFA for 15minutes. Long-term
cell cultures were maintained in SATO-medium which was changed by half every
second day with gradually reducing serum concentration in the medium and then
ﬁxed after 5-7 days in vitro (DIV) with 4% PFA for 15minutes. After three washes
with PBS at room temperature (RT) cells were processed for immunocytochemistry.
Figure 4.3: Frontal section of an E16 brain [Schambra et al., 1991]. Rectangles
schematically mark regions that were used for the primary cell prepara-
tions.
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4.6.2 Neurosphere cultures
4.6.2.1 Embryonic neurosphere preparation
Embryonic neurosphere cultures where prepared from the Ctx or GE of WT and
HDAC2 deﬁcient littermates at E14 as described above with the exception that these
cells were dissociated mechanically without enzymatic digestion, then pelleted and
cultured after dissociation at clonal density (10 cells/µl) in a T75 ﬂask in 15ml serum-
free DMEM/F-12medium (Invitrogen) containing B-27 supplement (concentration
1 :50 ) at 37 ◦C and 5% CO2. Cells were passaged once a week by centrifugation
at 172 g for 10minutes, followed by mechanical redissociation and replating in 50%
neurosphere-conditioned medium and 50% fresh medium. Cells were ﬁxed for im-
munostaining 2 or 7 days after passage 3 or 4 . This ensures that contaminating
aggregates of cells that are not neurosphere-forming are removed from the culture.
4.6.2.2 Adult neurosphere preparation
Adult neurospheres were obtained from the lateral wall of the lateral ventricle of
adult (about 10 week old) mice. The SEZ was prepared after sagittal sectioning
of the brain. The SEZ was cut in pieces and these pieces were incubated in a
dissociation solution in HBSS with 2mM glucose at 37 ◦C for 30minutes and gently
triturated. The cells were then centrifuged at 200 g for 5minutes, resuspended in
0,9M sucrose in 0,5× HBSS, and centrifuged for 10minutes at 750 g. The cell pellet
was resuspended in 2ml of culture medium, placed on top of 10ml 4% BSA in HBSS
solution, and centrifuged at 200 g for 7minutes, followed by washing in DMEM/F12 .
The culture conditions were identical to those described above for neurospheres from
embryonic brains.
4.6.2.3 Adult neurosphere cultures
Dissociated cells were cultured at low density (10 cells/µl) to ensure the clonal ori-
gin of neurospheres [Morshead et al., 1994] in a 24well plate (Falcon, well size: ≈
2 cm2). Every second day EGF and FGF2 were added to the cultures. Primary neu-
rospheres were quantiﬁed after 7 days and the spheres were dissociated mechanically
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into single cells again in order to get secondary neurosphere formation. Single cells
were cultured again for clonal density at 10 cells/µl in the same conditions in 24well
plates. Secondary neurospheres were quantiﬁed 7 days after taken in culture.
4.6.2.4 Diﬀerentiation of neurosphere cultures
For diﬀerentiation of cells from adult and embryonic neurospheres, spheres were spun
down 7 days after the last passage, trypsinized at 37 ◦C for 3minutes or mechanically
dissociated only. For mechanic dissociation a 200µl tip was used to triturate the
cells (30 times up and down). Dissociated cells were plated in PDL-coated glass
coverslips at a density of 1 -2× 105 cells/ml and cultured in DMEM-F12medium
with B27 supplement (diﬀerentiation medium) for maximum 7days without growth
factors.
4.6.2.5 Transduction of cultured cells
Cultured cells were infected in neurospere medium with retroviral vectors at a con-
centration of 0,5µl/ml either in the ﬂoating state or 2 hours after plating. After
24 hours medium was changed to diﬀerentiation medium. Then the cells were cul-
tured as described above for 2 -7 days.
4.7 In vivo injections
4.7.1 Anaesthesia
Animals were anaesthetized by intraperitoneal injection of Medetomidine (Domi-
tor, 0,5mg/kg body weight), Midazolam (Dormicum, 5mg/kg body weight) and
Fentanyl (Fentanyl Hexal, 0,005mg/kg body weight). The anesthesia was antago-
nized by intraperitoneal injection of Atipamezol (Antsedam, 5mg/kg body weight)
and Naloxon (Narcanti-vet, 1,2mg/kg body weight). All animal experiments were
revised and approved by the state of bavaria under the license number 209-211-2531-
23/04 .
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4.7.2 Stereotactic injections in adult mice
Injections of retroviral particles were done stereotactically on 9 -10weeks old WT
and HDAC2 deﬁcient mice as described [Carleton et al., 2003]. Brieﬂy, the head
of adult mice was ﬁxed in a stereotactic apparatus. Then a 1 cm midline cut was
performed and the skull was opened at the anterior-posterior and medio-lateral
coordinates (see below) using a drill (Multipro395PR, Dremel). About 500 nl of
virus were injected at one site of each hemisphere by means of a glass micropipette
or a Hamilton syringe. The solution with viral particles was injected very slowly
(100 nl/min). The following coordinates were used for virus injections (relative to
bregma): WT dentate gyrus (DG) = anterior-posterior = 2,0 ; medio-lateral =
1,6 ; dorso-ventral = 2,0 . HDAC2 deﬁcient DG = anterior-posterior = 1,8 ; medio-
lateral = 1,4 ; dorso-ventral = 1,8 . For the subcortical white matter (SCWM) in
WT, anterior-posterior = 1,9 ; medio-lateral = 1,32 ; dorso-ventral = 1,1 . HDAC2
deﬁcient SCWM = anterior-posterior = 1,7 ; medio-lateral = 1,1 ; dorso-ventral =
0,8 .
4.7.3 Transplantations
Cells isolated from the SEZ of mice expressing myristolated Venus [Rhee et al., 2006]
were dissociated as described [Seidenfaden et al., 2006] and injected into the SEZ of
HDAC2 deﬁcient mice at 0,6 (anterior-posterior), 1,1 (medio-lateral) and 1,6 (dorso-
ventral) relative to Bregma.
4.8 BrdU administration
4.8.1 BrdU pulse labeling
For some experiments WT and HDAC2 deﬁcient mice were injected intraperitoneally
with a DNA synthesis marker, 5 -bromo-2 'deoxyuridine (BrdU; 50mg/kg of body
weight, dissolved in 0,9% NaCl with 0,4N NaOH) 1 hour prior to transcardial per-
fusion of the animal. Cryosections were then prepared and stained as described
above.
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4.8.2 BrdU label retaining analysis
To study the number of stem cells and the generation of postmitotic cells within
a speciﬁc time window BrdU was applied in drinking water (1mg/ml in H2O) for
2weeks followed by 1week without BrdU. Afterward mice were sacriﬁced and brains
were treated as described above.
4.9 In situ hybridization
4.9.1 Plasmid preparation and in vitro transcription
10 ng plasmid DNA was added to 25µl chemically competent Top10 cells and in-
cubated for 30minutes on ice. Cells obtained a heat shock at 42 ◦C for 45 seconds.
After bacteria recovered for 10minutes on ice, 1ml LB-medium was added and cells
were incubated on a bacterial shaker for 45minutes at 37 ◦C. Then 50 -100µl of
bacterial suspension were plated on e.g. ampicillin containing (50 g/ml) LB-agar
plates, depending on the resistance encoded by the plasmid, and incubated at 37 ◦C
overnight. One colony was picked the next day and grown for about 4 hours in
5ml antibiotica-containing LB-medium. This preculture then was added to 50ml
LB-ampicillin-medium and was incubated overnight at 37 ◦C on the rotary shaker.
Plasmid-DNA was harvested following the Qiagen-Midiprep protocol using a midi
Tip100 column. The DNA pellet was dissolved in 200µl ddH2O and 20µg of plasmid-
DNA, quantiﬁed by spectrophotometry at 260 nm, were linearized with the appropri-
ate enzyme (40U) in a total volume of 50µl of the appropriate buﬀer for 2 -3 hours
at 37 ◦C. The plasmid-DNA then was puriﬁed by phenol extraction. First, water
was added to a total volume of 200µl, then 200µl phenolchloroform-isoamylalcohol
(50 :49 :1 ) was added and strongly vortexed for about 1minute. After 5minutes of
centrifugation in an Eppendorf-centrifuge at maximum speed, the water phase was
recovered and 1 /10× volume 3M sodium acetate and 0,7 volume Isopropanol were
added and incubated for 10minutes at RT for precipitation. After a centrifugation
at maximum speed in an Eppendorf-centrifuge for 15minutes the pellet was washed
shortly with 70% EtOH and resuspended in 18µl TE (pH 8 , RNAse-free). For in
vitro transcription of the linearized plasmid, 1µl (about 1µg) of the plasmid-DNA
was mixed with 2µl dNTP-mix containing Digoxygenin labeled UTP (DIG-UTP,
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Roche; concentration was 10mM ATP, 10mM CTP, 10mM GTP, 6,5mM UTP
and 3,5mM DIG-UTP ), 4µl 5× transcription buﬀer (Fermentas), 1µl RNAse in-
hibitor (Fermentas; 40U/µl, 2500U) and 1µl (20U/µl, 5000U) of the respective
RNA-polymerase (T7, Stratagene). Pure RNAse-free ddH2O was added up to a
ﬁnal volume of 20µl and the plasmid-mix was incubated for 2 hours at 37 ◦C. To
stop the reaction 2µl 0,2M EDTA was added followed by addition of 2,5µl 4M
LiCl and 75µl pure EtOH to precipitate the RNA either at −20 ◦C overnight or at
−80 ◦C for 2 hours. The RNA probe was centrifuged for 7minutes at 37 ◦C. RNA
precipitation was repeated by addition of 2,5µl 4M LiCl and 75µl 100% EtOH,
incubation for 2 hours at −20 ◦C and centrifugation for 7minutes at 4 ◦C. The pellet
was resuspended in 20µl ddH2O and hybridization buﬀer was added to a ﬁnal RNA
concentration of around 100 ng/µl.
4.9.1.1 Plasmids
Mouse cDNAs of NeuroD and Cux2 in pBluescript II KS were used as templates for
in situ hybridization probes (Table 4.5).
Table 4.5: in situ plasmids
Name Digestion Transcription
NeuroD HindIII T7
Cux2 SalI T7
4.9.2 Non-radioactive in situ hybridization
In situ hybridizations were performed on 20µm thick cryostat sections with 1-2µg
of the respective probe in hybridization buﬀer (1× Salt Solution), 50% Formamid,
10% Dextran Sulfate (Sigma), 1mg/ml wheat germ tRNA (Sigma, R7876), 1× Den-
hard's solution (Sigma, D2532), 0,5% CHAPS (3 -[(3 -cholamidopropyl)dimethyl-
ammonio]-1 -propanesulfonic acid) and ddH2O) at 65 ◦C overnight. The next day
slides were washed ﬁrst with washing solution containing 1× SSC, 50%Formamid,
0,1% Tween 20 at 65 ◦C followed by washing with 1× MABT (100mM Maleic Acid,
150mM NaCl-pH 7,5 , 0,02% Tween 20 ). Slides were incubated 1 hour at room
temperature in blocking solution in 1× MABT and blocking reagent (Boehringer
36
4 Materials and Methods
Mannheim), and 20% heat inactivated sheep serum (Sigma, G6767). Anti-digoxygenin
FAB fragments coupled to alkaline phosphatase were diluted 1 :2500 in blocking so-
lution and applied on slides for overnight incubation. At the third day slides were
again washed with 1×MABT and kept in staining solution containing the substrates
for alkaline phosphatase, NBT and BCIP (Sigma) in a concentration of 350 g/ml for
NBT and BCIP.
4.10 Western Blotting
4.10.1 Cell lysates and tissue preparation
4.10.2 Protein detection
Prtotein detection was performed according to Bradford (1976 ) with the "BioRad
Proteinassay" following the manufactors instructions. Calf-serumalbumine was used
as a protein standard.
4.10.3 Protein analysis
4.10.3.1 SDS-Polyacrylamidgelectrophoresis
The following reagents are needed:
5 x sample buﬀer
10% w/v SDS
10mM β-mercaptoethanol
20% v/v Glycerol
0,2M Tris-HCl, pH 6,8
0,05% Bromophenolblue
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1 x Running buﬀer
25mM Tris-HCl
200mM Glycine
0,1% SDS
1 x Running Gel solution
7% 10% 12% 15%
H2O 15,3ml 12,3ml 10,2ml 7,2ml
1,5M Tris-HCl, pH 8,8 7,5ml 7,5ml 7,5ml 7,5ml
20% (w/v) SDS 0,15ml 0,15ml 0,15ml 0,15ml
Acrylamide 6,9ml 9,9ml 12,0ml 15,0ml
10% APS 0,15ml 0,15ml 0,15ml 0,15ml
TEMED 0,02ml 0,02ml 0,02ml 0,02ml
The percentage of acrylamide is according to the molecular weight of the proteins
of interest. In the case of HDAC2 that is 55kDa, a 10% gel gave the best resolution.
After adding TEMED and APS the gel polymerized fairly quick.
Stacking Gel solution (4% acrylamide)
H2O 3,075ml
0,5M Tris-HCl, pH 6,8 1,25ml
20% (w/v) SDS 0,025ml
Acrylamide 0,67ml
10% APS 0,025ml
TEMED 0,005ml
After mixing the ingredients needed for the chosen percentage and pouring the
solution quickly into the gel casting form, it is important to leave enough space for
the stacking gel. The top of the gel layer was loaded with water saturated isopropanol
to remove bubbles at the top of the gel and ensure this part won't dry out. After
30 minutes the gel was polymerized completely. Then the stacking gel solution was
added together with desired combs after removing the isopropanol. After 1 hour
the gel is polymerized fully and ready for loading the samples. The samples were
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prepared by mixing the protein of interest with sample buﬀer 4 :1 . For denaturation
the mixture was heated for 5minutes at 95 ◦C. The gel run was done at 100 -150V
for 1 -3 hours at RT.
4.10.3.2 Western Blot analysis
The Western Blot method was designed to transfer extracted proteins on a mem-
brane. Proteins were before uploaded with SDS, so they can now travel in the
electric ﬁeld to the Anode and can be separated from the gel matrix onto the mem-
brane. Membranes used here were exclusively PVDF-membranes (Milipore) that
were incubated prior to the blotting for 1minute in methanol to activate them. In
the so called "`semi-dry"' method, membranes and ﬁlter papers (Whatman-3MM-
Chromatography papers) were cut to the exact size of the gel and soaked in transfer
buﬀer. Now a blot-sandwich was built out of: anode, four soaked ﬁlter papers, acti-
vated PVDF membrane, SDS gel, four soaked ﬁlter papers, cathode. The blot was
run with 0,8 -1mA/cm2 for 90minutes. After successfully transferred the proteins
onto the membrane, proteins of interest could be detected by immunostaining.
4.11 Viral vectors
4.11.1 Retroviral vectors and retrovirus production
For lineage tracing experiments retroviral vectors expressing the green ﬂuorescent
protein (GFP) were used, that were either pMXIG or CMMP [Hack et al., 2004]. For
viral infection of adult Brg1 ﬂoxed neurospheres a retrovirus containing CreIRES-
GFP was used. This virus expresses Cre and GFP behind an IRES (internal riboso-
mal entry side) [Hack et al., 2005; Colak et al., 2008]. Gpg293 cells [Ory et al., 1996]
were cultured in DMEM (Gibco) containing 10% (v/v) FCS (heat inactivated for
30minutes at 56 ◦C; Gibco), 1% (v/v) penicillin-streptomycin in DMEM (Gibco),
1 g/ml tetracycline (Sigma), 2 g/ml puromycin (Sigma) and 0,3mg/ml G418 (Gibco).
Cells were passaged once per week with PBS and trypsin containing 1 g/ml tetracy-
cline. These cells allow the production of high titer amphotropic retrovirus. Many
retrovirus packaging cell lines lose packaging eﬃciency as they are cultured due to
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the gradual loss of expression of the packaging genes. The packaging plasmids in-
troduced to this cell line were chosen using diﬀerent selection markers (gentamycin
(G418), puromycin). Therefore, expression of packaging proteins can be fairly well
maintained by culturing the cells continuously in media containing the correspond-
ing antibiotics. In addition, the vesicular stomatitis virus G (VSV-G) protein is
toxic to gpg293 cells, so expression of this gene is controlled by tetracycline. There-
fore, these cells are maintained in tetracycline, puromycin and G418 containing
medium. Retroviral vectors pseudotyped with VSV-G diﬀer from standard murine
retroviruses by their very broad tropism and the capacity to be concentrated by ul-
tracentrifugation without loss of activity. Gpg helper-free packaging cells were used
for viral production [Pear et al., 1993]. For retrovirus production 90 -95% conﬂuent
gpg cells were transfected using Lipofectamin 2000 (Invitrogen) and Opti-MEM I re-
duced serum medium (Invitrogen) as described in the Lipofectamin 2000 transfection
protocol for adherent cells (Invitrogen). Transfection medium was replaced after 8 -
10 hours, and gpg cells were further cultured in DMEM containing 10% (v/v) FCS
(heat inactivated for 30minutes at 56 ◦C; Gibco), 1% (v/v) penicillin-streptomycin
in DMEM (Gibco). After 48 hours the virus containing medium was collected and
ﬁltered through a 0,4µm ﬁlter to remove the cell debris but maintain the viral par-
ticles (Becton Dickinson) and centrifuged at 50000 x g for 90minutes at 4 ◦C. The
virus pellet was resuspended in TNE (50mM Tris-HCl pH 7,8 , 130mM NaCl, 1mM
EDTA) and aliquoted. Virus aliquots were stored at −80 ◦C. Virus titers (viral par-
ticles/ml) were measured by adding viral vectors serially diluted to primary cerebral
Ctx cells isolated from embryonic day 14 cortices. Cells were cultured for 2 days to
allow the expression of the transgene and then the number of infected clones (clus-
ters of GFP-positive cells) was counted. The number of infected clones corresponds
to the viral particles used for transduction of primary cells and was then referred to
viral particles.
4.12 Fluorescence-activated cell sorting (FACS)
For FAC sorting, SEZ and OB of 5WT and 5HDAC2 deﬁcient mice were dissected
separately and enzymatically dissociated in 0,7mg/ml hyaluronic acid, 1,33mg/ml
trypsin in HBSS with 2mM glucose at 37 ◦C for 15minutes. After the ﬁrst 15minutes
of trypsinization the cells were triturated very strongly with a ﬁre polished and
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fetal calf serum coated Pasteur pipet to avoid clumps. This step was followed by
one more digestion for 15minutes at 37 ◦C. The cells were centrifuged at 200 g for
5minutes, resuspended in 0,9M sucrose in 0,5×HBSS and centrifuged for 10minutes
at 750 g. The cell pellet was resuspended in 2ml of culture medium, placed on
top of 10ml 4% BSA in EBSS solution, and centrifuged at 200 g for 7minutes,
followed by washing in Dulbecco's modiﬁed eagle medium: F-12 nutrient mixture
(DMEM/F12; Gibco). Then cells were dissolved in staining medium containing
PSANCAM antibody. PSANCAM+ cells were then isolated using a FACSAria
(BD). Flow cytometry is a method to characterize cells on single-cell level according
to their light scattering qualities and emitted ﬂuorescence radiation. Cells pass in
a liquid ﬂow hydrodynamically focussed one after the other a laser beam. The
FACSAria is set at purity mode and the appropriate sort rate (below 1000 cells
per second for high purity and recovery of cells). The forward scatter (FSC) is
determined by the light dispersion of 3 to 10° and correlates with cell size. The
sideward scatter (SSC) is determined by a 90° reﬂection of the light and correlates
with the granularity of the cell. These gating parameters determined by side and
forward scatter are used to eliminate debris, dead and aggegrate cells. After sorting,
the cells were centrifuged for 30 minutes at 1000 rpm and resuspend in 100 µl of
lysis buﬀer (RLT from QIAGEN containing β-mercaptoethanol) for RNA isolation.
4.13 RNA extraction and microarray
4.13.1 RNA extraction
For microarray analysis either RNA from FAC sorted cells or RNA was prepared
from SEZ and OB of WT and HDAC2 deﬁcient animals. RNA was extracted from
selected cells/tissue with Qiagen RNAeasy Kit. FAC sorted cells or tissue were
stored in lysis buﬀer (RLT) containing β-mercaptoethanol after sorting/dissection.
After 15minutes centrifugation at maximum speed (13100 rpm) the supernatant was
collected in a QIAshredder (purple) spin columns placed in 2ml collection tubes.
Following a 2minutes centrifugation at maximum speed the supernatant of the ﬂow-
through fraction was transferred to a new RNase-free 1,5ml microcentrifuge tube
without disturbing the cell-debris pellet. 0,5 volume (half of initial lysis volume)
of room temperature 96 -100% EtOH was added to the clear lysate and mixed
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immediately. The mixture was applied to a RNeasy (pink) mini column placed in a
2ml collection tube. This was followed by a 15 seconds centrifugation at 11.000 rpm.
At this stage RNA and DNA arebound to silica gel membrane in the RNeasy column.
DNA was digested in the same column with DNase I for 15minutes. After proper
washing steps the columns were transferred into RNase-free 1,5ml microcentrifuge
tubes. 30µl of RNase-free water (supplied with the kit) was put directly on the
center of the silica-gel membrane of the RNeasy columns for elution. The samples
were then centrifuged twice for 1minute at maximum speed. The eluted RNA was
measured at Nanodrop Spectrophotometer.
4.13.2 Microarray
The quality of puriﬁed RNA was examined using the Agilent Bioanalyser and re-
vealed high quality of all RNA preparations. 80 ng of total RNA was used for
each microarray from 3biological replicates of control and HDAC2 deﬁcient mice
in the case of HC analysis (tissue preparation). FACS sorted cells from OB were
isolated in two independent preparations from 5WT and 5HDAC2 deﬁcient mice.
The RNA ampliﬁcation was performed with MessageAmp II-Biotin Enhanced Kit
(Ambion, 1791 ). This single round RNA ampliﬁcation kit was used for all samples
to avoid variations resulting from multiple rounds of ampliﬁcation. Hybridization
to Aﬀymetrix MOE430 2.0 GeneChips (46 k probe sets) was performed according
to standard protocols provided by Aﬀymetrix. All housekeeping genes were present
and number of present calls was determined as 40% or higher. To process the data
we calculated probe set summaries (according to RMA) [Bolstad et al., 2003] and
normalized the data (lmp, nonlinear transformation employing the loss smoother
[Cleveland, 1981]. To test the quality and reproducibility of the samples, hierarchi-
cal clustering was used to ﬁnd (dis)similarities between the samples showing that
the replicates of each group of cells analyzed were clustering together. Hierarchi-
cal clustering was performed on normalized data (RMA) using packages available
from http://cran.r-project.org. For statistical analysis of the expression data the
Bioconductor software package implemented in Carma web was employed using the
moderated limma test. The Benjamini-Hochberg algorithm [Benjamini, 1997] was
used to identify genes with a false discovery rate < 5%.
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4.14 cDNA preparation and Real Time (RT) PCR
4.14.1 cDNA synthesis
To conﬁrm the expression diﬀerences as predicted by the microarray analysis mRNA
expression levels of some of the genes of interest by RT-PCR were compared. For
complementary DNA preparation RNA was reverse transcribed by SuperScriptTM
III Reverse Transcriptase Kit from Invitrogen. As shown below (components and
their amounts for 1 reaction) after mixing the RNA template with Oligo(dT) and
dNTPs the samples were kept at 65 ◦C for 5minutes for annealing of oligo(dT)s to the
messenger RNA. This was followed by addition of reverse transcriptase together with
other components which were listed below (Table 4.6). Transcription took place
for 50minutes at 50 ◦C. The samples were then incubated at 85 ◦C for 5minutes for
the inactivation of the reverse transcriptase. cDNA was stored at −20 ◦C.
Table 4.6: cDNA Reaction Mix
Components ONE Reaction
dNTPs 1µl
Oligo(dT) 1µl
10× RT buﬀer 2µl
25mM MgCl2 4µl
0,1M DTT 2µl
RNaseOUT 1µl
SuperScriptIIIRT 1µl
RNA template X µl
Total volume 20 µl
4.14.2 Real Time (RT) PCR
Real-time PCR was done using iQSYBRGreen kit from BIO-Rad in an Opticon
qPCR machine. For 1 reaction see the components listed in Table 4.7. 2× iQSYBR
Green Supermix contains 100mM KCl, 40mM Tris-HCl, pH 8,4 , 0,4mM of each
dNTP, iTaq DNA polymerase, 50 units/ml, 6mM MgCl2, SYBR Green I, 20 nM
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ﬂuorescein and stabilizers. Primers used for genes of interest were listed in Table
4.8. The observed expression levels were all normalized to GAPDH.
Table 4.7: Real Time PCR reaction mix
Components ONE Reaction
iQSYBR Green Supermix 12,5µl
Primer 1 0,5µl (100 nM)
Primer 2 0,5µl (100 nM)
Sterile water X µl
DNA template 2-5µl (10 ng)
Total volume 25 µl
Table 4.8: RT PCR primers
Primer Name Primer Sequence
HDAC1 forward 5 '-tgttccagcctagtgcagtg-3 '
HDAC1 reverse 5 '-aacattccggatggtgtagc-3 '
HDAC2 forward 5 '-tggaggaggctacacaatcc-3 '
HDAC2 reverse 5 '-caccaggtgcatgtggtaac-3 '
Brg1 forward 5 '-aggttcagctcatggattgg-3 '
Brg1 reverse 5 '-cacactgcttccctccttct-3 '
4.15 HDAC activity assay
The HDAC activity assay was performed in collaboration with Sabine Lagger (Max
F. Perutz Laboratories, Medical University of Vienna, Institute of Medical Biochem-
istry, Dr. Bohr-Gasse 9/2, A-1030 Vienna) using 10µg total protein extract from
freshly isolated hippocampus (HC), OB and cerebellum (CB) of WT and HDAC2
deﬁcient mice. First isolation buﬀer (Hunt buﬀer) was added to a ﬁnal volume of
20µl and then 10µl of tritium labeled chicken erythrocyte histones (1,5mg/ml) and
incubated at 30 ◦C for 1 hour. After this incubation step reactions were stopped with
35µl Histone Stop and 800µl ethylacetate followed by a vortex step of 15 seconds and
spin down 4minutes at 10.000 rpm in a swing out bucket rotor. Measurement was
done using 600µl of the organic upper phase in 3ml Scintillation solution. Counts
were measured on a Scintillation counter for 1minute.
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4.16 Materials
4.16.1 Microscopy
The following microscopes were used:
- AxioPhot ﬂuorescent microscope, AxioCam HRc camera and AxioVision software
with the objectives from Plan Neoﬂuar series (Objective Plan Neoﬂuar 5 x/0,15 ;
10 x/0,30 ; 20 x/0,50 ; 40 x/0,75 ).
- Olympus BX61 ﬂuorescent microscope, F-view II camera and Olympus Cell∧F
software with the objectives U Plan S Apo 4 x, 10 x, 20 x, 40 x oil and 60 x oil.
- Olympus FV1000 confocal laser microscope, inversiv stativ Oplympus IX81 and
FV12 software with the objectives U Plan Semi Apo Objective 4 x, 10 x, 20 x, 40 x,
40 x oil and 60 x oil.
4.16.2 Complex media, buﬀers and solutions
Alkaline-phosphatase staining buﬀer (AP-buﬀer) for ISH
100mM NaCl
50mM MgCl2
100mMTris pH9,5
0,1% Tween-20
1mM Levamisole in dd H2O
AP-NBT/BCIP (ISH)
AP
350µg/ml NBT
175µg/ml
APS10%
100mg Ammoniumpersulfat
in 1ml ddH2O
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Blocking solution (ISH)
MABT
2% blocking reagent
20% heat inactivated sheep serum
Diﬀerentiation medium for adult neurospheres
DMEM/F12
B27 1 :50
2mM glutamine
100U/ml penicillin
10µg/ml streptomycin
Di-sodium-tetraborate-buﬀer (0,1M, pH 8,5 )
0,1M Na2B4O7
in ddH2O
Dissociation solution for adult neurospheres
0,7mg/ml hyaluronic acid
0,2mg/ml kynurenic acid
1,33mg/ml trypsin
2mM glucose
in HBSS
Electrophorese buﬀer (10X)(Western Blot)
30,3 g TRIZMA
144 g Glycine
10 g SDS
in 1ml ddH2O
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0,5M EDTA, pH 7,6 , 50ml
9,31 g disodium dihydrate (M=373,2 g/mol)
add 30ml DEPC-H2O
adjust pH with 5N NaOH
FCS-PS-medium
10% (v/v) FCS (heat inactivated 30minutes at 55 ◦C
1% (v/v) Penicillin-Streptomycin
in DMEM
HCl (2,4N)
2,4N HCl (37% (w/v)
10mM β-mercaptoethanol
20% v/v Glycerol
0,2M Tris-HCl, pH 6,8
0,05% Bromophenolblue
LB (Luria-Bertani) medium
20 g/l LB broth base
in ddH2O
LB-agar
LB-medium
10mM β-mercaptoethanol
15 g/l agar
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Lysis buﬀer pH 8,5
100mM TrisHCl
5mM EDTA
0,2% SDS
200mM NaCl
100µg/ml Proteinase K
MABT (5 x pH 7,5 )
500mM maleic acid
750mM NaCl
0,1% Tween-20
ddH2O
NaAc (3M), pH 5,2
24,61 g NaAc (M= 82,03 g/mol)
in 100ml ddH2O
NaN3-PBS (0,05%)
0,05% (w/v) NaN3
in 1 x PBS
Neurosphere medium
DMEM/F12 (glucose 1,8 g/l
3,5mg glucose)
1% (v/v) Penicillin-Streptomycin
B27 1 :50
EGF 20 ng/ml
FGF 20 ng/ml
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NP40 (0,1%)
0,1% NP40 (w/v)
in 1 x PBS
PBS (Phosphate buﬀered salt solution, 1 x) pH 7,4
137mM NaCl
2,7mM KCl
80,9mM Na2HPO4
1,5mM KH2PO4
in ddH2O
Poly-D-lysin-hydrobromide solution
1% (w/v) PDL solved (1mg/ml PDL in ddH2O)
in 0,1M sodium-tetraborate buﬀer
Preparation buﬀer
10mM HEPES
in HBSS
Saline
0,9% (w/v) NaCl
in ddH2O
Salt solution (10 x)(ISH)
2M NaCl
90mM Tris HCl, pH 7,5
10mM Tris base
70mM NaH2PO4
50mM Na2HPO4
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50mM EDTA
ddH2O
SATO-medium
DMEM
1g/l Glucose
2mM Glutamine
10µg/ml Insulin (bovine)
100µg/ml Transferrin (human)
0,0286% BSA-pathocyte
0,2µM Progesterone
0,1µM Putrescine
0,45µM Thyroxine
0,224µM Selenite
0,5µM Tri-iodo-thyronine
Sodium-citrate buﬀer
10 x 0,1M sodium-citrate, pH 6,0 in ddH2O
SSC (20 x)(ISH)
3M NaCl
0,3M sodium citrate
in ddH2O
Sucrose-PBS-solution (30%)
30% (w/v) sucrose
in 1 x PBS
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TAE (Tris-acetate-EDTA)(50 x)
242 g Tris base
57,1ml acetic acid
100ml 0,5M EDTA
in ddH2O
TBE (10 x)
450mM Tris base
440mM boric acid
10mM EDTA
in ddH2O
TE pH 8,0
10mM Tris HCl
1mM EDTA
in ddH2O
TE-buﬀer pH 7,5
10mM Tris HCl
0,1mM EDTA
in ddH2O
Triton X-100 10%
10% (w/v) Triton X-100
in 1 x PBS
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Trypsin-EDTA
0,05% trypsin
0,02% EDTA
in HBSS
Washing solution (ISH)
1 x SSC
50% formamide
0,1% tween-20
4.16.3 Product list
Acrylamide BioRad
Agarose Biozym
Ampicillin Sigma
Anti-DIG-FAB-fragments alkaline phosphatase Roche
APS Sigma
Aqua Poly Mount Polyscience
BCIP(5-bromo-4-chloro-3-indolyl-phosphate, 4-toluidine salt) Roche
beta-mercaptoethanol Sigma
Blocking reagent Roche
BrdU Sigma
BSA Sigma
cDNA-synthesis Kit Invitrogen
Chloralhydrate Sigma
Corn oil Sigma
DAPI Sigma
Denhardt's solution Sigma
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Dextran sulfate Sigma
diethylether for anaesthesia Merck
DIG-RNA labeling mix Roche
Di-Sodiumhydrogenphosphate Na2HPO4 Merck
dNTP Pharmacia Biotech
Dulbecco's modiﬁed Eagle medium (DMEM) Invitrogen
EDTA Sigma
Ethanol absolute Roth
Fetal Calf serum(FCS) Sigma
Formamide Merck
Geneticin (G418-sulfate) Invitrogen
Gentamycin Invitrogen
Glucose Merck
Glycerol (87%) Sigma
Glycin Sigma
Hank's buﬀered salt solution (HBSS) Invitrogen
Heat inactivated sheep serum Sigma
HEPES-Buﬀersolution 1M, pH 7,2-7,5 Invitrogen
Hydrochlorid acid (37%) HCl Merck
Insulin Sigma
iQSYBRGreen Kit BioRad
Isopropanol Roth
Kaliumchloride KCl Merck
Kaliumdihydrogenphosphat KH2PO4 Merck
LB broth base Invitrogen
Lipofectamine 2000 Invitrogen
L-glutamine Invitrogen
LiCl Merck
MessageAmp II-Biotin Enhanced Kit Ambion
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Methanol absolute (MetOH) Merck
MgCl2 Sigma
MidiPrep-Kit Qiagen
Molecular weight marker (1 kb ladder) Invitrogen
NaCl Merck
Natriumdihydrogenphosphat NaKH2PO4 Merck
NaHCO3 Merck
Natriumtetraborate (borax) Na2B4O7-H2O Merck
NBT (Nitroblue tetrazolium chloride) Roche
Normal goat serum (NGS) Vector Laboratories
NP40-Igepal Sigma
Oligo(dT) primers Roche
Olympus immersion oil Olympus
Opti-MEM I reduced serum medium Invitrogen
Paraformaldehyde(PFA) Merck
PCR-buﬀer (10x) Qiagen
Penicillin/Streptomycin solution Invitrogen
Phenol-chloroform-isoamylalcohol (50:49:1 Roth
Poly-D-Lysine Hydrobromide (PDL) Sigma
Progesterone Sigma
Proteinase K Roche
Putresine Sigma
PVDF membranes (Western Blot) Milipore
Q-solution (5x) Qiagen
Reverse transcriptase kit Invitrogen
Restriction enzymes New England Biolabs
RNA polymerase T7 Stratagene
RNase inhibitor Fermentas
RNeasy kit Qiagen
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SDS Roth
Selenite Sigma
Sodium citrate Sigma
Sodium acetate Merck
Sucrose Merck
Tamoxifen Sigma
Taq-DNA-polymerase Qiagen
TEMED BioRad
Top10 cells Invitrogen
Transcription buﬀer (5x)(ISH) Fermentas
Transferrin Sigma
TrisBase Merck
TrisHCl Merck
Triton X-100 Roth
Trizol Invitrogen
Trypsin Type XII, 9000 BASF units/mg Sigma
Trypsin-EDTA (1x) Invitrogen
Tyramide ampliﬁcation kit Perkin Elmer
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5.1 Expression analysis of HDAC1, HDAC2 and
Brg1
5.1.1 mRNA analysis of HDAC1, HDAC2 and Brg1
Microarray data from FAC sorted cells of embryonic cortices of the transgenic mouse
line hGFAPeGFP were analyzed to ﬁgure out chromatin modiﬁcation genes which
are involved in neurogenesis. In this mouse line eGFP is expressed under the hG-
FAP promoter active in astrocytes [Nolte et al., 2001]. According to the intensity
and levels of GFP expression two populations of cells were separated. One popula-
tion of radial glial cells expresses GFP intensively and is supposed to contain the
gliogenic precursors (GP) whereas in the other neurogenic population the hGFAP
promoter is downregulated and hence expresses less GFP (NP) [Pinto et al., 2008].
This study is also described in the PhD work of Michael A. Hack (2006 ). In these
microarray data sets certain genes were found to be diﬀerentially regulated which
are involved in chromatin remodeling, such as Brg1 or chromatin modiﬁcation such
as HDAC1 and 2. Therefore, the expression of these candidate genes was examined
by the real time RT-PCR method to evaluate whether diﬀerential expression can be
detected. The expression of HDAC1, HDAC2 and Brg1 was studied in undiﬀerenti-
ated versus diﬀerentiated cell populations and in more speciﬁed populations, such as
astrocytes cultured in the presence or absence of the growth factors EGF and FGF
(see Materials and Methods 4.6.) and FAC sorted neurons from TauGFP transgenic
mice [Jacobs et al., 2007]. HDAC2 and Brg1 mRNAs are enriched in neurogenic
and gliogenic precursors compared to HDAC1 (Figure 5.1). The increase was 6-7x
higher (all normalized to GAPDH, see Materials and Methods 4.14.2.). HDAC1
and HDAC2 were both highly expressed in postmitotic neurons, not tested for Brg1
(Figure 5.1 a,b). Brg1 was not only enriched in both progenitor populations but
also in the population of undiﬀerentiated neurospheres (Figure 5.1 c).
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Figure 5.1: RT-PCR expression levels of candidate genes found in the Microarray
studies
a-c Histograms of expression levels of HDAC1 (a), HDAC2 (b) and Brg1 (c) in speciﬁc cell
populations relative to GAPDH=1 . Brg1 and HDAC2 are intensively enriched in gliogenic and
neurogenic precursors compared to HDAC1. Both HDACs are highly expressed in neurons. NP=
neurogenic precursors, GP= gliogenic precursors, ud= undiﬀerentiated neurosphere cultured
cells, dd1= neurospheres diﬀerentiated for 1 day, dd3= neurospheres diﬀerentiated for 3 days,
astro+= astrocyte cultures with growth factors, astro-= astrocyte cultures without growth
factors, neuron= postmitotic neurons from E14 Ctx.
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5.1.2 Protein expression analysis of HDAC1, HDAC2 and
Brg1 in vitro
First, the expression of the three candidate genes in vitro was examined to under-
line the RNA expression results. Neurosphere cultured cells from E14 cortices were
stained by immunocytochemistry using, besides the antibodies to detect the candi-
date proteins, β-IIItubulin for young born neurons and GFAP for astrocytes and
neural progenitors. HDAC1 protein was expressed at overall weak levels, but de-
tectable in GFAP+ astrocytes and in β-IIItubulin+ young neurons (Figure 5.2 a).
HDAC2 immunoreactivity was high in β-IIItubulin+ neurons and weak in GFAP+
cells (Figure 5.2 b). This suggests that HDAC2 protein is not as highly expressed
in neural progenitor cells as implicated in the mRNA levels, whereas the higher im-
munoreactivity in postmitotic neurons is consistent with the high mRNA levels in
neurons. By contrast, Brg1 was high in the progenitor populations and in undiﬀer-
entiated neurospheres at mRNA level. In order to examine this at the protein level,
embryonic neurospheres ﬁxed 2 hours after plating were stained for Brg1. Most of
the cells were not yet diﬀerentiated at all, but showed stem cell properties. These
undiﬀerentiated cells show high levels of nuclear Brg1 immunostaining (Figure 5.2
c). After 3 days of diﬀerentiation Brg1-immunoreactivity is still present in GFAP+
astrocytes and also in β-IIItubulin+ neurons (Figure 5.2 d), suggesting that Brg1
is present in neural precursor cells as well as in diﬀerentiated cells.
5.1.3 HDAC1 immunoreactivity in vivo
5.1.3.1 HDAC1 immunoreactivity during embryonic and postnatal brain
development
In addition to the studies on mRNA- and protein levels in vitro, the HDAC1 protein
expression in vivo was studied by immunocytochemistry. In contrast to previous
reports of an ubiquitous expression of HDACs, a very speciﬁc expression pattern was
observed already at E14. The HDAC1 protein was expressed at high levels in neural
precursor cells which are located in the ventricular zone (VZ) during embryonic
neurogenesis and are positive for Ki67, a protein expressed in all dividing cells.
Besides the prominent existence of the protein in neural precursors, it was also
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Figure 5.2: Cell-type speciﬁc localization of HDAC1,2 and Brg1 in vitro
Neurosphere cultures of E14 cortices. a HDAC1 immunoreactivity (green) is weak in E14 NS
cultures, detectable in some β-IIItubulin+ neurons and a bit more enhanced in GFAP+
astrocytes. b HDAC2 (red) is strongly expressed in postmitotic neurons that are β-IIItubulin+
and weakly in GFAP+ astrocytes. c Brg1 immunoreactivity is high in undiﬀerentiated
neurosphere cells. d After 3 days of diﬀerentiation, Brg1 immunoreactivity is present in GFAP+
cells as well as in β-IIItubulin+ neurons. Small arrows depict cells double-positive with GFAP,
bold arrows depict cells double-positive with β-IIItubulin. Scale bar: 20µm.
weakly expressed in postmitotic neurons that are NeuN+ in the cortical plate (CP)
(Figure 5.3 a). At neonatal stages HDAC1-immunoreactivity was mainly found in
glial cells but could not be detected in neurogenic regions, such as the HC anlage,
except for a low remaining expression in glial cells (Figure 5.3 b). Later, at
P5, the HDAC1 protein was not detectable in neuronal cells immunopositive for
NeuN (Figure 5.3 d). Around P21, when postnatal development ends, HDAC1 is
expressed in the WM, the only region where a partial overlap of HDAC1 and 2 in the
same cell can be observed. No change compared to earlier stages in the postnatal
development can be found in the Ctx with HDAC1 not expressed in NeuN+ cells
(Figure 5.3 f). To prove the fact that the HDAC1 protein can only be observed in
glial cells, glial markers were stained such as GFAP labeling astrocytes and Olig2
labeling oligodendrocyte progenitors. Figure 5.3 g,h shows the presence of HDAC1
protein in both cell types.
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Figure 5.3: HDAC1 immunoreactivity during developmental stages
a HDAC1 immunoreactivity at E14 is highly present in neural precursors located in the VZ and
weakly expressed in NeuN+ neurons in the CP. b At neonatal stages HDAC1 is not expressed in
neurogenic regions, such as the HC anlage except presumably in glial cells. c,d HDAC1 is
expressed in a scattered pattern and does not colocalize with NeuN at P5. e,f HDAC1 expression
at P21 in the Ctx is not detectable in NeuN+ cells. g Overlay of HDAC1-immunoreactivity . h
HDAC1 is detectable in Olig2+ cells. Arrows depict double-positive cells. Ctx= cortex, HC=
hippocampal anlage, OB= olfactory bulb, SEZ= subependymal zone. Scale bars: a, c-f 50µm; b,
g-h 20µm.
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5.1.3.2 HDAC1 immunoreactivity in the adult brain
At adult stages the expression of HDAC1 is still detectable in glial cells and is absent
in postmitotic neurons that are NeuN+ (Figure 5.4). This scattered pattern of
HDAC1 indicative of the expression in glial cells was also observed in other brain
regions, such as the Ctx, OB or the CB. A summary of HDAC1 immunoreactivity
at diﬀerent stages as reported is depicted in Table 5.1 at the end of this chapter.
Figure 5.4: HDAC1 immunoreactivity in the adult brain
In the adult brain, here in the DG, HDAC1 is not present in NeuN+ neurons. Scale bar: 50µm.
5.1.4 HDAC2 expression in vivo
5.1.4.1 HDAC2 immunoeactivity during embryonic neurogenesis
To examine whether the cell-type speciﬁc immunoreactivity of HDAC1 was also
consistent for other HDACs, the expression pattern of the second candidate gene,
HDAC2, was studied. HDAC2 immunoreactivity at E14 (midneurogenesis) was re-
stricted to postmitotic neurons identiﬁed by NeuN-immunostaining in the forebrain,
e.g. in the cortical plate (CP) and in the diﬀerentiating parts of the GE, while it was
absent in progenitor cells identiﬁed by the Ki67 antigen, labeling all proliferating
cells at the VZ, in contrast to the observed pattern of HDAC1 (Figure 5.5 a-c). An-
other region in the embryonic forebrain that shows a speciﬁc expression of HDAC2,
was the Zona limitans intrathalamica (ZLi), a region in the diencephalon composed
of neural precursor cells at E14 and one of the few regions where HDAC2 was found
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in progenitor cells. This supports the tight regulation and cell-type speciﬁc expres-
sion of HDAC2 (Figure 5.6). Later on, at E18, when embryonic neurogenesis is
about to ﬁnish, HDAC2 was still highly present in postmitotic neurons, but now a
weak presence of the protein was observed in the VZ in Ki67+ cells (Figure 5.5
d-f), suggesting the fact that HDAC2 starts to be expressed in another cell type
except postmitotic neurons in the Ctx.
Figure 5.5: HDAC2 immunoreactivity at embryonic stages
a-c HDAC2 immunoreactivity in the E14 telencephalon. High levels of HDAC2 protein were
observed in NeuN+ neurons in the CP (b), but were absent in Ki67+ precursors lining the VZ
(c). d-f HDAC2 immunoreactivity at E18. HDAC2 is still expressed in NeuN+ cells in the CP
(e). Weak expression of HDAC2 is also detectable in Ki67+ cells (f). The arrow depicts a
double-positive cell. GE= ganglionic eminence, VZ= ventricular zone. Scale bars: a, d 100µm; e
50µm; b, c 20µm; f 10µm.
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Figure 5.6: HDAC2 immunoreactivity at E14 in the Zona limithans intrathalamica
HDAC2 is expressed speciﬁcally in the Zli in the diencephalon. Zli= zona limithans
intrathalamica. C, D, R, V= caudal, dorsal, rostral, ventral. Scale bar: 20µm.
5.1.4.2 HDAC2 immunoreactivity during postnatal development
HDAC2 immunoreactivity is maintained during the postnatal development of the
brain starting on postnatal day 0 (P0) and ending at around P21. While neurogen-
esis is restricted to embryonic stages in the developing brain, gliogenesis starts after
birth (P0). Cells that are proliferating and can be detected by immunoreaction
against the antigen Ki67 have gliogenic potential. The ﬁrst glial precursors arise
around E18, when HDAC2 was observed to switch from its restricted presence in
postmitotic neuronal cells to an existence in proliferating cells that were presum-
ably glial precursors. The same pattern of immunostaining for HDAC2 could be
observed at the diﬀerent stages P0, P5 and P21 during postnatal development. At
P0, HDAC2 immunoreactivity is high in NeuN+ neurons (Figure 5.7 b). Moreover
it is expressed in Ki67+ cells in the HC, one of the regions where neurogenesis con-
tinues lifelong (Figure 5.7 c), as well as in the white matter (WM) full of gliogenic
precursors that are Ki67+ and GFAP+ (Figure 5.7 d,e).
At P5 HDAC2 showed a similar expression pattern to that at P0. High expression
was still maintained in neurons. Furthermore, speciﬁcally gliogenic precursors in
the WM showed weaker HDAC2 immunoreactivity (Figure 5.8 b,c) compared to
doublecortin (Dcx)+ neuroblasts and Ki67+ precursors in the HC which showed
increased HDAC2 immunoreactivity (Figure 5.8 d,e).
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Figure 5.7: HDAC2 immunoreactivity at postnatal day 0
a Overview of HDAC2 immunoreactivity at P0. b,c HDAC2 is highly expressed in NeuN+
neurons (b) and in Ki67+ cells in the HC (c). d,e In a gliogenic region, the WM, HDAC2 is
expressed in GFAP+ (d) and in Ki67+ cells (e). Arrows depict double-positive cells. White
rectangle shows higher magniﬁcation. WM= white matter. Scale bars: a 100µm; b, c 50µm; d, e
20µm.
The last time point to be discussed in postnatal development is P21, when the brain
development is about to be completed. The HDAC2 expression is still identical to
that at P0 or P5. The prominent postmitotic expression is detectable in neurons
(Figure 5.9 d) as well as in GFAP+ astrocytes (Figure 5.9 a) and in CC1+
oligodendrocytes (Figure 5.9 b). In the WM where glial progenitors can be found,
HDAC2 was also expressed in neurogenic progenitor cells that are Dcx+ located
in a stream between HC and Ctx, the so-called subcortical white matter (SCWM)
(Figure 5.9 c). In contrast to the normal neurogenic potential of Dcx+ cells, these
cells have glial progenitor properties and can also be labeled by a short pulse BrdU
1hour before sacriﬁcing the animal. At early postnatal stages neural progenitor
cells were described to generate Dcx+ cells in this region [Takemura, 2005]. Later,
at adult stages, Dcx+ cells in the subcortical white matter (SCWM) have almost
disappeared.
5.1.4.3 HDAC2 immunoreactivity in the adult brain
In the adult brain HDAC2 immunoreactivity was found in most cell types, including
neurons, glia and progenitors (Figure 5.10 a). Interestingly, a high expression
was also observed in the two regions of adult neurogenesis, SEZ/RMS/OB and
the subgranular zone (SGZ) in the DG. This raised the question, in which cell
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Figure 5.8: HDAC2 immunoreactivity at postnatal day 5
a,d HDAC2 immunoreactivity at P5 in the regions of the Ctx and WM (a) and the HC (d). b,c
Immunostaining of HDAC2 is weakly found in GFAP+ cells (b) and in Ki67+ cells in the WM
(c). d,e Strong HDAC2 immunoreactivity is observed in Dcx+ neuroblasts (d) and in Ki67+
precursors (e) in the HC. Arrows depict double-positive cells. White rectangles show higher
magniﬁcations. HC= hippocampus, WM= white matter. Scale bars: a 100µm; c 50µm; b, d, e, f
20µm.
65
5 Results
Figure 5.9: HDAC2 immunoreactivity at postnatal day 21
a HDAC2 immunoreactivity is observed in postmitotic GFAP+ astrocytes. b The HDAC2
protein is found in CC1+ oligodendrocytes. c HDAC2 is detectable in Dcx+ cells in the SCWM.
d HDAC2 stays on in postmitotic neurons. Arrows depict double-positive cells. RMS= rostral
migratory stream, SCWM= subcortical white matter, WM= white matter. Scale bars: a 10µm;
b, c 20µm; d 50µm.
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type HDAC2 is expressed there? To answer this, a lineage analysis using speciﬁc
markers to label each cell type existing in the adult neurogenic niches was performed.
As shown in P21 old animals, the HDAC2 protein was found in postmitotic glial
cells such as CC1+ cells, and it was still high in postmitotic neurons similar to
earlier stages (Figure 5.10 b). Dcx as a marker for neuroblasts was found to
be coexpressed with HDAC2 from postnatal day 0 on until adult stages in both
neurogenic regions (Figure 5.10 c,d; Figure 5.9 c; Figure 5.8 d). HDAC2 could
also be detected in transit-amplifying progenitor cells that are Dcx- negative but
divide fast and can be labeled by a short pulse of the DNA-base analogue 5-bromo-
2'deoxyuridine (BrdU)(Figure 5.10 e,f). BrdU is incorporated in the DNA of
dividing cells [Nowakowski et al., 1989]. In contrast, no HDAC2-immunoreactivity
could be observed in adult neural stem cells that show astroglial properties and
are labeled by the green ﬂuorescent protein (GFP), whose expression is driven by
the human GFAP promoter [Doetsch et al., 1999; Nolte et al., 2001](Figure 5.10
g,h). These cells can also be identiﬁed according to their location in the adult
neurogenic zones as well as their morphology. Therefore stem cells do not show
HDAC2 expression in the adult brain, whereas all other cells are HDAC2+. All
results for the expression analysis of HDAC2 are summarized in Table 5.1.
5.1.5 Overlap of HDAC2 and Brg1 immunoreactivity
Having analyzed the expression pattern of HDAC1 and HDAC2, the expression
pattern of Brg1 was examined in vivo. Interestingly, there was an almost complete
overlay in the immunoreactivity of both proteins after double stainings for HDAC2
and Brg1 in the adult brain. While the expression pattern of Brg1 and HDAC2 were
diﬀerent in the embryonic neurosphere cultures, with Brg1 being highly expressed in
neural precursors and HDAC2 mainly in postmitotic cells, the picture in the adult
brain was rather diﬀerent. The coexistence of the HDAC2 and Brg1 proteins was
present in all regions in the brain, in particular in the DG and SEZ as the zones of
adult neurogenesis (Figure 5.11).
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Figure 5.10: HDAC2 immunoreactivity in the adult brain
a HDAC2 immunoreactivity depicted in an overview. b HDAC2 is found in NeuN+ neurons in
the granule cell layer (GCL) of the DG. Note the HDAC2 presence in the inner cell layer of the
DG, the subgranular zone (SGZ). c,d HDAC2 is detectable in Dcx+ cells in the SGZ (c) as well
as in the RMS (d). e,f HDAC2 immunoreactivity in BrdU+ transit-amplifying precursors in the
DG (e) and at the SEZ, which are DCX- (f). g,h No coimmunoreactivity detectable on
hGFAPeGFP sections with GFP labeling neural stem cells in both regions. Arrows depict
double-positive cells. DG= dentate gyrus, RMS= rostral migratory stream, SEZ= subependymal
zone, SGZ= subgranular zone. Scale bars: a 100µm; b, e 50µm; c, d, f, g, h 20µm.
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Figure 5.11: HDAC2 and Brg1 immunoreactivity in the adult brain
a,b Immunoreactivity of Brg1 and HDAC2 in the DG. Note the virtual overlap of HDAC2
(green) and Brg1 (red) immunostaining in the same cells. c,d Colocalization of Brg1 and HDAC2
at the SEZ and Ctx. Scale bars: a-d 50µm.
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5.1.5.1 Brg1 immunoreactivity in adult neural stem cells
Given the almost complete overlay in the immunoreactivities for HDAC2 and Brg1,
it was also examined whether the Brg1 protein was absent in adult neural stem
cells equal to HDAC2. Therefore immunohistology on sections from the transgenic
mouse line hGFAPeGFP was performed, in which eGFP is expressed under the
hGFAP promoter that is only active in astrocyte-like cells and stem cells. In both
regions of adult neurogenesis Brg1 immunoreactivity in GFP expressing cells could
be detected (Figure 5.12 a,b).
Figure 5.12: Brg1 immunoreactivity in adult neural stem cells
Brg1 is detectable together with eGFP on sections of hGFAPeGFP mice in both adult neurogenic
regions, the DG (a) and the SEZ (b). Arrows depict double-positive cells. White rectangles
depict regions of higher magniﬁcation. Scale bars: a 20µm; b 50µm.
5.1.5.2 Brg1 immunoreactivity at embryonic stages
The near identical expression of HDAC2 and Brg1 in the adult brain, with the ex-
ception of the additional presence of Brg1 protein in adult neural stem cells, called
for an examination of the expression pattern during embryonic neurogenesis. In
comparison to the HDAC2 expression at E14, Brg1 was also observed in the CP,
where postmitotic neurons are located. In contrast to HDAC2, however, Brg1 was
also present in the VZ progenitor cells (Figure 5.13 a). At the end of embryonic
neurogenesis at E18 the Brg1 protein was, like HDAC2, observed at high levels in the
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Ctx but was downregulated in the VZ (Figure 5.13 b) where HDAC2 immunoreac-
tivity increased from E18 on in precursor-like cells (Figure 5.5 d-f). A summary
of Brg1 immunoreactivity at diﬀerent stages as reported is depicted in Table 5.1.
Figure 5.13: Brg1 expression at embryonic stages
a Expression of Brg1 at E14. Note the high amount of the Brg1 protein in the VZ, but also in
the CP and in the GE. b At E18 the expression remains high in the Ctx, whereas it is redundant
in the VZ. Arrows point to high levels of Brg1 protein at the VZ. CP= cortical plate, Ctx=
cortex, GE= ganglionic eminence, VZ= ventricular zone. Scale bars: 100µm.
5.2 Functional analysis of HDAC2
The high levels of HDAC2 in postmitotic cells at all stages analyzed during brain
development and the diﬀerential expression of HDAC2 protein in adult, but not
embryonic neurogenic precursors prompted us to study the function of HDAC2 in
the central nervous system (CNS).
5.2.1 HDAC2 deﬁcient mice - construct design
In order to perform a functional analysis, a mouse line deﬁcient of HDAC2 was used
that will be referred to as HDAC2 deﬁcient (HDAC2 def) in the following. This
mouse line was obtained from a gene trap clone (ES clone no. W035F03) from the
German Genetrap Consortium. The gene trap was performed by an insertion of a
pPT1-βgeo vector in the genomic locus of HDAC2 on chromosome 10 integrating in
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Table 5.1: Summary expression analysis
Time Cell type HDAC1 HDAC2 Brg1
E14 neuronal progenitors ++ − ++
postmitotic neurons + ++ ++
P0 neuronal progenitors − + n.d.
glial progenitors ++ + n.d.
astrocytes ++ + ++
neurons − ++ ++
P5 neuronal progenitors − ++ n.d.
glial progenitors ++ + n.d.
astrocytes ++ + ++
neurons − ++ n.d.
P21 Type B cells n.d. − +
Type C cells n.d. + n.d.
Type A cells n.d. ++ ++
astrocytes ++ + ++
oligodendrocytes ++ + n.d.
neurons − ++ ++
adult Type B cells n.d. − +
Type C cells n.d. + +
Type A cells n.d. ++ ++
astrocytes ++ + ++
oligodendrocytes ++ + ++
neurons − ++ ++
the region of intron 8 (Figure 5.14 a). This leads to an interruption of the gene
in the catalytic domain thereby creating a fusion protein. This can be detected by
βgalactosidase staining and is responsible for the loss of functional protein tested
by Western Blot as well as Southern Blot to reveal the partial deletion of HDAC2
gene [Trivedi et al., 2007; Zimmermann et al., 2007]. As the HDAC2 antibody binds
to the C-terminal end of HDAC2 protein and the mutant protein lacks the normal
C-term, it cannot be detected by normal immunostaining for HDAC2 (Figure 5.14
b).
72
5 Results
Figure 5.14: HDAC2 gene trap construct
a Schematic depiction of the HDAC2 WT allele and the HDAC2 def allele. The insertion of the
pPT1-βgeo vector in intron 8 results in a mutant lacZ fusion protein. b Schematic overview of
the gene trap construction and depiction of WT and mutant protein. Note the disruption of the
zinc-ﬁnger binding domain in the deﬁcient protein, inducing a loss of the catalytic domain of
HDAC2.
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5.2.2 HDAC activity assay from WT and HDAC2 def tissue
To examine whether the overall HDAC activity is diminished in diﬀerent regions of
the adult brain, an HDAC activity assay of WT and HDAC2 def tissue of the OB,
HC and CB was performed in collaboration with Sabine Lagger (Max F. Perutz
Laboratories, Medical University of Vienna, Institute of Medical Biochemistry, Dr.
Bohr-Gasse 9/2, A-1030 Vienna). The HDAC activity, measured as counts per
minute (CPM), was reduced in all 3 tested brain regions. In the HC the decrease in
HDAC activity was highly signiﬁcant compared to the OB and CB (Figure 5.15).
Interestingly, the highest HDAC activity was measured in the cerebellum, where
developmental defects could already be detected at postnatal stages, an observation
that, with a view to the speciﬁc focus on the forebrain, will not be further discussed
within this work.
5.2.3 HDAC2 def mice - oﬀspring
HDAC2 def mice were born according to Mendelian rates. Neonatal pups were all
monitored and then genotyped at the age of 3weeks. If pups died during the ﬁrst
postnatal weeks, they were included in the statistical analysis (Figure 5.16).
5.2.3.1 Survival rate of HDAC2 def mice
After HDAC2 def mice were born according to Mendelian rates suggesting no se-
vere defects during embryonic development, as will be further explained in the next
paragraph, severe defects in the postnatal development shortly after birth lead to
the dynamic increase in lethality of HDAC2 def pups compared to WT littermates.
The complete knock out (KO) of HDAC2 has a 100% lethality in the ﬁrst 2 post-
natal days [Montgomery et al., 2007]. The HDAC2 def mice studied here, showed a
postnatal lethality of about 70% compared to WT or heterozygous littermates that
have a survival rate of nearly 100% (Figure 5.17).
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Figure 5.15: HDAC activity assay
Tissue from speciﬁc regions of the adult forebrain of WT and HDAC2 def mice was processed
and an HDAC activity assay was designed to compare the overall HDAC activity between WT
and HDAC2 def mice. CB= cerebellum, CPM= counts per minute, OB= olfactory bulb, HC=
hippocampus. SEM=*;**;*** depict p≤0,04 ;0,002 ;0,0001 , respectively.
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Figure 5.16: Genotypes of HDAC2 progeny
Genotypes of HDAC2 progeny are distributed normally according to Mendelian rates.
Figure 5.17: Postnatal survival rate of HDAC2 def mice
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5.2.4 Embryonic brain development of HDAC2 def mice
Immunostaining was performed on sections of WT and HDAC2 def mice (Figure
5.18 a,b) to test the speciﬁcity of the HDAC2 antibody that binds to the C-terminal
end of the HDAC2 WT protein, which is disrupted in the HDAC2 def mice and re-
placed by a lacZ fusion protein (Figure 5.14 b). Note that immunoreactivity was
absent on sections from HDAC2 def brains, conﬁrming the speciﬁcity of the anti-
body. At E14 (midneurogenesis) embryonic neurogenesis occurs completely normal,
the newly born neurons labeled by β-IIItubulin (Figure 5.18 c,d) form the CP
with the diﬀerent neuronal layers. Therefore radial migration of young neurons to
their ﬁnal destination from the basal to the pial surface is not obviously aﬀected
by the loss of the HDAC2 function. This is also consistent with the normal pat-
tern of radial glial cells in the forebrain depicted by an immunostaining with Blbp
(brain lipid binding protein) that is expressed in radial glia from early stages on
(Figure 5.18 e,f). The thickness of the Ctx and of the whole brain is compa-
rable to WT littermates at this stage of development. Along this line, quantiﬁca-
tions to examine cell density also showed no diﬀerence between HDAC2 def mice
and WT littermates (WT= 233±15 DAPI+ cells/0,01mm2, n=2; HDAC2 def=
238±8 DAPI+ cells/0,01mm2, n=2). The same was true for the neuronal density
in the CP (WT= 87±7 NeuN+ cells/0,01mm2, n=2; HDAC2 def= 91±7 NeuN+
cells/0,01mm2, n=2). To test whether proliferation might be aﬀected in HDAC2
def brains, two diﬀerent immunostainings were performed using Ki67 (Figure 5.18
g,h), a marker for all dividing cells and PH3 (Figure 5.18 i,j) labeling only cy-
cling cells in M-phase of mitosis. The number of proliferating cells in total and, in
more detail, cells in speciﬁc phases of mitosis (WT= 563±12 PH3+ cells/mm2, n=2;
HDAC2 def= 566±22 NeuN+ cells/mm2, n=2) remained unchanged.
5.2.5 Postnatal brain development of HDAC2 def mice
5.2.5.1 Phenotypic diﬀerences in body and organ size
The high postnatal lethality rate points to severe defects in the postnatal develop-
ment of HDAC2 def mice. Adult mice have a clear growth retardation compared
to their WT littermates. This raises the question when this phenotype starts? At
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Figure 5.18: Embryonic brain development of HDAC2 def mice
a,b Expression of HDAC2 at E14 on WT brain sections(a) and on HDAC2 def sections (b). Note
the absence of detectable WT protein by HDAC2 immunostaining. c,d Expression of
β-IIItubulin that labels young neurons in the Ctx is comparable between WT and HDAC2 def
embryos. e,f Blbp expression is not changed in the mutant mice at E14. g-j Proliferation
examined by an immunostaining with Ki67 (g,h) and PH3 (i,j) is not aﬀected in HDAC2 def
embryonic brains. The white line in (i,j) marks the ventricle. Ctx= cortex, GE= ganglionic
eminence. Scale bars: a,b,g,h 100µm; c,d,i,j 50µm; e,f 20µm.
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P3 the surviving animals showed no obvious diﬀerence in body size (Figure 5.19
a) while at P21, when postnatal development had progressed, a severe growth re-
tardation became manifest in almost all HDAC2 def mice. They were half of the
size and the weight of their WT littermates (Figure 5.19 b). Interestingly, not
only the body size but also the adult brain of HDAC2 def mice in comparison to
WT brains showed the same phenomenon, namely being smaller in size and weight.
Other single organs also showed a decrease in weight (≈25%), however, not related
to the overall reduction in size and weight [Zimmermann et al., 2007], but rather
independent thereof. The cross morphology of HDAC2 def brains was normal exam-
ined by sagittal sections of perfused and ﬁxed WT and mutant brains (Figure 5.19
e,f).
Figure 5.19: Phenotypic diﬀerences in body and organ size
a At P3 no diﬀerence in body size between the genotypes could be detected. b At P21 a severe
growth defect of HDAC2 def mice becomes manifest. c,d Sideview of a WT (c) and HDAC2 def
brain (d). Note the reduced size of the brain in the mutant situation. e,f Sagittal section of adult
WT (e) and HDAC2 def brain (f). Note the smaller size, but the comparable morphology of the
mutant brain. +/+ = WT, +/− = heterozygous mutant, −/− = homozygous mutant.
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5.2.5.2 Increased cell death at postnatal stages
While the embryonic development was completely normal in HDAC2 def mice, there
must be several defects occuring at early postnatal stages that lead to the growth
retardation defect and to the high postnatal lethality. The smaller size of the brain
might be a result of apoptosis occuring as previously described in other organs
such as the intestine [Zimmermann et al., 2007] in these mice. Therefore, activated
caspase 3 (casp3) was checked, a protein that is activated by cleavage in a small time
window when cells undergo apoptosis [Riedl and Shi, 2004]. There was a signiﬁcant
increase in the number of activated casp3+ cells throughout the brain (Figure 5.20
a,b). Neurogenic regions such as the HC were aﬀected as well as nonneurogenic
regions, e.g. the Ctx, while all showing a higher number of dying cells in HDAC2
def mice (Figure 5.20 c). Notably the minority of the casp3+ cells have neuronal
identity (Figure 5.20 d). This could be observed by double stainings of activated
caspase 3+ cells with GFAP, a marker for astrocytes (Figure 5.20 d) and by then
counting the percentage of double-positive cells in WT and HDAC2 def postnatal
brains. In the mutant brains the number of neuronal cells that are casp3+ is only
≈ 30% compared to 45% in WT animals (Figure 5.20 e).
5.2.6 Phenotypic changes in the adult brain of HDAC2 def
mice
5.2.6.1 Cytoarchitecture of the mutant brain
To examine whether the observed deﬁcits in the postnatal brain development have
a direct inﬂuence on the morphology and cytoarchitecture of HDAC2 def brains,
NeuN-immunostainings in the Ctx were performed (Figure 5.21 a,b). No diﬀerence
regarding the cytoarchitecture was detectable. Equally, the formation of the diﬀerent
layers of the Ctx appeared to be completely normal as shown by the expression of
a speciﬁc layer marker such as Cux2, which is only expressed in neurons of layer
2/3 (Figure 5.21 c,d). After quantiﬁying NeuN+ cells and DAPI+ cells in the
WT and HDAC2 def Ctx no diﬀerence in cell number could be observed (Figure
5.21 e,f). These observations were in line with the expectations, since no defects
in embryonic neurogenesis were detectable.
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Figure 5.20: Postnatal cell death in HDAC2 def mice
a,b Immunostaining of activated caspase 3 depicts the increase in apoptosis postnatally in
HDAC2 def (b) compared to WT brains (a). c Histogram shows the widespread cell death allover
the mutant brain at P0. d Cells undergoing cell death are positive for GFAP in the Ctx. e
Histogram depicts the percentage of neuronal cells undergoing apoptosis in WT and HDAC2 def
mice. Arrows in (a,b) depict casp3+ cells, in (d) a double-positive cell. CB= cerebellum, Ctx=
cortex, HC= hippocampus, OB= olfactory bulb, Str= striatum. SEM=*** depict p≤0,001 (Ctx),
0,0007 (HC), 0,0006 (CB) and 0,0008 (Cell type analysis). Scale bars: a,b 50µm; d 20µm.
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Figure 5.21: Cytoarchitecture of WT and HDAC2 def brains
a,b NeuN immunostaining of WT and HDAC2 def cortices. c,d mRNA expression of Cux2 in the
upper layers of the Ctx in WT and HDAC2 def brains. e,f Histograms show the density of
neurons (NeuN+) and the density of all DAPI+ cells in the Ctx. Note that the mutant Ctx is
completely normal in terms of neuronal as well as cell density. Ctx= cortex. Scale bars: 50µm.
82
5 Results
5.2.6.2 Increased cell death in adult neurogenic regions
The higher rates of cell death in the postnatal HDAC2 def forebrain were transient in
nature and declined to normal levels when gliogenesis around P21 came to an end.
Only two regions of adult neurogenesis, the DG and the SEZ/RMS/OB system
showed higher levels of apoptosis in the adult mutant brain (Figure 5.22 a). The
colocalization of casp3 and neuronal markers such as NeuN revealed a prevalence
of neurons amongst the dying cells. In the HDAC2 def OB 72% of the activated
caspase 3+ cells were NeuN+, whereas in the WT OB only 43% of the dying cells
were NeuN+ (Figure 5.22 b,c). This points toward the fact that speciﬁcally adult
generated neurons die in HDAC2 def brains.
Figure 5.22: Cell death in the adult brain of WT and HDAC2 def mice
a Cell death persists in adult neurogenic regions, the DG and SEZ/RMS/OB system in HDAC2
def brains. b The number of neuronal cells (NeuN+) undergoing apoptosis in the OB of HDAC2
def mice is increased. c Fluorescent micrograph shows an apoptotic cell that is identiﬁed as a
neuron by NeuN double staining. OB= olfactory bulb. Arrow depicts a double-positive cell.
SEM=**;*** depict p≤0,0011 ;0,0001 (OB) and 0,0007 (Cell type analysis). Scale bar: 20µm.
5.2.7 The adult neurogenic regions in HDAC2 def mice: DG
5.2.7.1 Expression of Dcx in the DG
In order to examine adult neurogenesis in HDAC2 def mice the expression of dif-
ferent lineage markers, such as Dcx was analyzed. Dcx is expressed in dividing
neuroblasts and also in young immature neurons that have previously exited the
cell cycle [Abrous et al., 2005]. The immunostaining of Dcx show a remarkable ﬁnd-
ing in the DG. A prominent loss of Dcx+ cells in HDAC2 def DG (Figure 5.23
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a,b; Figure 5.24 a,b) could also be revealed by the quantiﬁcation of Dcx+ cells as
depicted in Figure 5.23 c. The signiﬁcant decrease concerned the total number of
Dcx+ cells in the DG of mutant mice suggesting that mitotic as well as postmitotic
Dcx+ cells could be diminished. The higher magniﬁcation of single Dcx+ cells also
revealed an aberrant morphology in the HDAC2 def DG. The dendrites appeared
shorter in length and the dendritic tree was reduced in size. As it was shown by other
research groups [Kronenberg et al., 2003], two types of Dcx+ cells are present in the
adult DG. The Dcx+ cells that are still cycling show a more horizontal morphology,
while Dcx+ postmitotic immature neurons have a characteristic radial morphology.
The latter type of Dcx+ cells appeared most aﬀected in the HDAC2 def brains.
5.2.7.2 Proliferation analysis in the HDAC2 def DG
In order to to unravel whether defects in proliferation caused the decrease in Dcx+
cells in adult neurogenesis, the proliferation rates in WT and mutant mice were
checked. This was done by giving a short pulse of BrdU 1hour before the animals
were sacriﬁced as described (Material and Methods 4.3). Consistent with the ob-
servations at earlier postnatal stages, a signiﬁcant increase in the overall number of
BrdU+, i.e. fast proliferating cells was observed in the SGZ of HDAC2 def mice
compared to WT littermates. BrdU labeled cells were then double-stained for sev-
eral lineage markers such as GFAP to label adult stem cells and Dcx to detect
proliferating neuroblasts. The cells that are only BrdU+ are supposed to be the
transit-amplifying precursor cells that are GFAP- and Dcx-. The histogram in Fig-
ure 5.23 d shows the quantiﬁcation of this cell type analysis of the BrdU-labeled
cells. The relative composition of cell types amongst the observed proliferating cells
revealed no diﬀerence between the WT and HDAC2 def DG.
5.2.7.3 BrdU label retaining experiment in the DG of HDAC2 def mice
To examine the progeny of the above labeled progenitors, mice were treated with
BrdU added to the drinking water for 2weeks followed by one additional week with
normal water to dilute the BrdU in the fast proliferating cells that had already
incorporated the DNA-base analogue. This protocol allows to monitor not only
the number of newly generated neurons but also the number of stem cells in the
mutant DG. If stem cells are diminished this could also lead to a loss of neurons
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Figure 5.23: Adult neurogenesis in the DG of WT and HDAC2 def mice
a,b Fluorescent micrographs depict the reduced number of Dcx+ cells in the HDAC2 def DG. c
Statistical analysis underlines the signiﬁcant decrease in number of Dcx+ neuroblasts and newly
generated neurons. d A BrdU short pulse analysis shows an increase in fast proliferating cells in
the mutant DG. Note that cell type composition remained unchanged. e-h BrdU label retaining
experiment (2 weeks BrdU/1 week water). The number of newly generated NeuN+ neurons is
signiﬁcantly reduced (e). The number of stem cells (yellow fraction) is not altered in HDAC2 def
DG. (f). Fluorescent micrographs in g,h underline the reduced number of newly generated
neurons after 3 weeks of BrdU treatment. White and red rectangles depict cells in higher
magniﬁcation. SEM=*;**;*** depict p≤0,01 ;0,005 ;0,0001 . Scale bars: a,b 50µm; g,h 20µm.
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at the end of the neurogenic diﬀerentiation pathway. As the histograms in Figure
5.23 e,f show, the number of BrdU+NeuN+ cells was signiﬁcantly reduced in the
HDAC2 def DG, whereas the stem cell number (BrdU+GFAP+) was not altered.
The fraction of BrdU+Dcx+ cells was increased, whereas already the number of
BrdU+Dcx+NeuN+ cells starts to decline in the HDAC2 def DG. Therefore the
number of maturating neurons declines in the HDAC2 def DG at the time of NeuN
upregulation (Figure 5.23 e,f). These are very likely the cells that die as observed
by casp3 staining.
5.2.7.4 Expression of neuron-speciﬁc genes in the HDAC2 def DG
To further determine when neuronal maturation resulted in the initiation of cell
death that is then reﬂected in a reduction of cells positive for Calretinin (Calr), a
Ca-binding protein expressed at the time of transition from Dcx to NeuN expression
of maturating neurons [Johansson et al., 1999] was examined in the DG of WT
and mutant mice. In Figure 5.24 a-c the reduction in the number of Calretinin+
neurons in the HDAC2 def DG is depicted via a double-immunostaining with Dcx.
In the BrdU label retaining experiment 6% of BrdU+ cells were Calretinin+ in the
WT, whereas only 1% contained Calretinin in the mutant DG. A more global marker
for cells diﬀerentiating along the neuronal lineage is NeuroD1, a bHLH transcription
factor that has been implicated in the regulation of neuronal diﬀerentiation in the
DG during development [Miyata et al., 1999]. Also NeuroD1 mRNA was found to
be reduced in the HDAC2 def DG shown by in situ hybridization (Figure 5.24
d,e).
5.2.7.5 Retroviral injection of GFP in the HDAC2 def DG
In order to rule out that neuronal cell death in HDAC2 def mice cannot be explained
by a speciﬁc sensitivity of HDAC2 def cells to BrdU-labeling [Caldwell et al., 2005]
we injected a retrovirus containing green ﬂuorescent protein (GFP) into the DG
to trace the progeny of infected precursor cells in the DG [Breunig et al., 2007].
Cells that were dividing at the time point of retroviral injection can incorporate
the viral DNA encoding for GFP into their genome and hence inherit it to all their
progeny that then continues to express GFP. WT and HDAC2 def animals were
sacriﬁced either 14 days or 21 days after viral injection. Brains were then analyzed
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Figure 5.24: Neuronal marker gene expression in the DG
a,b Fluorescent micrographs depict double-staining of Dcx and Calretinin. Note the reduced
number of cells positive for both markers in HDAC2 def DG. c Histogram shows the
quantiﬁcation of BrdU+Calr+ cells. Note the signiﬁcant reduction in the mutant DG. d,e in situ
hybridization of NeuroD1 shows an overall reduction of mRNA levels in the hippocampus of
HDAC2 def mice. SEM=* depict p≤0,01 . Scale bars: a,b 20µm; d,e 100µm.
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by immunohistochemical means. After 14 days the proportion of GFP+ cells that
express Dcx was slightly although not signiﬁcantly increased in the HDAC2 def
brains (Figure 5.25 a). After 21 days, some of the GFP+ cells had diﬀerentiated
into NeuN+ neurons. These mature neurons were strongly reduced to less than
half in number in HDAC2 def DG, consistent with the reduction of BrdU+NeuN+
cells after BrdU labeling (Figure 5.25 b). The proportion of GFP+Dcx+ cells was
still increased, suggesting a similar eﬀect to the results of the BrdU label retaining
experiment after 3 weeks. This experiment fully conﬁrmed the results obtained
by the performed BrdU studies, thereby demonstrating that the defect in neuronal
diﬀerentiation cannot be explained by the concern that HDAC2 def cells might be
BrdU sensitive and die after BrdU incorporation.
Figure 5.25: Retroviral injection of GFP in the DG of WT and HDAC2 def mice
a Histogram shows GFP+ cells 14 days after retroviral injection. In this experiment only one
pair of WT and HDAC2 brains was analyzed, both hemispheres were pooled. b Histogram shows
the identity of GFP+ cells 21 days after retroviral GFP injection into the DG of WT and
HDAC2 def mice. Note the signiﬁcant increase in Dcx+ cells and the signiﬁcant decrease in
NeuN+ cells amongst GFP+ cells after 21 days in the HDAC2 def mice. c,d Micrographs depict
GFP+NeuN+ cells 21 days after GFP injection in the WT and HDAC2 def DG. Arrows depict
double-positive cells. SEM=**;*** depict p≤ 0,005 ;0,0001 . Scale bars: c,d 20µm.
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5.2.7.6 Upregulation of Sox2 and Prox1 in the mutant DG
The increased proliferation of adult neurogenic precursors in HDAC2 def mice may
be due to the down-regulation of genes expressed at more immature stages during
neuronal maturation. As many progenitors in the SGZ express Sox2 [Gage, 1998],
Sox2+ cells in the HDAC2 def and WT DG were examined. As expected, not only
a slight increase in the number of Sox2+ cells was observed but also a persistence
of Sox2 in some Dcx+ cells in the HDAC2 def DG, an observation that was rarely
seen in the DG of WT littermates (Figure 5.26 a,b). Statistics underline the
colocalization of Sox2 and Dcx in a signiﬁcantly higher percentage (Figure 5.26 e,f).
The transcription factor Prox1 is expressed in young neurons in the DG [Lavado and
Oliver, 2007]. Prox1+ neurons appeared to be increased also in the mutant DG as
depicted in Figure 5.26 c,d as a broader band overlapping with the mature NeuN+
neurons in the HDAC2 def DG compared to the WT DG. Thus, the delay in the
downregulation of genes like Sox2 that are expressed in neuronal progenitors may
cause conﬂicting signals during further maturation of newly born cells in HDAC2
def mice.
5.2.8 The adult neurogenic regions in HDAC2 def mice: SEZ
To understand whether the detected phenotype in the DG was also present in the
second neurogenic region, the SEZ, adult neurogenesis in the SEZ and OB of HDAC2
def mice and their WT littermates was examined. Same as in the DG the number of
Dcx+ cells was also reduced in the OB of HDAC2 def mice. Adult neural stem cells
generate neuroblasts at the SEZ that then migrate toward the OB in the RMS. In
the OB itself they reach their ﬁnal destination by radial migration. This pattern was
signiﬁcantly altered in HDAC2 def mice (Figure 5.27 a,b), as Dcx+ neuroblasts
seem to spread in an unorganized manner in the OB. Similar to the results obtained
in the DG the number of BrdU-labeled cells in the SEZ was also increased after a
short BrdU pulse (Figure 5.27 c). Furthermore, cells that were BrdU+ in the BrdU
label retaining protocol were also reduced in number in the HDAC2 def SEZ, again
comparable to the DG results (Figure 5.27 d). The analysis of BrdU+NeuN+
neurons in the OB also revealed a decrease in the number of mature neurons in the
HDAC2 def OB (Figure 5.27 e-g). Taken together, the decrease in adult generated
neurons was observed to a similar extent in the two regions of adult neurogenesis.
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Figure 5.26: Upregulation of Sox2 and Prox1 in the HDAC2 def DG
a,b Double-staining with Sox2 and Dcx shows the increase of Sox2 expressing cells that are still
Dcx+ in the HDAC2 def DG. c,d Prox1 seems to be upregulated and diﬀerently localized in the
DG of mutant mice, shown in the inlay by a double-staining with NeuN. e Histogram shows the
slighty increased number of Sox2+ cells in the HDAC2 def DG. f Histogram shows the signiﬁcant
increase in the percentage of Sox2+Dcx+ cells in HDAC2 def DG. Arrows depict double-positive
cells. SEM=* depict p≤ 0,02 . Scale bars: a-d 20µm.
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Figure 5.27: Adult neurogenesis in the SEZ/RMS/OB of WT and HDAC2 def mice
a,b Fluorescent micrographs depict Dcx+ neuroblasts in the OB. Note the signiﬁcant reduction
in the mutant mice. c BrdU short pulse experiment shows an increase in proliferating neural
precursors in the SEZ. d,e The quantiﬁcation of the BrdU label retaining experiment shows a
signiﬁcant reduction in BrdU+ cells in the SEZ (d) as well as BrdU+NeuN+ cells in the OB (e).
f,g Antibody stainings against BrdU and NeuN depicting the reduced number of newly generated
neurons within 3 weeks of BrdU label retaining experiment. GCL= granule cell layer. SEM=*;**
depict p≤0,01 ;0,005 . Scale bar: 20µm.
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5.2.8.1 Fluorescence-activated cell sorting (FACS) analysis
To further quantify the proportion of neuroblasts in the SEZ and OB WT and mu-
tant SEZ and OB of 5mice, each was dissected and cells prepared as described in
Materials and Methods. Cells were stained against PSANCAM, a surface protein
expressed in neuroblasts. Fluorescent cells positive for PSANCAM were isolated
using a FACSAria (BD). Notably, the number of PSANCAM+ cells was reduced
in OB tissue of HDAC2 def mice, conﬁrming the reduced number of diﬀerentiating
neurons in the OB (Figure 5.28). By contrast, the number of neuroblasts posi-
tive for PSANCAM was increased after sorting cells from the SEZ of HDAC2 def
mice (Figure 5.29). This ﬁnding was also consistent with the increase in prolifer-
ating cells at the SEZ in HDAC2 mutant mice after a short pulse of BrdU. Both
FACS analysis experiments were performed twice with comparable results. Taken
together, these results reﬂect the observed phenotype in vivo, namely that neuronal
diﬀerentiation is impaired in adult neurogenic regions.
5.2.9 A gliogenic region in HDAC2 def mice: subcortical
white matter (SCWM)
5.2.9.1 Proliferation analysis in the HDAC2 def SCWM
Besides the phenotypic changes in the adult neurogenic regions, a prominent increase
in cells that have incorporated BrdU within 1 hour before analysis could be observed
in the region of the subcortical white matter. This region is located between the
Ctx and the HC extending from the caudal edge of the lateral ventricle and ending
in the caudal part of the Ctx. It is described to contain gliogenic precursors but it
was shown previously, that also some cells may carry neurogenic potential as they
express Dcx [Nunes et al., 2003; Takemura, 2005]. In HDAC2 def mice a broad
band of BrdU+ cells lining the HC in a sagittal view after a short pulse of BrdU
could be detected (Figure 5.30). To examine the identity of these proliferating
cells, sections were double-stained with Dcx and GFAP. 56% of BrdU+ cells were
Dcx+, and 10% expressed GFAP (remaining 34% was only BrdU+) compared to
the WT SCWM where 10% of BrdU+ cells were Dcx+, the remaining 90% was
only BrdU+, pointing to the fact that they were supposedly a mixed population of
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Figure 5.28: FAC sorting with PSANCAM from OB of WT and HDAC2 def mice
a,b FAC sorted cells of WT (a) and mutant OBs (b) were measured according to size (y-axis
depicts FSC-A) and granularity (x-axis depicts SSC-A) of individual cells. a',b' The predeﬁned
cells in a,b were measured according to width (y-axis depicts FSC-W) and height (x-axis depicts
FSC-H) of individual cells to exclude cell clumps. a,b All chosen PSANCAM+ cells (APC-A
on y-axis) were measured according to their size again (x-axis depicts FSC-A). a ',b ' Note the
reduced percentage of P3 containing predeﬁned PSANCAM+ cells in HDAC2 def OBs. FSC-A=
forward scatter all, FSC-H= forward scatter height, FSC-W= forward scatter width, SSC-A=
side scatter.
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Figure 5.29: FAC sorting with PSANCAM from SEZ of WT and HDAC2 def mice
a,b All FAC sorted cells of WT (a) and mutant SEZs (b) were measured according to size (y-axis
depicts FSC-A) and granularity (x-axis depicts SSC-A) of individual cells. a',b' The predeﬁned
cells in a,b were measured according to width (y-axis depicts FSC-W) and height (x-axis depicts
FSC-H) of individual cells to exclude cell clumps. a,b All chosen PSANCAM+ cells (APC-A
on y-axis) were measured according to their size again (x-axis depicts FSC-A). a ',b ' Note the
increased percentage of P3 containing predeﬁned PSANCAM+ cells in HDAC2 def SEZs.
FSC-A= forward scatter all, FSC-H= forward scatter height, FSC-W= forward scatter width,
SSC-A= side scatter.
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precursor cells that have either neurogenic or gliogenic potential. This suggests that
a loss of the HDAC2 function caused a widespread increase in fast proliferating cells
in both neurogenic and non-neurogenic regions of the forebrain.
Figure 5.30: BrdU short pulse analysis in the SCWM
a,b Proliferating cells labeled with a short BrdU pulse in the WT (a) and HDAC2 def SCWM
(b) shown in a sagittal view. Ctx= cortex, HC= hippocampus, SCWM= subcortical white
matter. Anterior is to the left, posterior is to the right side of the panel. Scale bars: a,b 50µm.
5.2.9.2 Retroviral injection of GFP in the SCWM
To examine the progeny of the cycling cells in the mutant SCWM more directly,
we injected the GFP-containing retrovirus in the SCWM of HDAC2 def mice and
analyzed the GFP+ cells 14 days after injection. GFP labeled cells could be detected
some distance away from the injection site that is located in the center of the panel in
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Figure 5.31. GFP+ cells had spread either to the lateral ventricle or to the caudal
end of the Ctx. GFP+ cells express to some extent GFAP as shown by costaining.
In order to further examine whether GFP+ cells may enter the grey matter (GM) at
later stages, mice were analyzed 21 days after GFP injection. However, no GFP+
cells were observed in the GM of the Ctx after 21 days, while GFP+ cells remained
restricted to the WM.
Figure 5.31: GFP injection in the SCWM of HDAC2 def mice
Lineage tracing of proliferating cells in the SCWM. GFP labeled cells can be detected either in
the caudal Ctx (right) or at the dorsal wall of the lateral ventricle (left) and partially express
GFAP. Ctx= cortex, HC= hippocampus, SCWM= subcortical white matter. Arrows depict
double-positive cells. White rectangles show GFP+ cells in higher magniﬁcation. Scale bar:
50µm.
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5.2.10 Analysis of the HDAC2 function in vitro
5.2.10.1 Expression of HDAC2 in neurosphere cultures
Since the HDAC2 function lacks in all tissues of this HDAC2 gene trap mouse
line and hence may exert indirect eﬀects on adult neurogenesis, the neurosphere as-
say was used to examine the propagation and diﬀerentiation of neural stem and
progenitor cells and their diﬀerentiation properties were isolated under in vitro
conditions. Embryonic neurosphere cultures were prepared by isolating E14 Ctx
and adult neurosphere cultures were done by dissecting the SEZ. The expression of
HDAC2 in embryonic neurospheres is mainly present in postmitotic neurons that
are β-IIItubulin+ and weakly detectable in GFAP+ astrocytes (Figure 5.2 b).
In adult neurosphere cultures HDAC2 immunoreactivity was observed more ubiqui-
tously including strongly expressing GFAP+ cells that after 2 hours are probably still
proliferating. As it is believed that the neural precursors in neurosphere cultures are
not multipotent, slow-dividing stem cells but even more likely fast-dividing, transit-
amplifying progenitor cells that also express GFAP [Capela and Temple, 2002; Imura
et al., 2003]. This suggests that HDAC2 immunoreactivity is weakly detectable in
those cells in vitro (Figure 5.32 a). After 2 days of diﬀerentiation HDAC2 is
strongly expressed in young neurons that are β-IIItubulin+ (Figure 5.32 b).
5.2.10.2 HDAC2 function in embryonic neurosphere cultures
As our in vivo analysis had demonstrated a speciﬁc eﬀect of HDAC2 on adult, but
not embryonic neurogenesis, we tested whether this diﬀerence could be veriﬁed in
the neurosphere in vitro system. Furthermore, the striking diﬀerence in HDAC2
expression in embryonic versus adult neurosphere cultures prompted us to examine
the neuronal diﬀerentiation of HDAC2 def neurosphere cells derived from the embry-
onic Ctx. Consistent with the in vivo results, these cells could diﬀerentiate well into
mature neurons and no defects were observed in the process formation or neuronal
survival after 7 days in vitro (DIV) (Figure 5.33).
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Figure 5.32: HDAC2 expression in neurosphere cultures
a In adult neurospheres already 2 hours after plating HDAC2 immunoreactivity is detectable in
almost all cells with the highest immunoreactivity in diﬀerentiating neurons that are
β-IIItubulin+ and weaker in GFAP+ astrocytes. b HDAC2 immunoreactivity in adult
neurospheres from the SEZ 2 days after plating. Note that HDAC2 immunoreactivity increases in
GFAP+ astrocytes and strong HDAC2 immunoreactivity persists in β-IIItubulin+ neurons. Scale
bar: 20µm.
Figure 5.33: WT and HDAC2 def embryonic neurospheres
a,b WT and HDAC2 def cortical embryonic neurosphere cultures. Note the normal
diﬀerentiation of β-IIItubulin+ neurons in HDAC2 def cultures after 7 days in vitro. c Histogram
depicts the comparable number of β-IIItubulin+ neurons generated after 7 days of diﬀerentiation
in WT and HDAC2 def neurosphere cultures of the E14 Ctx. Scale bar: 20µm.
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5.2.10.3 HDAC2 function in adult SEZ neurosphere cultures
Consistent with the higher number of progenitors observed in the HDAC2 def SEZ in
vivo, a signiﬁcantly increased number of primary neurospheres formed by the HDAC2
def adult SEZ (aSEZ) cells was also observed compared to those derived from the
WT SEZ (Figure 5.34 a). Further consistent with the in vivo results, the number
of self-renewing stem cells appeared no diﬀerent in this assay as the number of
secondary neurospheres formed by HDAC2 def or WT neurosphere cells was identical
(Figure 5.34 b) although these cells showed weak HDAC2 immunoreactivity. In
the next step we exposed neurosphere cells to diﬀerentiating conditions by plating
them onto adhesive substrates and omitting the growth factors EGF and FGF2. At
this stage cells were infected with a GFP-containing retroviral vector to identify
the cells that were still proliferating at the time of plating and follow their lineage
[Hack et al., 2004]. Already after 8 days, neuronal diﬀerentiation of HDAC2 def cells
was impaired as neurons exhibited fewer and shorter neurites than those derived
from WT littermates (Figure 5.34 c,d). While the proportion of diﬀerentiating
neurons amongst the GFP labeled cells was only weakly reduced in the HDAC2
def cultures by 8DIV with diﬀerentiating conditions (Figure 5.34 e), it became
severely reduced to less than half after 14 days (Figure 5.34 f). Thus, neuronal
diﬀerentiation defects of HDAC2 def cells appear de novo in isolated cells in vitro,
suggesting that this phenotype is not due to general alterations in the HDAC2 def
mice.
5.2.11 Transplantation of WT cells into the HDAC2 def SEZ
While the above results imply a cell-autonomous role of HDAC2 in the adult neuro-
genic lineage, additional defects in the adult neurogenic niche that might add to the
cell-autonomous eﬀects in vivo cannot be excluded. We therefore tested whether WT
cells could diﬀerentiate normally in an HDAC2 def environment by transplanting
them into the adult SEZ of HDAC2 def mice (Figure 5.35 a). As described previ-
ously [Colak et al., 2008], cells were isolated from the SEZ of 6 week old mice that
ubiquitously express the ﬂuorescent protein Venus targeted to the plasma membrane
[Rhee et al., 2006] and transplanted into the SEZ of 8week old WT and HDAC2 def
littermates. Transplanted cells were detected 7 or 21 days after transplantation and
double-stained for neuron-speciﬁc antigens, e.g. Dcx or NeuN. For each time point
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Figure 5.34: WT and HDAC2 def adult SEZ neurospheres
a,b Histograms depict the increase in the number of primary neurosphere forming cells (=
proliferating cells) (a), but not self-renewing neurospheres (=stem cells) (b) isolated from
HDAC2 def SEZ. c,d Fluorescent micrographs show that HDAC2 def cells exhibit shorter
processes already after 8 days in diﬀerentiationg conditions. e,f Histograms depict the slight
decrease of neurons generated in HDAC2 def cultures after 8DIV (e). After 14DIV upon loss of
HDAC2 neurons are reduced to half compared to WT neurons, presumably through cell death.
SEM=*;** depict p≤0,03 ;0,006 . Scale bar: 20µm.
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2WT and 2HDAC2 def mice were used for transplantation. Already after 7 days
GFP+ cells that are Dcx+ and show a neuroblast morphology (Figure 5.35 b)
could be observed in the RMS migrating towards the OB. After 21 days a similar
proportion of transplanted WT cells had diﬀerentiated into mature NeuN-positive
neurons in the HDAC2 def environment (Figure 5.35 c). Taken together, these
experiments imply no major changes in the adult neurogenic niche in the HDAC2
def mice but rather demonstrate a cell-autonomous role for the catalytically active
form of HDAC2 in proliferation and neuronal diﬀerentiation of adult progenitors.
Figure 5.35: Transplantation of WT cells into the HDAC2 def SEZ
a Technique of the transplantation of GFP-labeled WT SEZ cells into the HDAC2 def SEZ. b
Fluorescent micrographs depict a transplanted cell (GFP+) that expresses Dcx in the RMS and
shows normal morphology typical for neuroblasts. c Histogram shows the quantiﬁcation of GFP+
cells after 21 days that were found to be NeuN+ in the HDAC2 def OB. Note the comparable
numbers in WT controls and HDAC2 def mice. Arrows depict double-positive cells. Scale bar:
10µm.
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5.2.12 The role of HDAC1 during brain development of
HDAC2 def mice
As HDAC1 and HDAC2 are often found in the same repressor complexes but show
a complementary protein expression pattern, one possibility could be that HDAC1
compensates for the loss of the HDAC2 function. HDAC1 is expressed at the ven-
tricular zone in neural precursor cells at embryonic stages and starts to be expressed
in postmitotic neurons in the CP on mutant sections. However, during postnatal
brain development HDAC1 was exclusively expressed in non-neuronal cells given
that no protein could be detected in postmitotic NeuN+ neurons (Figure 5.36
a,b). This holds true until postnatal development ends at around P21 (Figure
5.36 c). Furthermore, no HDAC1 protein could be found in neurogenic regions at
postnatal stages, e.g. in the developing HC (Figure 5.3 b). At late postnatal stages
HDAC1 is expressed in the HC but does not seem to be upregulated in the HDAC2
def DG to compensate for the loss of HDAC2 in adult neurogenic regions (Figure
5.36 d,h). By contrast, in HDAC2 def brains HDAC1 was present in NeuN+ neu-
rons from neonatal stages on, here shown at P5 (Figure 5.36 e,f). Later on, at
the end of postnatal development HDAC1 expression began to decline to normal
levels and from there on was observed only in non-neuronal (NeuN-) cells (Figure
5.36 g). These ﬁndings show that HDAC1 might compensate for the loss of func-
tional HDAC2 protein during brain development as it was upregulated in neurons
in HDAC2 def mice, but not in adult neurogenic regions.
5.2.13 Western Blots of HDAC1 and HDAC2 of WT and
HDAC2 def brain tissue
To further examine the protein levels of HDAC1 in the WT and the HDAC2 def
background, Western Blots were performed to show the protein levels of HDAC1
and HDAC2 in diﬀerent brain regions. The HDAC2 protein could be detected in
tissue lysates from all tested WT brain regions, whereas HDAC2 was not detectable
in HDAC2 def brain regions (Figure 5.37). HDAC1 as a potent candidate to
compensate for the loss of functional HDAC2 protein was found to be reduced also
in HDAC2 def tissue lysates compared to WT and normalized to β-actin control
(Figure 5.37). Thus, in the adult brain there is no upregulation of a closely related
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Figure 5.36: HDAC1 immunoreactivity during development in WT and HDAC2 def
mice
a,b In WT sections at P5 HDAC1 expression is restricted to non-neuronal cells and shows no
overlap with NeuN expression. c At P21 it is not detectable in NeuN+ cells. d Expression of
HDAC1 in zones of neurogenesis at P40 is restricted to non-neuronal cells. e,f HDAC1 comes up
in NeuN+ neurons in HDAC2 def brains at P5. g At the end of postnatal development
upregulation of HDAC1 in neurons declines to normal levels again. h No upregulation of HDAC1
in neurogenic zones, e.g. the DG at P40. Ctx= cortex, DG= dentate gyrus, WM= white matter.
White rectangles show higher magniﬁcation. Scale bars: a-g 50µm.
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HDAC family member, HDAC1, in HDAC2 def brain regions.
Figure 5.37: HDAC Western Blots
The Western Blots show the HDAC1 protein (upper panel) in all WT brain regions that becomes
reduced in HDAC2 def brain regions, e.g. the SEZ, HC as the zones of adult neurogenesis. The
HDAC2 protein was completely undetectable in HDAC2 def brain tissue (middle panel). The
lower panel shows β-actin control. CB= cerebellum, Ctx= cortex, HC= hippocampus, OB=
olfactory bulb, SEZ= subependymal zone.
5.2.14 Microarray analysis of WT and HDAC2 def brain
regions
The results of the functional analysis of HDAC2 prompted us to perform a gene
expression analysis of WT and HDAC2 def brain tissue from the HC, OB and SEZ
by oligonucleotide microarrays. The aim of this detailed examination was to identify
candidate genes that are diﬀerentially regulated between the two genotypes provid-
ing hints which mechanisms might be involved in the above described phenotype
of HDAC2 def mice in adult neurogenesis. Figure 5.38 shows the clustering of
the tissue derived from WT and HDAC2 def animals (here labeled with KO). The
OB analysis was performed by using tissue from three diﬀerent WT and HDAC2
def animals. For the HC analysis tissue from 3 WT but only 2HDAC2 def animals
were used excluding one HDAC2 def mouse, given its RNA expression was only half
reduced compared to WT, suggesting that this animal was a heterozygous mouse.
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For the SEZ only one pair was studied, because all other RNA preparations showed
a high variance in regard to quality and thus could not be compared. This had
to be taken into account when analyzing and interpreting the data. The cluster-
ing was performed on normalized RMA data (see Materials and Methods 4.13.2)
and showed a separation of diﬀerent tissues although not a complete separation of
genotypes, which is relevant for the reproducibility and signiﬁcance of these data
(Figure 5.38).
Figure 5.38: Clustering of RMA microarray data
Hierarchical clustering of HDAC2 microarray data. In both types of clustering, agglomerative or
divisive, there is a separation of tissue but not genotypes.
However, despite the redundant diﬀerence between brain regions, the highest expres-
sion diﬀerences between genotypes should give some insights into key genes that are
diﬀerentially expressed in the HDAC2 def neurogenic regions. In order to have an
impression of possible genes that are diﬀerentially regulated the list of the 55Best-
of-results that were signiﬁcantly diﬀerent regulated in WT and HDAC2 def brain
regions, either the OB or HC, was analyzed. More genes were found to be upregu-
lated than one would assume from the repressor function of HDAC2 (Figure 5.39).
One of the most highly regulated gene found amongst them was Protocadherine β
9 (Pcdhb9). Protocadherines are expressed in the central nervous system, where
they play a role in synapse formation [Junghans et al., 2008]. Therefore, it might be
interesting to study Pcdh9 in more detail in HDAC2 def mice. Moreover, 22 genes
were also found to be downregulated in HDAC2 def brain regions (Figure 5.40),
of which the calcium/-calmodulin-dependent protein kinase IIa (CamKIIa) is the
most interesting. It was reported for CamKII that it interacts with Nr2b, a sub-
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Figure 5.39: Best-of list of all upregulated genes
Figure 5.40: Best-of list of all downregulated genes
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unit of the NMDA receptor expressed in neurons and involved in synaptic plasticity
and learning [Zhou et al., 2007]. NMDA receptors are important for the survival
of newly generated neurons in the adult brain [Tashiro et al., 2006]. As proof of
principle, the two diﬀerent probe sets of HDAC2 were also found to be downreg-
ulated to undetectable levels (Probe set IDs 1445684 and 1449080). Both probe
sets bind to the C-terminal end of HDAC2, which is altered in the mutant mice.
Moreover, the observed defects in HDAC2 def mice occurred only in a small amount
of cells, namely the neuronal progenitors and the newly generated neurons in the
tissue examined. Therefore, this microarray analysis was decided not to follow in
more detail, but rather to perform a more clear microarray analysis with FAC sorted
cells from HDAC2 ﬂoxed/ﬂoxed mice. This mouse line crossed with an inducible
GLASTCreERT2line [Mori et al., 2006] and in addition with a reporter line (ZEG)
can be used to speciﬁcally delete HDAC2 in adult neural stem cells and their progeny
which will be GFP+. Only then can these GFP+ cells that lack HDAC2 in adult
neurogenic regions be used for a microarray analysis.
5.3 Functional analysis of Brg1
5.3.1 Brg1 ﬂoxed mice - construct
Former studies have suggested that HDAC2-containing complexes and chromatin re-
modeling complexes recruit each other and act in an orchestratic manner [Narlikar
et al., 2002]. After examining the extent of the overlay of Brg1 and HDAC2 expres-
sion in the adult brain we wanted to check whether deletion of Brg1 would cause the
same phenotype as observed in the HDAC2 def mice. Brg1 ﬂoxed/ﬂoxed mice were
received from Pierre Chambon, Institut de Genetique et de Biologie Moleculaire et
Cellulaire, CNRS/INSERM/ULP, College de France, 67404 Illkirch Cedex, CU de
Strasbourg [Sumi-Ichinose et al., 1997] generated through the homologous recombi-
nation in ES cells using the pSNF2βL:LHLa targeting vector. The Brg1 ﬂoxed locus
and the targeting strategy are shown in Figure 5.41. The insertion of the vector
leads to the deletion of exons 2 and 3 of the genomic coding sequence. The Brg1 L2
allele can be detected by PCR with the primers TG57 (indicated as P1) and TH185
(indicated as P2) (Table 4.1), as described above to identify animals homozygous
for the ﬂoxed Brg1 allele.
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Figure 5.41: Brg1 ﬂoxed locus
Targeting strategy of the mouse Brg1 locus to generate mice harboring Brg1 ﬂoxed alleles.
Partial structure of the Brg1 locus [Brg1 (+) allele]. Exons are indicated by black boxes. The
Brg1 L3 allele containing the three loxP sites (lox) and the hygromycin resistance marker (Hygro)
is presented. The expected genomic maps after excision of the ﬂoxed marker Hygromycin (Brg1
L2 allele) and excision of both the marker and exons 2 and 3 (Brg1 L allele) are shown. The
arrows indicate the PCR primer location (P1-P3). The location of the Southern Blot 5'-probe
[Sumi-Ichinose et al., 1997] is shown. The size of DNA segments obtained after BamHI restriction
digest and detection with the 5'-probe are indicated. B, BamHI; E, EcoRV; N, NheI; X, XbaI.
Graph taken from Kumar Indra, A et al. 2005.
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5.3.2 Brg1 deletion during embryonic neurogenesis
The ﬂoxed Brg1 mouse line was crossed with the Emx1Cre mouse line [Guo et al.,
2000] to delete Brg1 speciﬁcally in the developing Ctx. In this Emx1Cre transgenic
line Cre is driven by the Emx1 promoter which is only active after E 9.5 [Guo et al.,
2000] exclusively in the developing Ctx. Brg1 loxP sites will be detected by Cre and
the ﬂanked region will be cut out. This leads to a loss of the Brg1 protein in all cells
where Cre is active and also in their progeny as this is an irreversible event. The
principle of using the CreloxP-system is illustrated in Figure 5.42. The embryonic
analysis of Brg1 knockout oﬀsprings was performed by Sebastian Maas, a bachelor
student supervised by me. Figure 5.43 shows that the Brg1 protein was lost in the
mutant Ctx at E14, 4 days after recombination has started, whereas the Brg1 protein
in the GE was still detectable. Brg1 KO embryos showed a completely disorganized
Ctx. Morphologically the Ctx was smaller and extended in length. Cortical layers
were not formed at all, since migration was also highly aﬀected, which means that
the migrating neurons were diﬀusely distributed allover the Ctx. Proliferating cells
showed no spatial restriction to the VZ either. β-IIItubulin immunoreactivity depicts
the neurons and reveals the disorganized structure of the Ctx lacking Brg1 (Figure
5.43).
5.3.3 Brg1 deletion in adult neural stem cells
In order to focus the analysis on the deletion of Brg1 selectively in adult neural stem
cells, the inducible GLASTCreERT2 mouse line [Mori et al., 2006] was used. This in-
ducible Cre line causes ablation of Brg1 protein after the induction with tamoxifen
(see Materials and Methods, 4.2.) speciﬁcally in cells expressing the glutamate-
aspartate transporter (GLAST). The inducible form of a Cre-loxP system used here
functions in the way that Cre is fused to an estrogen receptor 2 which localizes the
translated protein Cre in the cytoplasm leading to no recombination of ﬂoxed alleles.
After the tamoxifen injection, the tamoxifen binds to the receptor as a ligand and
this results in a translocation of the complex into the nucleus, where Cre recognizes
the loxP-sites and recombines the DNA. As CreERT2 is only expressed in GLAST+
cells in this mouse line [Mori et al., 2006] recombination only occurs in GLAST
expressing astrocytes in the adult brain [Rothstein et al., 1994; Storck et al., 1992;
Ninkovic and Gotz, 2007]. Moreover, as GLAST was also shown to be expressed
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Figure 5.42: creLoxP system
Illustration of the CreLoxP-system. A mouse line in which Cre is driven by a speciﬁc promoter is
crossed to a transgenic mouse in which a target gene is ﬂanked by loxP sites. This crossing leads
to the deletion of the ﬂoxed gene in all cells with active Cre recombinase.
Figure 5.43: Phenotype during embryonic neurogenesis
a,b Fluorescent micrographs depict Brg1 expression double-stained with β-IIItubulin in WT (a)
and in Brg1 KO (b) sections of E14 brains. Note the ablation of the Brg1 protein in the KO Ctx
which is highly aﬀected during brain development, while the protein is still detectable in the GE.
Ctx=cortex, GE=ganglionic eminence. Scale bar: 20µm.
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in adult neural stem cells at the SEZ as they were shown to be astroglial-like cells
[Jackson and Alvarez-Buylla, 2008], Brg1 will also be deleted in neural stem cells.
In order to monitor the recombined cells, Brg1 ﬂoxed/ﬂoxed mice were crossed with
a double reporter mouse line called Z/EG in which the lacZ protein is expressed
without Cre-mediated excision and eGFP is expressed after recombination [Novak
et al., 2000]. According to the literature Brg1 is known to play an important role
in the embryonic brain in stem cell maintenance and later on in glial diﬀerentia-
tion [Matsumoto et al., 2006]. To examine the Brg1 function in the adult brain
and especially its role in neural stem cells and their diﬀerentiation the following
mice were analyzed: Mice that were Brg1 ﬂoxed/ﬂoxed//GLASTCreERT2//ZEG+
were used as experimental mice and Brg1 wt/wt//GLASTCreERT2//ZEG+ and
Brg1 ﬂoxed/wt//GLASTCreERT2//ZEG+ mice as the appropriate controls since
the heterozygous mice did not display a phenotype.
5.3.3.1 Analysis of Brg1 ﬂoxed mice 6 days after tamoxifen induction
Mice of comparable age (10weeks) were induced twice a day for 5 days with an intra
peritoneal (IP) injection of tamoxifen. The applied dosis of tamoxifen each day was
2µg and therefore the total amount of applied tamoxifen 10µg. This was shown to
be the optimal induction method [Mori et al., 2006]. To this point, only one pair of
Brg1 WT and Brg1 ﬂoxed mice could be analyzed. To monitor whether the Brg1
protein was already lost 6 days after tamoxifen treatment, Brg1 immunoreactivity
was examined as shown in Figure 5.44. The Brg1 protein was still detectable in
GFP+ recombined cells in the WT Ctx as well as in GFP+ cells at the SEZ. In
the mutant situation the Brg1 protein is still present in some GFP+ cells at the
SEZ, showing that Brg1 protein is not completely deleted. Moreover, BrdU was
applied 1 hour before sacriﬁcing the animals to monitor cells in the S-phase in the
adult neurogenic regions. This preliminary data revealed a decrease in BrdU+ cells
along the ventricle and in the RMS (Figure 5.45). Furthermore, GFP+ cells also
seem to be reduced. This might be due to a reduction in the recombination rate
in Brg1 ﬂoxed mice or to a speciﬁc decrease of recombined cells after Brg1 deletion.
However, these ﬁndings have to be conﬁrmed with further experiments to exclude
artefacts of BrdU-labeling or tamoxifen induction.
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Figure 5.44: Brg1 protein detection in some recombined cells 6 days after tamoxifen
induction
a,b The Brg1 protein is still detectable in some GFP+ recombined cells 6 days after tamoxifen
induction. Arrows depict double-positive cells. SEZ= subependymal zone. White rectangles
depict the region shown as insert in higher magniﬁcation. Scale bar: 20µm.
5.3.3.2 Analysis of Brg1 ﬂoxed mice after 14 days of tamoxifen induction
The next time point analyzed was 14 days after the end of tamoxifen induction. First
of all, it was checked whether the Brg1 protein had vanished in GFP recombined cells,
because this is a crucial event for the interpretation of the data. If the Brg1 protein
can still be detected, the recombination eﬃciency may be too low or the half life
of the protein may be too long. As Brg1 is ubiquitously expressed including neural
stem cells and postmitotic astrocytes, it might be assumed that it is in most of the
recombined cells in the control situation. Figure 5.46 shows Brg1 immunoreactivity
in many GFP+ cells in the control whereas no Brg1-immunoreactive GFP+ cells
were detectable in homozygous Brg1 ﬂoxed mice. Thus, two weeks after tamoxifen
treatment Brg1 protein had fully disappeared.
Since the downregulation of Brg1 was proved 14 days after recombination, WT and
mutant brains were stained for GFP to monitor cells that lack Brg1, and Dcx to
label neuroblasts. At the WT SEZ many of the GFP+ cells are Dcx+, meaning that
these cells diﬀerentiated into neuroblasts within 14 days after tamoxifen induction
(Figure 5.47 a). In homozygous Brg1 ﬂoxed mice less GFP+ cells are Dcx+ and
they seem to spread in an uncoordinated fashion, in such a way that GFP+ cells
are found in the WM, which suggests that they migrate out of the RMS into the
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Figure 5.45: Brg1 ﬂoxed mice analyzed 6 days after tamoxifen induction
a,b The deletion of the Brg1 protein results in a decrease of BrdU positive cells amongst the
recombined cells after 6 days. Roughly half of the GFP+ cells express Dcx, hardly any
double-positive cell was found in the mutant. c,d In the RMS GFP+ cells were mainly BrdU+ in
the WT compared to mutant. RMS= rostral migratory stream, SEZ= subependymal zone. Scale
bar: 20µm.
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Figure 5.46: Brg1 protein is gone 14 days after tamoxifen induction
a,b The Brg1 protein is undetectable in Brg1 ﬂoxed mice 14 days after tamoxifen induction,
whereas in Brg1 WT mice most of the GFP recombined cells express Brg1 protein. SEZ=
subependymal zone. Arrows depict double-positive cells. White rectangles depict the region
shown as insert in higher magniﬁcation. Scale bar: 20µm.
WM (Figure 5.47 b). Further along the RMS where Dcx+ neuroblasts enter the
OB GFP+ cells migrate radially toward the GCL and GL (Figure 5.47 c,e,f). In
the homozygous Brg1 ﬂoxed mice GFP+ cells have an altered morphology and few
of them are Dcx+, suggesting that they lose their neuronal identity (Figure 5.47
d,g).
Since the morphology of the Brg1 −/− cells was reminiscent of glial cells, the identity
of the GFP+ cells in the mutant brains was examined by staining for glial markers.
In the mutant, GFP+ cells express NG2, a marker for oligodendrocyte precursors.
This colocalization is virtually never observed in the control mice (Figure 5.48 a,b).
These data support the hypothesis of a switch from neuronal to glial cell fate due to
the lack of Brg1. The quantiﬁcation of Dcx+ cells at the SEZ in two pairs of WT
and Brg1 ﬂoxed animals show a slight reduction of neuroblasts already after 14 days
(Figure 5.48 c), while the percentage of Dcx+ cells amongst GFP+ cells counted
was signiﬁcantly reduced in the OB. These data suggest a change from neuronal to
an NG2 glial fate as a result of the loss of the Brg1 protein.
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Figure 5.47: Analysis of Brg1 ﬂoxed mice 14 days after tamoxifen induction - Dcx
expression
a,b In the control animals GFP+ cells mainly expressed Dcx at the SEZ (a), which was not the
case in the Brg1 ﬂoxed mice. Note the migration of GFP+ cells into the WM indicated by white
triangles and the reduced overlay of GFP and Dcx upon Brg1 deletion. c,d In the RMS many
GFP+ cells coexpress Dcx in the WT brains (c), whereas in the Brg1 ﬂoxed mice GFP+ lose
their neuronal identity and are mainly Dcx-. Note the change in the morphological shape of Brg1
deleted cells (d). e-g Higher magniﬁcation of GFP+ cells in the RMS entering the OB shows the
colocalization of GFP+ cells with Dcx in WT brains and also in the outer layers of the OB (f).
In Brg1 ﬂoxed mice GFP+ cells are mainly Dcx-. Note some GFP+ cells expressing Dcx, but
they look unhealthy. OB= olfactory bulb, RMS= rostral migratory stream, SEZ= subependymal
zone, WM= white matter. Arrows in a depict double-positive cells. Arrows in d depict cells with
altered morphology. Arrows in e and f depict double-positive cells. White triangles depict GFP+
cells in the WM. White rectangles depict the region shown as insert in higher magniﬁcation.
Scale bars: a,b 50µm; c,d,f,g 20µm; e 10µm.
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Figure 5.48: Analysis of Brg1 ﬂoxed mice 14 days after tamoxifen induction - NG2
expression and quantiﬁcations
a,b GFP+ cells normally do not express glial markers, e.g. NG2 in the WT (a). GFP+ cells in
the mutant often double-stained for NG2, indicative of a switch to a glial fate (b). c Histogram
depicts the percentage of Dcx+ cells out of recombined cells in the WT and Brg1 homozygous
SEZ. Note the slight reduction of Dcx+ cells already at the SEZ in homozygous Brg1 mice 14
days after tamoxifen induction. d Histogram shows the percentage of Dcx+ cells amongst GFP
recombined cells counted in the OB of WT and Brg1 homozygous mice (n=2). Note the
signiﬁcant reduction of Dcx+ cells in the mutant. OB= olfactory bulb. Arrows depict
double-positive cells. White rectangles depict the region shown as insert in higher magniﬁcation.
SEM=*** depicts p≤0,001 . Scale bar: 20µm.
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5.3.3.3 Analysis of Brg1 ﬂoxed mice 28 days after tamoxifen induction
To examine whether the phenotype is progressive, mice were analyzed 28 days after
tamoxifen induction. The main question was whether Brg1 deﬁcient cells integrate
into the normal circuitry of the OB or whether they disappear, presumably under-
going cell death. To understand this, the results from the analysis in Brg1 WT
and ﬂoxed mice 14 days after tamoxifen induction were compared with the Dcx-
immunoreactivity amongst all GFP+ cells analyzed after 28 days. Figure 5.49 a,b
shows that GFP-recombined cells at the SEZ were fewer in number in WT and Brg1
ﬂoxed animals compared to the observed ﬁndings 14 days after tamoxifen induction
although most of them were still Dcx+ in the WT. GFP+ cells in the Brg1 mutant
animals were still found to spread out of the RMS into the WM. As a possible con-
sequence of this, very few GFP+ cells were observed to migrate toward the OB in
Brg1 ﬂoxed mice and the majority of them were Dcx-negative (Figure 5.49 c,d).
In the WT situation GFP+ cells migrate radially to the outer layers of the OB
where they become integrated into the circuitry. Some of these GFP+ cells are still
Dcx+, whereas in the mutants 4weeks post recombination almost no cells were seen
in the GCL. GFP+ cells were only found in the OB close to the RMS (Figure 5.49
e,f). Additionally several immunostainings were performed with anitbodies directed
against antigens characteristic for mature neurons and glia. In the WT OB many
GFP+ cells were already NeuN-immunoreactive, suggesting that they were mature
neurons. Homozygous Brg1 ﬂoxed mice did not display the ability to give rise to
NeuN+ neurons 4 weeks after Brg1 ablation. The preliminary analysis of GFAP-
and S100β-immunostainings showed no aberrant astroglial identity of GFP+ cells
in homozygous Brg1 ﬂoxed mice.
The observed data in the analysis 14 days after Brg1 protein ablation revealed that
GFP+ cells were able to migrate to the OB but already start to express oligodendro-
cyte progenitor markers while entering the OB. Two weeks later GFP+ cells could
still be detected as immunoreactive for NG2 in the mutant OB (Figure 5.50 a,b),
although GFP+ cells also expressing Olig2 were rarely present. The histograms in
Figure 5.50 c,d depict the signiﬁcant decrease in the percentage of recombined
cells reaching the OB in homozygous Brg1 ﬂoxed mice that were Dcx+, whereas
the percentage of GFP+ Dcx+ cells at the SEZ was comparable. The percentage
of Dcx+ cells amongst all GFP+ cells compared to two weeks before remained un-
changed, but due to the overall decrease in GFP cell number, the Dcx+ cell number
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Figure 5.49: Analysis of Brg1 ﬂoxed mice 28 days after tamoxifen induction
a,b At the SEZ GFP+ recombined cells were fewer in number compared to 14 days after
tamoxifen treatment. Some cells still expressed Dcx in both Brg1 WT and ﬂoxed mice. In Brg1
ﬂoxed mice green cells still spread out of the RMS into the WM. c,d In the WT OB many GFP+
cells are Dcx-immunoreactive, whereas in the Brg1 ﬂoxed mice fewer cells reach the OB out of
which only a minority show Dcx-immunostaining. e,f In the outer layers of the OB, the GL,
many GFP+ recombined cells were found in WT mice but almost no cells were found at this
position in homozygous Brg1 ﬂoxed mice. GCL= granule cell layer, OB= olfactory bulb, RMS=
rostral migratory stream, SEZ= subependymal zone. WM=white matter. Arrows depict
double-positive cells. Arrowheads depict GFP+ cells in the WM. White rectangles depict the
region shown as insert in higher magniﬁcation. Scale bar: a,b 20µm; c-f 10µm.
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continued to further decline. These data suggest that GFP+ cells change their cell
fate to a glial fate 14 days after Brg1 protein loss but then fail to diﬀerentiate further
into mature oligodendrocytes and eventually die.
Figure 5.50: Analysis of Brg1 ﬂoxed mice 28 days after tamoxifen induction - NG2
expression and quantiﬁcations
a,b GFP+ cells normally do not show immunoreactivity for glial markers, e.g. NG2 in the WT
OB (a). In the OB of homozygous Brg1 ﬂoxed mice GFP+ cells were found to double-stain for
NG2 (b). c Histogram depicts the percentage of Dcx+ cells out of GFP+ cells in the WT and
Brg1 homozygous SEZ. Note the comparable percentage of Dcx+ cells 28 days after Brg1
deletion. d Histogram shows the percentage of Dcx+ cells amongst GFP recombined cells
counted in the OB of WT and homozygous Brg1 mice. Note the signiﬁcant reduction of Dcx+
cells in the mutant. OB= olfactory bulb. Arrow depicts a double-positive cell. White rectangles
depict higher magniﬁcation. SEM=*** depicts p≤0,001 . Scale bar: 20µm.
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5.3.4 Brg1 deletion in adult neurosphere cultures
5.3.4.1 Expression of Brg1 in adult neurosphere cultures
In line with the expression of Brg1 in embryonic neurosphere cultures (see 4.1.2.)
Brg1 immunoreactivity was also detected in many cells in adult neurospheres derived
from SEZ of WT mice already 2 hours after plating. When cells had diﬀerentiated
for 7 days Brg1 immunoreactivity was still present in almost all cells, including
postmitotic neurons labeled with β-IIItubulin (Figure 5.51).
Figure 5.51: Brg1 expression in adult neurospheres
a Brg1 immunoreactivity 2 hours after plating of adult SEZ neurosphere cells, where most of the
cells are Brg1+. Note the background staining in red. b After 7DIV the Brg1 protein is
detectable in β-IIItubulin+ neurons. White rectangle depicts the region shown in higher
magniﬁcation in the insert. Scale bar: 20µm.
5.3.4.2 Adult neurosphere cultures from Brg1 ﬂoxed mice
After the ablation of Brg1 protein in vivo the consequences of the Brg1 protein
loss were analyzed in vitro to examine whether Brg1 is required already in the
stem cells or at later stages during diﬀerentiation. Therefore neurosphere cultures
from adult homozygous Brg1 ﬂoxed mice were performed. These cultures were
comparable to those derived fromWT mice. Cultures were infected with a retrovirus
CreIRESGFP expressing Cre in all infected cells that also express GFP behind the
IRES sequence (see Materials and Methods 4.11.). All cells that then appear GFP-
labeled in the cultures lack the Brg1 protein. After the infection of neurospheres
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from adult homozygous Brg1 ﬂoxed mice in the proliferative state in the ﬂoating
medium, the number and size of neurospheres was reduced 7 days in the proliferation
medium after infection (Figure 5.52). Moreover, after the third passage the growth
of the spheres decreased almost to zero.
Figure 5.52: Adult neurospheres from SEZ of Brg1 ﬂoxed mice
a Adult neurospheres derived from Brg1 ﬂoxed mice in culture. Note the size and number of
neurospheres in the control cultures. b The same cultures analyzed 7 days after infection with a
CreGFP retrovirus 2 hours after splitting. Note the reduced size and number of neurospheres.
The small panel shows the ﬂuorescent staining of a CreIRESGFP infected neurosphere. GFP+
cells are shown in green, DAPI in blue and β-IIItubulin in red. Scale bar: 20µm.
5.3.4.3 Diﬀerentiation analysis of Brg1 ﬂoxed neurospheres
After observing a proliferation defect in Brg1 KO cultures, the diﬀerentiation of
neurospheres derived from homozygous Brg1 ﬂoxed mice was analyzed. The control
cultures were not infected and only ﬁxed and stained with antibodies directed against
GFAP and β-IIItubulin 7 days after diﬀerentiation (Figure 5.53 a). When the cells
were infected in the proliferation phase in the ﬂoating medium followed by diﬀer-
entiation for 7 days, the cells appeared improperly diﬀerentiated and β-IIItubulin+
neurons could only rarely be observed (Figure 5.53 b). When cells were infected
2 hours after plating GFP+ cells showed a diﬀerent morphology after 7DIV, they
displayed now a more oligodendrocytic shape (Figure 5.53 c,d). GFP+ neurons
labeled by β-IIItubulin immunostaining were rarely observed after Brg1 deletion.
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Figure 5.53: Diﬀerentiation of adult Brg1 ﬂoxed neurospheres
a Brg1 ﬂoxed neurospheres used as controls were not infected. After 7 days of diﬀerentiation
neurons show a normal maturation state. b Neurospheres infected during the proliferation phase
and analyzed 7 days later. Diﬀerentiation seems to be impaired in these cultures. Only a few
β-IIItubulin+ cells can be found. c,d Cells were infected 2 hours after plating and analyzed
7 days after diﬀerentiation. GFP+ cells show an oligendrocytic morphology depicted in small
panels with high magniﬁcation. Only a few GFP+ cells also express β-IIItubulin. White
rectangles depict higher magniﬁcations. Scale bars: a,b 20µm; c,d 10µm.
To summarize the results of the functional analysis of the Brg1 protein in vivo and
in vitro it appears that Brg1 plays a crucial role in the maintenance of stem cell fate
as the number of neurospheres was drastically reduced after Brg1 deletion. During
diﬀerentiation Brg1 is also required for a normal neuronal diﬀerentiation. Without
Brg1, cells switched to a NG2 glia fate.
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The role of epigenetic factors involved in speciﬁc regulatory mechanisms such as
neuronal diﬀerentiation has become increasingly important over the last few years.
Chromatin modiﬁcations have been characterized and the principal functions of
diﬀerent modiﬁcation forms such as methylation, acetylation and phosphorylation
have, in the mean time, become well understood. However, little is known about
speciﬁc functions of single HDACs in the nervous system. HDACs are members
of a small enzyme family that have the capacity to act as transcriptional repres-
sors, often recruited in complexes such as Sin3 or NuRD. HDACs are described as
ubiquitously expressed in certain tissues, e.g. the brain. In order to describe the
function of HDACs, studies were conducted in which the catalytic domain of almost
all HDACs was inhibited in order to interrupt their activity. This was achieved by
HDAC inhibitors such as trichostatin A (TSA), which counteracts predominantly
class II HDACs but was also shown to interfere with class I HDACs [Finnin et al.,
1999]. While the application of broad-range HDAC inhibitors reﬂected strong ef-
fects with regard to neuronal degeneration and survival [Morrison et al., 2007], it
is important to understand the speciﬁc functions of individual HDACs in diﬀerent
cellular contexts.
The expression proﬁle and functional analysis of HDAC2 and Brg1 in the developing
and adult mouse brain was presented in this work. For HDAC2 a speciﬁc expression
of HDAC2 in postmitotic neurons and glia at diﬀerent stages of the brain devel-
opment and in the adult was observed. Thereby a rather intriguing diﬀerence in
its expression in adult, but not embryonic progenitor cells was discovered. Based
on this, the function of HDAC2 in a gene trap mouse mutant lacking the catalytic
domain of HDAC2 was analyzed [Trivedi et al., 2007]. The lack of the functional
HDAC2 protein resulted in an aberrant increase in apoptotic cells in most regions
of the postnatal brain, while it is redundant in all regions in the adult brain with
the exception of those regions where neurogenesis persists. Dying cells in the adult
HDAC2 def brain were identiﬁed to be mainly adult generated neurons. Moreover,
neuronal progenitors were found to be increased in adult neurogenic regions in the
HDAC2 def brains. While the initial steps of neuronal progenitors toward neuronal
diﬀerentiation were accomplished, further maturation was not possible in the ab-
sence of the functional HDAC2 protein.
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Besides certain chromatin modiﬁcations, the remodeling of chromatin was shown
to be suﬃcient for an optimal transcriptional access of DNA. An almost complete
overlap with HDAC2 in the adult brain for Brg1 as the ATPase subunit of the most
common chromatin remodeling complex SWI/SNF was observed. During develop-
ment, however, Brg1 as opposed to HDAC2 is already present in progenitor cells
and remains expressed in adult neural stem cells. To ablate the Brg1 protein only
in adult neural stem cells and to analyze the consequences of its loss in its progeny,
the Brg1 ﬂoxed mice crossed with an inducible Cre-mouse line (GLASTCreERT2)
and a reporter line (Z/EG) were used. Preliminary data derived from the analysis
of mice lacking the Brg1 protein in adult neural stem cells points toward a speciﬁc
role at diﬀerent stages along the diﬀerentiation pathway of neurons. The deletion
of Brg1 in adult neural stem cells results in a reduced number of progenitor cells.
Later, the progeny migrating to the OB change their cell fate from neuronal to glial,
more speciﬁcally to NG2 glia. Therefore, these data suggest that Brg1 acts as a
crucial factor in the development of a cell toward a neuronal phenotype.
Despite their coexpression, these results highlight the speciﬁc roles of a single HDAC,
namely HDAC2, and the ATPase subunit of a chromatin remodeling complex SWI/SNF,
namely Brg1, in the central nervous system, especially in adult neurogenic regions.
6.1 HDAC2 expression proﬁle
In order to examine the function of a single class I HDAC, I analyzed the speciﬁcity
of the cellular expression of HDAC2. Already in the analysis of RNA expression it
became obvious that HDAC2 was not expressed ubiquitously but rather in a very
speciﬁc manner. It was found to be enriched in neurogenic and gliogenic precursor
populations, highly expressed in postmitotic neurons, but low in astrocytic-enriched
cultures (Figure 5.1 b). Immunostainings of HDAC2 in E14 neurosphere cultures
could only partially conﬁrm the observed RNA expression proﬁle given that HDAC2
protein was very weakly expressed in GFAP+ astrocytes containing the stem cells
in these cultures. Consistent with the RNA expression levels, the immunoreactivity
of HDAC2 was high in β-IIItubulin+ postmitotic neurons (Figure 5.2 b). Fur-
thermore, constant levels of HDAC2 immunoreactivity in vivo could be observed
in postmitotic neurons in the developing as well as in the adult brain. A rather
intriguing diﬀerence in the appearance of the HDAC2 protein was found in neu-
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ronal precursor cells in the adult neurogenic regions (Figure 5.10), where it was
expressed at high levels compared to embryonic neurogenic precursors in which it
was virtually absent (Figure 5.5). This discrepancy of HDAC2 protein presence
in adult, but not embryonic neurogenic precursors raised the question of whether
HDAC2 carries a speciﬁc function in adult neurogenesis. As HDAC2 together with
its highly related family member HDAC1 is often found to be part of the same
transcriptional repressor complexes [de Ruijter et al., 2003], I performed the same
expression analysis for HDAC1. As already described for HDAC2, the RNA expres-
sion levels of HDAC1 appeared high in neurons but low in progenitor populations
(Figure 5.1 a). However, immunostainings for HDAC1 in E14 neurosphere cultures
also revealed an expression in GFAP+ astrocytes as well as in many β-IIItubulin+
neurons (Figure 5.2 a). Already at embryonic stages this was found to be notably
diﬀerent in vivo. HDAC1 was weakly expressed in postmitotic neurons, although
highly expressed in neural progenitor cells at the VZ (Figure 5.3 a). During postna-
tal development this diﬀerence in expression became more pronounced. HDAC1 was
then only expressed in a scattered pattern typical for glial cells whilst completely
absent in neuronal cells (Figure 5.3 d,f). In the adult brain HDAC1 was detected
in GFAP+ as well as in CC1+ cells suggesting that astrocytes as well as oligoden-
drocytes contain the HDAC1 protein (Figure 5.3). Taken together, HDAC1 and
HDAC2 were never found to be expressed in the same cell in the adult nervous
system in vivo except in the WM where both proteins were expressed in glial cells
(Figure 5.9 a,b). This complementary appearance in a very speciﬁc pattern of
two individual class I HDACs suggests that HDAC1 and 2 might repress each other.
Furthermore, with regard to the data presented here the coexistence of HDAC1 and
2 in the repressor complexes (Sin3, NuRD or CoREST) [Ayer, 1999; Zhang et al.,
1999] in the brain is rather unlikely at least with respect to the protein expression
analyzed here and remains to be proven.
6.2 HDAC2 - functional analysis
6.2.1 Phenotypical description of HDAC2 def mice
Given the speciﬁc expression patterns of HDAC1 and HDAC2 and the diﬀerence in
the presence of the HDAC2 protein in adult, but not embryonic progenitor cells, a
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gene trap mouse line deﬁcient of the HDAC2 function was analyzed. This mouse line
was already used in a former study concerning heart diseases, showing that HDAC2
def mice are prone to attenuated cardiac hypertrophy associated with an increased
expression of Inpp5f, a gene encoding inositol polyphosphate-5-phosphatase f. This
results in a constitutive activation of glycogen synthase kinase 3β (Gsk3β) via inac-
tivation of the Pi3K-Akt-Gsk3β pathway [Trivedi et al., 2007]. Trivedi et al. (2007)
identiﬁed an important function of HDAC2 in the regulation of cardiac hypertrophy
over a well-known molecule Gsk3β, which is also a key regulatory molecule in the
canonical Wnt signaling pathway [Lange et al., 2006]. Several studies in the past
showed that predominantly the canonical Wnt signaling pathway plays important
roles in the nervous system. It was revealed to be crucial for stem cell proliferation
and expansion [Chenn and Walsh, 2002] as well as for the inhibition of neural dif-
ferentiation [Haegele et al., 2003], in particular, the inhibition of Gsk3β promoted
polarization and axon formation in hippocampal neurons [Yoshimura et al., 2005].
This interaction of HDAC2 and Gsk3β might also be a reason for the observed phe-
notype in the adult neurogenic regions in HDAC2 def mice in the sence that HDAC2
would suppress Pi3K-Akt-Gsk3β pathway and hence promote neuronal diﬀerentia-
tion.
Trivedi et al. (2007) demonstrated that HDAC2 def mice not only display this heart
phenotype. They also refer to a high postnatal lethality and a severe growth retarda-
tion of HDAC2 def pups similar to the observations presented here. While HDAC2
def mice were born according to Mendelian rates (Figure 5.16), a postnatal lethal-
ity rate of about 70% compared to wildtype littermates between postnatal day 0
and 2 (P0-P2) (Figure 5.17) could be observed. A full genetic deletion (KO) of
HDAC2 [Montgomery et al., 2007] is also described to exhibit a postnatal lethality
rate of 100% within the ﬁrst 24 hours after birth due to cyanosis reﬂecting cardiac
defects upon the complete loss of HDAC2. The fully penetrant lethality of these
HDAC2-null mice contrasts with the phenotype observed in HDAC2 def mice. This
raises the question if a hypomorphic allele can still have residual functionality. Af-
ter LacZ insertion several phenotypes could be observed due to alternative splicing
within the mutant locus [Voss et al., 1998]. This could be the reason for having
suﬃcient levels of HDAC2 for viability and for the penetrance of the phenotype in
HDAC2 def mice. Diﬀerent genetic backgrounds of the mice tested in the two stud-
ies might also contribute to the diﬀerent phenotypes. While HDAC2−/− mice have a
mixed background of 129, C57BL/6/, CD1 [Montgomery et al., 2007] while HDAC2
def mice are on clean C57BL/6 background only [Zimmermann et al., 2007]. Several
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experiments such as co-immunoprecipitation for HDAC2 and Sin3B have ruled out
the possibility that a hypomorphic allele is responsible for the survival of HDAC2
def mice. Without a functional catalytic domain HDAC2 is not able to perform its
normal catalytic function [Zimmermann et al., 2007].
However, an HDAC activity assay performed on brain regions of WT and HDAC2
def littermate mice showed a signiﬁcant reduction in the overall HDAC activity in
various brain regions (Figure 5.15), indicating that the fusion protein present in
HDAC2 def mice leads to an overall decrease of HDAC activity most prominent in
the HC. The growth retardation of HDAC2 def mice develops in the ﬁrst weeks after
birth. Compared to WT no obvious diﬀerence in body size could be detected at P3.
At P21, however, HDAC2 def mice were severely aﬀected in body size and weight
(Figure 5.19). These ﬁndings were also reported by Zimmermann et al. (2007).
Despite the early postnatal lethality the embryonic brain of HDAC2 def mice devel-
oped normally. Neurogenesis from E10-E18 occurred completely normal, as revealed
by β-IIItubulin immunostaining at E14 and E18 (Figure 5.18). Along these lines,
other aspects such as radial glia formation, shown by the Blbp-immunoreactivity
(Figure 5.18 e,f), and proliferation (Figure 5.18 g-j) remained unchanged. The
lack of an obvious brain phenotype during early development is consistent with its
speciﬁc expression in postmitotic neurons during embryonic stages. With regard
to the embryonic development, no obvious defects could be observed in HDAC2−/−
mice either [Montgomery et al., 2007]. Moreover, embryonic neurosphere cultures
from E14 WT and HDAC2 def embryos showed no defects in neuronal diﬀerentia-
tion at all (Figure 5.33). However, it was recently reported that HDACs control
neurogenesis in embryonic brain cultures derived either from the Ctx or GE respec-
tively [Shaked et al., 2008]. These researchers inhibited all HDACs with TSA and
were able to show a reduction in neurogenesis in the GE and a modest increase of
neurogenesis in the Ctx. They then suggested a mechanistical interaction between
HDACs and Bmp2/4 signaling pathway in radial glia cells, in which HDACs inhibit
Bmp2 leading to a reduction in neurogenesis in the GE and an opposite function in
the Ctx. These data strongly propose a function of HDACs in embryonic neurogene-
sis. Nevertheless, which HDAC is the most important to reveal this interaction with
Bmps remains to be shown. Taken together, HDAC2 def mice as well as HDAC2−/−
show phenotypic defects from early postnatal stages on, whereas HDAC2 seems to
play no major role during the embryonic development. In the absence thereof other
closely related HDACs such as HDAC1 might assume a compensatory role, as will
be discussed below.
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6.2.2 The role of HDAC2 in postnatal brain development
Having analyzed to this point the postnatal lethality and the observed growth re-
tardation of HDAC2 def mice during the early postnatal days, this raised the ﬁrst
question of whether only the whole body was aﬀected or if, in addition to this, also
single organs became reduced in size compared to WT. Zimmermann et al. (2007)
examined the size and weight of several organs, such as the testis and brain. They
were found to have the predicted normalized ratio of the body size between WT and
HDAC2 def mice. To determine the cause of the decreased brain size immunostain-
ings for activated caspase 3 (casp3), a protein that is only activated in a small time
window when cells undergo apoptosis [Riedl and Shi, 2004] were performed. Already
at early postnatal stages (P0) there was a widespread increase in cell death in most
regions of the HDAC2 def brains observed compared to WT (Figure 5.20 a-c). A
colocalization analysis of casp3 and cell-type speciﬁc markers revealed a prevalence
of non-neuronal cells dying at this developmental stage (Figure 5.20 d,e). During
early postnatal stages gliogenesis takes place while neurogenesis is completed. The
SEZ at neonatal stages gives rise to astrocytes and oligodendrocytes that migrate
to the neocortex, the subcortical white matter (SCWM) and the deep gray matter
[Kakita and Goldman, 1999]. These glial progenitors divide asynchronously giving
rise to mixed clones of astrocytes and oligodendrocytes or both types of glia [Zerlin
et al., 2004]. HDAC2 was found to be expressed in either GFAP+ and/or Ki67+
cells at P0 in proliferating zones such as the white matter (Figure 5.7 b). As the
majority of the casp3+ cells are glial cells, postnatal gliogenesis could be aﬀected in
HDAC2 def mice thereby causing the smaller brain size that is already very obvious
1-2 weeks after birth [Trivedi et al., 2007]. Importantly, 70% of postnatal lethality
occurring in the ﬁrst 2 days are not due to brain defects but more likely due to de-
fects in other organs such as the described heart defect in HDAC2 def mice [Trivedi
et al., 2007]. Pups analyzed in these ﬁrst two days after birth include the ones that
are sure to die. Therefore, it could be that mice that survive and are deﬁcient of
HDAC2 probably display a milder eﬀect in postnatal brain development and adult
neurogenesis than the ones that died already. As previously discussed, mice that
survived and studied at adult stages can have suﬃcient levels of HDAC2 to sur-
vive and they show a penetrance in the strength of phenotypic changes like growth
retardation or an increase in apoptosis. The further discussed defects in adult neuro-
genesis would probably be also more severe in mice fully lacking HDAC2. Therefore,
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a future perspective will be to analyze HDAC2 ﬂoxed mice with regard to adult
neurogenesis. This analysis is already underway with the ﬁrst data obtained clearly
pointing to a severe defect in neuronal diﬀerentiation of newly generated neurons in
the adult brain.
6.2.2.1 Compensatory function of HDAC1 during embryonic and postnatal
development in HDAC2 def mice
After having observed the complementary expression of HDAC1 and HDAC2, it was
examined whether HDAC1 might compensate the loss of HDAC2 protein during
embryonic and postnatal development. Already at early postnatal stages HDAC1
protein was found to be upregulated in NeuN+ postmitotic neurons, whilst it was
not found in the WT (Figure 5.36). This upregulation of HDAC1 in NeuN+ cells
could be observed until brain development was nearly completed (P21). Afterward
HDAC1 declined to normal levels and normal localization. In fact, no defects in
the embryonic development could be observed. It may well be that HDAC1 can
take over the function of HDAC2, since they reveal a high sequence identity and
are often found to be part of the same repressor complexes [de Ruijter et al., 2003].
Postnatally HDAC2 cannot fully be rescued by HDAC1. Otherwise no such defects
as the increase in cell death would occur in HDAC2 def mice. The upregulation
of HDAC1 upon the absence of HDAC2 may be also explained by a repression of
HDAC1 gene by HDAC2 and vice versa. In the adult brain, HDAC1 is expressed
only in glia cells, where HDAC2 is normally not expressed except in the white matter,
where both proteins were found in glia cells. In the regions of adult neurogenesis
HDAC1 is not upregulated in HDAC2 def mice, because it might be fully absent
in these cells. This was also conﬁrmed by the Western Blot analysis performed
on tissue of diﬀerent brain regions from WT and HDAC2 def littermates (Figure
5.37). Taken together, after the brain development is completed it seems to be
that HDAC1 is not compensating HDAC2 in postmitotic neurons, where HDAC2
is predominantly expressed. This can be due to the fact that either HDAC1 is not
present in those cells at all or the function of HDAC2 in postmitotic neurons is
redundant because its function is more important in processes leading eventually
to a functional neuron. Another possibility might be that the repressor complexes
where HDAC1 and 2 can be recruited to recruit only HDAC2 in postmitotic neurons,
but this remains to be shown. Moreover, HDAC2 may act on the protein level of
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speciﬁc key regulators in adult neurogenesis accomplished by the presence of the
diﬀerent repressor complexes, while HDAC1 does not seem to play a role in adult
neurogenesis in contrast to its importance in embryonic neurogenesis.
6.2.3 Apoptosis in the adult brain of HDAC2 def mice
The increase in apoptosis was not only limited to early postnatal stages. A higher
number of cells undergoing cell death in the adult neurogenic regions of the brain,
the HC and the OB, could also be observed. While cell death was very low in WT
and mutant mice in non-neurogenic regions such as the Ctx, there was a signiﬁcant
increase in casp3+ cells in the mutant versus WT OB. In the HDAC2 def HC casp3+
cells were only slightly increased (Figure 5.22 a). The generation of newly born
cells in the HC ranges from 1000-3000 cells per day, while in the SEZ/RMS/OB
system 30.000 cells are generated each day [Alvarez-Buylla et al., 2001; Cameron
and McKay, 2001]. Therefore, the turnover in the OB is obviously much higher than
in the HC. It was previously shown that there are two modes of adding new and
replacing old neurons in the existing network in the OB. Interneurons arriving newly
in the GL were constantly added and increased over time whereas the proportion
of newly generated neurons reaches a plateau in the GCL. This was also shown to
be the case in the DG [Ninkovic et al., 2007]. This leads to the conclusion that the
addition of newly generated neurons to the preexisting network is rather diﬀerently
regulated in the GL compared to the GCL and DG. However, hardly any casp3+
cells were found in the WT HC. In the HDAC2 def HC a higher number of casp3+
cells could be found, but less than in the OB, where the diﬀerence between WT
and HDAC2 def mice was striking. With the latter, cells that undergo apoptosis in
the adult brain speciﬁcally in the neurogenic areas were mainly neuronal cells that
could be identiﬁed by neuronal markers, such as Dcx or NeuN (Figure 5.22 b,c).
Zimmermann et al. (2007) isolated mouse embryonic ﬁbroblasts (MEF) from E13.5
embryos to examine cell growth. They also observed an increase in apoptosis in
HDAC2 def MEFs, while cell growth and proliferation remained unchanged. In gen-
eral little is known about HDACs playing a role in apoptosis. It is known that
HDAC2 interacts with p53, a tumor suppressor which is also involved in apop-
tosis [Luo et al., 2000; Juan et al., 2000]. p53 activity is modulated by post-
translational modiﬁcations including acetylation. Deacetylation leads to p53 re-
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pression and thereby to a downregulation of p53-dependent gene activation and
consequently to the induction of programmed cell death. Interestingly this interac-
tion with p53 has been shown for HDAC1, 2 and 3 respectively [Juan et al., 2000].
Huang et al. (2005) found out a speciﬁc functional signiﬁcance for HDAC2 in HeLa
cells inducing apoptosis associated with an increase in p21 expression independent
of p53 [Huang et al., 2005]. They could also show that HDAC1 and HDAC2 were
diﬀerentially expressed in cervical dysplasias and carcinoma, namely that HDAC2
is upregulated in colonic polyps and cancer cells which was not the case for HDAC1.
Several studies linked to neurodegeneration argue indirectly for a role of class II
HDACs in apoptotic regulation. It has been revealed for HDAC5 that it can in-
duce cell death in cultured neurons [Linseman et al., 2003], whereas a splice variant
of HDAC9 called HDAC-related protein (HDRP) promotes the survival of neurons
[Morrison et al., 2006]. Recently a neuroprotective function was shown for HDAC4.
Mice lacking HDAC4 have elevated cyclin-dependant kinase-1 (CDK1) activity and
display cerebellar abnormalities including a progressive loss of Purkinje neurons
postnatally, suggesting that HDAC4 neuroprotective function is mediated by its
function in preventing cell-cycle progression [Majdzadeh et al., 2008]. Furthermore,
most of the studies connecting HDACs with apoptosis were carried out with HDAC
inhibitor treatment in several contexts. Regarding neurogenesis it has been shown
by Salminen et al. (1998) that after HDAC inhibitor treatment excessive histone
acetylation induces a stress response and apoptotic cell death in neurons [Salminen
et al., 1998]. As the commonly used HDAC inhibitors block all HDAC proteins
eﬃciently, it is not clear whether the promotion or reduction of neuronal cell death
may be context-dependent and inﬂuenced substantially by the relative levels of pro-
and anti-apoptotic HDAC proteins in the speciﬁc cell type. Taken together, the
data reported here suggest an important function of HDAC2 preventing apoptosis
in neuronal cells in the adult brain, more speciﬁcally in adult generated neurons.
6.2.4 The adult brain of HDAC2 def mice
Apart from the increase in apoptosis resulting in the reduced growth of the HDAC2
def brain, the overall brain morphology and cytoarchitecture appeared normal, ex-
cept for the CB (Figure 5.19 e,f), which shows aberrations in the formation of
the diﬀerent lobi and a reduced thickness of the outer cell layer. These phenotypic
changes of the CB remains to be further studied in the future on the molecular level.
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In contrast, the six layers in the Ctx were clearly visible by NeuN-immunostaining
(Figure 5.21 a,b) and, furthermore, Cux2, a transcription factor only expressed in
the upper layers 2 and 3 was present at normal levels, taking into consideration that
the brain and therefore also the Ctx are smaller (Figure 5.21 c,d). In addition
to this the cell density as well as the neuronal density was unchanged either during
embryonic and postnatal brain development or in the adult Ctx (Figure 5.21 e,f).
The normal cytoarchitecture of adult HDAC2 def brains further supports the notion
that embryonic neurogenesis is not aﬀected.
6.2.5 The role of HDAC2 in adult neurogenic regions
6.2.5.1 The subgranular zone of the DG
Besides the increase in apoptotic cells in the adult neurogenic regions of HDAC2
def mice an obvious reduction of Dcx+ cells in the DG (Figure 5.23 a-c) was
observed. As previously described, Dcx is expressed in neuroblasts that are still
dividing and in immature neurons that have exited the cell cycle and have become
postmitotic. Several studies have shown the existence of two types of Dcx+ cells in
the SGZ [Kronenberg et al., 2003] and other research has described even three types
[Seri et al., 2004]. These diﬀerent types are categorized as Type D cells and are
identiﬁed as the intermediate precursors in the generation of new granule neurons in
the DG [Seri et al., 2001]. The three subtypes diﬀer in their morphology as well as
in their maturation state, either being neuroblasts or immature neurons. The higher
magniﬁcation of Dcx+ cells in the HDAC2 def DG showed an aberrant morphology
of those Dcx+ cells having a radial process with a reduced dendritic tree. These
cells are classiﬁed as D3 cells, which have the certain characteristics of immature
granule neurons. Furthermore, speciﬁcally these D3-cells seem to be diminished
in the HDAC2 def mice due to their aﬀected maturation shown in the aberrant
morphology in HDAC2 def mice.
The reduction of Dcx+ cells in the mutant DG raises the question of how and when
this reduction occurs. In order to examine a proliferation defect in the mutant DG,
HDAC2 def mice were analyzed after a short pulse of BrdU 1 hour before the ani-
mals were sacriﬁced. In HDAC2 def mice a signiﬁcant increase of cycling cells was
detectable. The composition of the diﬀerent cycling subtypes, namely the three
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diﬀerent precursor cell types existing in the adult neurogenic regions, Type B, C
and A cells [Abrous et al., 2005], was not changed at all (Figure 5.23 d). An
increased number of multipotent stem cells might possibly be conducive to higher
numbers of fast dividing progenitors in HDAC2 def mice. To examine this and
to further understand the composition of the progeny of these progenitors labeled
with a short pulse of BrdU, a BrdU label retaining experiment (BrdU for 2weeks in
drinking water followed by one week with only water) was performed. The number
of multipotent stem cells (BrdU+GFAP+) remained unaﬀected while the number
of newly generated NeuN+ neurons labeled with this BrdU protocol was strongly
decreased in the absence of catalytically active HDAC2 in the DG. This decrease
in the number of BrdU+NeuN+ cells leads to the overall decrease of BrdU+ cells
after 3 weeks of BrdU application (Figure 5.23 e-h). The number of BrdU+ cells
containing Dcx, but not yet NeuN was even increased in HDAC2 def DG, whereas
the proportion of BrdU+Dcx+NeuN+ cells was already reduced in number, suggest-
ing a defect in neuronal diﬀerentiation at the transition from an immature Dcx+
cell into a more mature NeuN+ neuron [Kempermann et al., 2004]. Moreover, these
cells are probably the cells undergoing apoptosis in the HDAC2 def mice. A simi-
lar eﬀect of increasing proliferation of neural precursors was observed for sirtuin 1
(Sirt1), a NAD+ dependent HDAC. Redox alterations were shown to be critical and
to aﬀect the self-renewal capacity of neural precursor cells mediated by Sirt1. Under
reducing conditions Sirt1 is repressed which leads to an increase in the proliferation
of neuronal progenitors but is then followed by an enhancement of the neuronal
diﬀerentiation by upregulation of Mash1 [Prozorovski et al., 2008]. To obtain more
evidence for the speciﬁc block in neuronal maturation other markers expressed at
the transition from a Dcx+ neuroblast to a mature NeuN+ neuron were analyzed.
Calretinin, a Ca-binding protein and NeuroD1, a transcription factor thought to
regulate neuronal diﬀerentiation in Xenopus laevis [Lee et al., 1995] by promoting
premature cell cycle exit and diﬀerentiation in neural precursor cells are expressed
at the time of transition from Dcx to NeuN expression [Kempermann et al., 2004].
In the mouse HC NeuroD was highly expressed in developing neurons supporting
its role as a neuronal diﬀerentiation factor [Miyata et al., 1999; Chae et al., 2004].
NeuroD as well as Calretinin expression were strongly reduced in the HDAC2 def
DG, (Figure 5.24). Taken together, neuronal diﬀerentiation factors are reduced in
HDAC2 def DG resulting in the decrease of generating new mature neurons in the
mutant brain. In order to demonstrate that the defect in neuronal diﬀerentiation
and maturation cannot be explained by the concern that HDAC2 def cells may be
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more sensitive to BrdU than WT cells, retroviral injections of GFP into the DG of
WT and HDAC2 def mice were performed. The same results as for the BrdU label
retaining experiment were obtained, namely a signiﬁcant reduction in the number of
GFP+NeuN+ cells 3weeks after viral injection in the HDAC2 def DG (Figure 5.26
a,b). Given the increase in proliferation in HDAC2 def mice, the eﬀects may be due
to the upregulation of factors that have the capacity to maintain progenitors in a
proliferating state and failed to become downregulated in the absence of functional
HDAC2. Such factors could be Sox2 and Prox1. Sox2 is expressed in many progeni-
tor cells including neural stem cells and thereby demonstrated to be suﬃcient for the
multipotency and self-renewal of these cells [Gage, 1998; Ellis et al., 2004]. The ex-
pression of Sox2 in WT compared to HDAC2 def mice points to an increase in Sox2+
cells in the SGZ of the mutant mice that seem to colocalize with Dcx in a respective
percentage of cells. This colocalization was rarely observed in the WT situation.
Prox1 is also a transcription factor exclusively expressed in immature young granule
neurons in the DG. The loss of the HDAC2 function also resulted in an increase in
the number of Prox1+ cells that are not yet NeuN+ (Figure 5.26). The upreg-
ulation of those factors speciﬁcally expressed in proliferating cells or in immature
neurons could explain the phenotype where progenitor cells by the loss of HDAC2
fail to downregulate factors such as Sox2, thereby prolonging the proliferation of
the respective cells in HDAC2 def mice. Moreover, the aberrant upregulation of cell
cycle-related proteins has been implicated as a mechanism underlying neuronal cell
death in a variety of experimental paradigms [Copani et al., 2001].
6.2.5.2 The subependymal zone - rostral migratory stream - OB system
The observations in the second neurogenic region, the SEZ, were comparable to
the ﬁndings in the DG. Multipotent stem cells located in the subependymal zone
of the lateral ventricle give rise to transit-amplifying precursors that then generate
neuroblasts that migrate along the rostral migratory stream to reach the OB [Zhao
et al., 2008]. These young neuroblasts expressing Dcx diﬀerentiate into NeuN+
neurons in the OB to become integrated into the neuronal circuitry. In the OB of
HDAC2 def mice a reduction of Dcx+ cells as compared to the DG (Figure 5.27
a,b) could also be observed. More fast proliferating cells could be found after a short
pulse of BrdU (Figure 5.27 c) at the SEZ followed by a signiﬁcant reduction in the
number of newly generated neurons after 3weeks of BrdU label retaining experiment
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in the OB (Figure 5.27 e-g). As an independent approach to quantify neuroblasts
in the OB FACS to sort PSANCAM+ cells was used. It was shown that Dcx and
PSANCAM are expressed in the same cells, namely the neuroblasts [Seri et al.,
2004]. The percentage of PSANCAM+ cells sorted from tissue of the SEZ of WT
and HDAC2 def mice was slightly increased, supporting the fact that the number of
proliferating neuroblasts is increased in HDAC2 def mice (Figure 5.29). In contrast
to this, the number of PSANCAM+ cells is reduced while sorting cells from tissue of
WT and HDAC2 def OBs, which suggests the fact that newly generated neurons are
diminished when reaching the OB in HDAC2 def mice (Figure 5.28). These data
demonstrate that proliferation is increased while neuronal diﬀerentiation is impaired
in the HDAC2 def OB neurogenic system.
Since the HDAC2 function is lacking in all tissues of the HDAC2 def mice and hence
may exert indirect eﬀects on adult neurogenesis, the neurosphere assay was used
to examine the propagation and diﬀerentiation of neural progenitor cells and their
diﬀerentiation properties isolated under in vitro conditions. Consistent with the
increase in proliferation in vivo, the formation of primary neurospheres from adult
SEZ (aSEZ) was slightly increased whereas the secondary neurosphere formation
was not changed in HDAC2 def neurosphere cultures (Figure 5.34 a,b). Already
after 8 days of diﬀerentiation, neuronal maturation was aﬀected, meaning in partic-
ular that cells were able to express neuronal markers such as β-IIItubulin but failed
to form a neuronal network because their neurite outgrowth was severely aﬀected.
Once more, this suggests an important function of HDAC2 in neuronal maturation
(Figure 5.34 c,d). While the number of neurons in HDAC2 def SEZ neurosphere
cultures in diﬀerentiation medium was only slightly decreased after 8DIV, the num-
ber of newly generated neurons was strongly reduced after 14DIV compared to the
number of WT neurons (Figure 5.34 e,f). These data point toward the fact that
under isolated conditions in an in vitro system HDAC2 is important for neuronal dif-
ferentiation and maturation. This reﬂects that the HDAC2 function is mediated via
cell-autonomous mechanisms that are present also in isolated neurosphere cells in
vitro. The treatment of aSEZ neurospheres with general HDAC inhibitors (valproic
acid (VPA) or TSA) resulted in an increase of neuronal diﬀerentiation [Siebzehnrubl
et al., 2007], suggesting that other HDACs rather than HDAC2 reveal this function
in aSEZ neurospheres. In order to address the question of whether HDAC2 acts in a
cell-autonomous manner in adult neurogenesis, we therefore tested the HDAC2 func-
tion in vivo by transplanting WT derived SEZ cells into the mutant SEZ. Since adult
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neurogenic niches secrete several factors that could inﬂuence the cell-autonomous
eﬀect in vivo the diﬀerentiation capability of the transplanted cells was monitored.
3weeks after transplantation a similar number of NeuN+ neurons reaching the OB
in the WT compared to the HDAC2 def mice (Figure 5.35). Taken together, these
experiments imply no major changes in the adult neurogenic niche of HDAC2 def
mice, but rather demonstrate a cell-autonomous role for the catalytically active form
of HDAC2 in neuronal diﬀerentiation of adult generated neurons. In the following
possible explanations for the defects described in HDAC2 def mice shall be described.
6.2.5.3 REST as a key regulator of neuronal genes
As REST (RE1 silencing transcription factor, also known as NRSF) mediates ac-
tive repression via recruitment of HDACs by its corepressors mSIN3 and COREST
[Ballas et al., 2001], it appears to be a good candidate to act together with HDAC2
in the context of adult neurogenesis. REST is expressed in neural progenitor cells
as well as in non-neuronal cells to repress neuronal diﬀerentiation. REST binds to
the RE1 binding sites and there are two classes of genes described to be repressed
by REST [Ballas et al., 2005]. Class I are neuronal genes downregulated in neural
progenitor cells . Class II are neuronal genes that are repressed while REST binds to
the RE1 binding site. Additionally, the two repressor complexes Sin3 and CoREST
bind to methylated CpG islands known to be highly concentrated in heterochromatic
regions [Bird, 2002; Craig, 2005]. Upon diﬀerentiation into cortical neurons, both
repressor complexes bind to the promoters thereby preventing high transcription
rates to regulate these genes. As REST is described to be absent in postmitotic neu-
rons, it is likely that HDAC1 interacts in this play with REST. The group of Ballas
et al. could only identify HDAC1 as an interaction partner with REST by CHIP
experiments on several promoters of neuronal genes, such as BDNF or calbindin.
Moreover, given that HDAC2 is also expressed in progenitor cells during postnatal
brain development, HDAC2 could also be involved in the repression of neuronal
genes in progenitor cells together with REST. Later, in the adult brain, HDAC2 is
maintained in postmitotic neurons but its function to repress neuronal genes there
is no longer required. On the other hand, in adult neurogenic regions HDAC2 seems
to repress a set of genes in neuronal progenitor cells possibly suﬃcient for stem
cell maintenance as it was shown for Sox2. Another recent study has reported a
REST mediated pathway over a microRNA miR-124a repressing non-neuronal mR-
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NAs in neuronal cells, while REST is absent and cannot repress this micro RNA
itself. In non-neuronal cells REST represses the activity of miR-124a and neuronal
genes thereby preventing neuronal diﬀerentiation [Conaco et al., 2006]. The study
of Hsieh et al. (2004) is in line with the assumption that REST functions in concert
with two transcriptional repressor complexes known to contain also HDAC2. They
were able to show an induction of neuronal diﬀerentiation of adult hippocampal neu-
ral progenitors after HDAC inhibitor treatment. This is contradictory to the results
observed in the HDAC2 def mice, suggesting that using broad range inhibitors for
HDACs results in the loss of a variety of derepressed genes that display functions in
a variety of diﬀerent mechanisms.
6.2.5.4 Implications of HDAC inhibitor treatment in the context of lineage
decision
Other studies on HDAC inhibitor treatment refer to oligodendrocyte progenitor
cells (OPC) by aﬀecting the timing of their diﬀerentiation. Histone deacetylation is
known to be essential during a speciﬁc temporal window of development, and this
was dependent on the activity of HDACs [Shen et al., 2005] by repressing genes
inhibiting diﬀerentiation in OPCs. In line with these observations another study de-
scribed the necessity of HDAC activity for oligodendrocyte lineage progression. By
blocking HDAC activity using TSA in cultures derived from neonatal rat cortices
the progression of oligodendrocyte progenitors into mature oligodendrocytes was
prevented [Marin-Husstege et al., 2002] while no increase in astrocyte or neuronal
diﬀerentiation was observed. Using TSA to treat embryonic mouse neural stem cells
an increase of neuronal diﬀerentiation was observed while astrocyte diﬀerentiation
was decreased [Balasubramaniyan et al., 2006]. By contrast, the inhibition of HDAC
activity with VPA induced the neuronal diﬀerentiation of adult hippocampal pro-
genitors. Moreover, VPA inhibited astrocyte and oligodendrocyte diﬀerentiation,
respectively [Hsieh et al., 2004]. In another study VPA was reported to promote dif-
ferentiation and cell death of neuroblastoma cells which were shown to have neuronal
precursor characteristics [Stockhausen et al., 2005]. In the study of Lyssiotis et al.
(2007) a genome-wide expression analysis after inhibiting HDAC activity in OPCs
was reported, in which the reactivation of Sox2 and several other genes responsible
for maintaining the neural stem cell state leads to developmental plasticity in these
progenitor cells also capable of having neuronal diﬀerentiation potential [Lyssiotis
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et al., 2007]. These observations are well in agreement with our results of an in-
crease in proliferation in the adult neurogenic regions and the upregulation of Sox2
in HDAC2 def mice.
Most of the studies reporting the role of HDAC inhibitors cannot explain speciﬁc
functions of single HDACs. Furthermore, all studies reported here showed HDAC
inhibitor treatment in diﬀerent cell culture systems at diﬀerent developmental stages
of neural progenitors, so that a comparison is not possible. However, studies inhibit-
ing all HDACs could give hints about the involvement of speciﬁc mechanisms and
oﬀer a direction that future studies can follow. This should be done by deﬁning
speciﬁc functions of single HDACs along the lines of what this work revealed for
HDAC2 in adult neurogenesis.
6.2.5.5 Speciﬁc functions for single class I HDACs
A study in zebraﬁsh addressed the role of HDAC1 in two independent aspects. First,
it was reported that in HDAC1 mutant zebraﬁsh hindbrain the speciﬁcation of oligo-
dendrocytes fails to occur, while the persistence of neural progenitors in the mutant
hindbrain VZ, which express Pax6a and Sox2, is independent of HDAC1 activity
[Cunliﬀe, 2004]. Interestingly, HDAC1 expression is restricted to glial cells in which
Sox2 is also expressed. This implies that HDAC1 does not suppress Sox2, although
they are often coexpressed. Moreover, according to the data shown here, HDAC2
seems to repress Sox2 in neuronal progenitors allowing them to diﬀerentiate further,
while HDAC1 cannot and is therefore not upregulated in the adult neurogenic regions
in the HDAC2 def mice. Another group described HDAC1 as a necessary component
for the switch from proliferation to neuronal diﬀerentiation in the zebraﬁsh retina
by antagonizing the Wnt and Notch/Hes pathway to promote cell-cycle exit and
neurogenesis in the zebraﬁsh retina [Yamaguchi et al., 2005]. In more detail, their
data support the possibility that aberrant activation of Wnt signaling causes hyper-
proliferation in HDAC1 mutant retinas. Overexpression experiments further show
that HDAC1 suppresses cell cycle progression and promotes the cell cycle exit of
retinal progenitor cells. They further suggest that this suppression of Wnt signaling
is achieved by the repression of genes that normally are activated by Wnt signaling
such as cyclinD1. Several pharmacological components that inhibit HDAC activ-
ity, such as TSA or butyrate also cause cell cycle arrest at both G1 and G2 phases
[Yoshida and Beppu, 1988]. Indeed, this function provides the basis for using HDAC
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inhibitors to treat cancer. What is the molecular basis behind these cell cycle ef-
fects induced by HDAC inhibitors? The G1-arrest phenotype may be caused by the
repression of key cell cycle regulating genes such as p21 by HDACs. The eﬀects on
G2/M may be a result of the role of HDACs in providing deacetylated histones to
be deposited during the replication processes [Kouzarides, 1999]. This suggests a
possible role for HDAC2 in the regulation of cell cycle, because the loss of HDAC2
also causes a hyperproliferation in adult neuronal progenitors.
6.2.5.6 Diﬀerentiation and maturation of newly generated neurons in the
adult brain
As new neurons are continuously generated and integrated into existing neuronal
circuits in the DG or the OB [Zhao et al., 2008], the hypothesis is that the survival
or death of newly generated neurons is information-dependent. Because neurons re-
ceive their information primarily through their input synaptic activity, it was shown
that the survival of new neurons is regulated by a speciﬁc NMDA-type glutamate
receptor during a short, critical period soon after neuronal birth. This suggests that
the survival of new neurons and their integration in preexisting neuronal circuits is
information- and cell-type speciﬁc [Tashiro et al., 2006]. The synaptic integration
is regulated not only by information- and cell speciﬁcity but also by their activa-
tion catalyzed by γ-aminobutyric acid (GABA), a major neurotransmitter in the
adult brain. During embryonic neurogenesis, until the ﬁrst postnatal week GABA
induces depolarization resulting in an excitatory function [Ben-Ari, 2002]. In the
adult brain, when newly born neurons mature, a conversion from GABA-induced
depolarization into hyperpolarization occurs and this turns out to be essential for
the establishment of functional GABAergic and glutamatergic synapses of newly
generated neurons such as in the GCL of the DG [Ge et al., 2006]. The sequential
expression of the Na+-K+-2Cl− transporter NKCC1 (a Cl− importer) and the K+-
coupled Cl− transporter KCC2 (a Cl− exporter) is believed to underlie the conver-
sion from depolarization to hyperpolarization by GABA during neuronal maturation
in the brain [Ben-Ari, 2002; Owens and Kriegstein, 2002; Payne et al., 2003]. After
shRNA treatment against NKCC1, newly generated GCL neurons exhibited signiﬁ-
cant defects in their dendritic arborization as shown by a reduction of the dendritic
complexity. This suggests a GABA-induced depolarization as well as a reduction of
the dendritic development of newborn neurons in adult neurogenic regions [Ge et al.,
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2006], while in mature neurons GABA carries mainly inhibitory functions during the
synaptic transmission. Given that the dendritic complexity in the HDAC2 def DG
is aﬀected in line with the neuronal maturation, it is likely that newborn neurons
are not able to transduce local information needed for a proper integration into the
preexisting neuronal network. This can have several causes. One might be that the
depolarization/hyperproliferation shift mediated by the transporters NKCC1 and
KCC2 does not occur correctly in HDAC2 def mice. This calls for further examina-
tion in the future.
Thus, the function of HDAC2 is crucial for the proper speciﬁcation and subsequent
survival of adult generated neurons, thereby revealing remarkable diﬀerences in the
molecular mechanisms governing neuronal maturation in the embryonic and adult
brain. The classiﬁcation of neural stem cells and the diﬀerentiation toward the neu-
ronal lineage in the adult brain is summarized in the diagram in Figure 6.1 with
respect to the observed phenotypic changes in the HDAC2 def mice. HDAC2 is
necessary for regulating proliferation and diﬀerentiation of adult neurogenic progen-
itors. In the absence of HDAC2 proliferation genes are not repressed anymore and
cells cannot diﬀerentiate properly to eventually undergo cell death.
6.2.6 The role of HDAC2 in non-neurogenic regions in the
adult brain
We also observed prominent diﬀerences in the subcortical white matter (SCWM)
of HDAC2 def mice (10 weeks old) with a signiﬁcant increase of cells that incorpo-
rated BrdU after 1 hour short pulse, suggesting that these are cycling cells described
to have gliogenic potential [Takemura, 2005; Nunes et al., 2003]. Double-staining
with Dcx and GFAP displayed that the majority of these cells were Dcx+ (56%)
compared to 10% in the WT and hence may be neuroblasts as Dcx encodes a
microtubule-associated protein expressed in migrating neuroblasts [Abrous et al.,
2005]. Proliferating cells in this region are described to have glial rather than neu-
ronal potential [Nunes et al., 2003] and some of the BrdU+ cells in the SCWM also
express glial markers such as GFAP and Olig2. In order to trace these proliferating
Dcx-expressing cells and to examine whether they have the capacity to migrate to-
ward the SCWM or other regions such as the Ctx, we injected GFP retrovirus in
the region of the SCWM. After 14 days GFP+ cells could be detected at the edge
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Figure 6.1: Summary of the phenotypic changes in HDAC2 def mice
Multipotent stem cells (GFAP+, Blbp+) give rise to transit-amplifying precursors (BrdU+) that
generate neuroblasts (Dcx+) which then generate neurons. HDAC2 is expressed in all cell types
except multipotent stem cells. Fast dividing cells are increased in HDAC2 def mice and the pool
of adult generated postmitotic cells is depleted while cells undergo apoptosis.
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of the lateral ventricle and at the caudal end of the SCWM, suggesting a migratory
capacity rostrally and caudally. However, the cells remained in the SCWM. GFP+
cells that were found at the ventricle expressed to some extent GFAP (Figure 5.31).
GFP+ cells did not label for other cell-type speciﬁc antigens such as Olig2 or Dcx.
After a longer survival period of GFP injection (21 days) no GFP+ cells could be
monitored in the GM of the Ctx. Instead, GFP+ cells remained in the WM. This
suggests that besides the fact that they are able to migrate they do not have the
neurogenic potential to generate new neurons entering the GM of the Ctx. In con-
trast to this it was recently shown that transplanted oligodendrocyte precursors
(NG2+) from the neonatal rat Ctx into the corpus callosum (CC) of pups (same
age) have under normal conditions the potential to generate only oligodendrocytes.
After treatment with VPA these oligodendrocyte precursors can now also generate
neurons [Liu et al., 2007]. The reprogramming of these speciﬁed precursor cells is
due to the loss of epigenetic memory after HDAC inhibition, because global histone
acetylation is detected in precursor cells during the early stages of brain develop-
ment [Shen et al., 2005]. Taken together, the studies in the SCWM of HDAC2 def
mice show another non-neurogenic region where proliferation is increased, but these
cells does not seem to have neurogenic potential. The function of these proliferating
cells has to be addressed in further studies.
6.3 Brg1 expression proﬁle
Brg1 as a key molecule in the chromatin remodeling complex SWI/SNF showed a
very speciﬁc expression pattern during the diﬀerent stages of brain development.
The comparison of the HDAC2 and Brg1 proteins was highly interesting especially
when a high colocalization at diﬀerent stages of neurogenesis became apparent. Dur-
ing embryonic neurogenesis Brg1 was already detectable in neural precursor cells on
the mRNA level (Figure 5.1 c) as well as on the protein level at E14 (Figure 5.2
c). Brg1 was also present in diﬀerentiated cells, such as β-IIItubulin+ neurons at
this age (Figure 5.2 d). Later, at the end of embryonic neurogenesis at E18, Brg1
immunoreactivity was present in postmitotic neurons in the cortical plate and low
levels remained at the VZ similar to HDAC2 at this stage (Figure 5.13). Another
research group also described Brg1 protein upregulation after E13 in the mouse em-
bryonic VZ and also in postmitotic neurons [Matsumoto et al., 2006]. In contrast
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to the absence of HDAC2 immunoreactivity in adult neural stem cells, Brg1 was
also present in these cells in the SGZ of the DG and in the SEZ (Figure 5.12 a,b).
Besides this diﬀerence the overlap of HDAC2 and Brg1 was very remarkable in the
adult brain (Figure 5.11). Given the very speciﬁc colocalization of a protein that
is part of the main transcriptional repressor complexes existing in the mammalian
system and a protein function as an ATPase-subunit in the most prominent chro-
matin remodeling complex it could be shown that these complexes can be recruited
to act in an orchestratic manner and coordinate with each other and with the tran-
scription machinery to create speciﬁc regulation of speciﬁc genes [Narlikar et al.,
2002]. Despite this similar expression pattern, the observed phenotypes were rather
diﬀerent.
6.4 Brg1 - functional analysis
6.4.1 Ablation of Brg1 protein in adult neural stem cells
In order to address the function of Brg1 in adult neural stem cells, the Brg1 protein
was ablated by using an inducible GLASTCreERT2 line to speciﬁcally delete the pro-
tein in GLAST expressing astrocytes that are described to contain the multipotent
stem cells in the adult neurogenic regions [Ninkovic and Gotz, 2007; Jackson and
Alvarez-Buylla, 2008]. Supported by previous studies it became clear that Brg1 holds
an important function in embryonic neural stem cells as reported by Matsumoto et
al. (2006). The researchers claimed that stem cell maintenance is mediated by Brg1
and later during diﬀerentiation it seemed to be important for glial diﬀerentiation
rather than neuronal diﬀerentiation. The two temporal as well as spatial indepen-
dent roles of Brg1 were also well described by Lessard et al. (2007). They reported
that a switch in the subunit composition of Brg1-containing complexes may pro-
mote neural stem cell self-renewal/proliferation. The specialized function of Brg1
in neural stem cells was likely mediated through its interaction with the progenitor-
speciﬁc subunits of the SWI/SNF chromatin remodeling complexes. The transition
from proliferative to neurogenic divisions required the exchange of these subunits
speciﬁc for stem cell maintenance and thereby promoting neuronal diﬀerentiation.
Therefore two diﬀerent, very speciﬁc Brg1 containing complexes appeared at two
distinguishable time points in embryonic neurogenesis [Lessard et al., 2007] and it
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is believed that Brg1 is required for neuronal diﬀerentiation [Seo et al., 2005b]. An
antagonist of Brg1 function with regard to neuronal diﬀerentiation was shown to
be Geminin, a novel coiled-coil protein which was previously characterized to play
a role in maintenance of genome integrity through regulation of DNA replication
licensing [Seo and Kroll, 2006]. Geminin was found to be highly expressed in embry-
onic neuronal progenitor cells where it blocks the association of Brg1 with proneural
genes, such as Neurogenin or NeuroD [Seo et al., 2005b]. In diﬀerentiating neurons
Gem levels diminish and allow Brg1 to promote neuronal diﬀerentiation [Seo et al.,
2005a]. However, the function of Brg1 containing complexes and the interaction
with other regulatory proteins in adult neurogenesis was so far unknown.
By analyzing Brg1 ﬂoxed mice crossed with GLASTCreERT2 and a reporter line
(Z/EG) to follow the recombined cells after tamoxifen induction in the adult brain at
3 diﬀerent survival times an important phenotype in neuronal diﬀerentiation could be
detected. The Brg1 protein was not completely disappeared 6 days after tamoxifen
induction (Figure 5.44), but after 14 days Brg1 protein was no longer detectable
in GFP+ recombined cells (Figure 5.46). GFP+ Dcx+ cells were slightly reduced
at the SEZ in Brg1 ﬂoxed mice suggesting a reduction in the number of newly
generated neuroblasts 14 days after tamoxifen induction. GFP+ cells entering the
RMS to migrate to the OB seemed to disperse and migrate into other areas, such
as the nearby white matter or the striatum (Figure 5.47 b). The few recombined
cells that managed to reach the OB were often not neuronal as they did not con-
tain Dcx but started to express glial markers such as NG2 (Figure 5.48 a,b) and
also showed a clear change in cell morphology as the cells positive for GFP had a
branched process formation characteristic for oligodendrocyte progenitors (Figure
5.47 c-g). The quantiﬁcation of GFP+Dcx+ cells in the OB reﬂected a signiﬁcant
reduction in Brg1 ﬂoxed mice from ≈ 85% to 40% suggesting the possibility that
Brg1 is important for neuronal diﬀerentiation in the adult SEZ/RMS/OB system
(Figure 5.48 c,d). The DG remains to be examined in the future to compare the
observed eﬀects after Brg1 deletion in both neurogenic areas.
The third time point analyzed 28 days after tamoxifen application conﬁrmed the
observations made already after 14 days. Moreover, the observed change in Brg1
ﬂoxed mice became more prominent as very few cells reached the OB and none
of the GFP+ cells migrated toward the GL of the OB to become integrated in the
neuronal circuitry (Figure 5.49). Furthermore, the expression of glial markers such
as NG2 was also more prominent in the longer survival analysis than after 14 days
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(Figure 5.50 a,b).
In order to study adult neural stem cells derived from the SEZ of Brg1 ﬂoxed mice
were infected with a Cre-containing retrovirus to delete Brg1 in all dividing cells
in the ﬂoating state. The control cultures were not infected at all. The number
and size of neurospheres were reduced in cultures where Cre led to the ablation of
Brg1 protein (Figure 5.52). This observation was completely consistent with the
ﬁndings that Lessard et al. (2007) reported. Their in vitro analysis was done with
embryonic neurospheres from WT and Brg1 ﬂoxed mice crossed with a nestinCre
mouse line to speciﬁcally delete Brg1 protein in cells expressing nestin starting at
E10.5. When they analyzed the number and size of the neurospheres, both were
signiﬁcantly reduced in Brg1-deﬁcient cultures compared to WT cultures [Lessard
et al., 2007] after 7 days, suggesting a crucial role for Brg1 in stem cell maintenance
and a potent function in embryonic neurogenic precursors as well as in adult neu-
rogenic precursors. As Brg1 was found to be expressed in almost all cells in adult
neural stem cell cultures it may also play a role in neuronal diﬀerentiation in vitro
as it was shown in vivo. Cells were infected with a Cre-containing retrovirus 2 hours
after plating. After 7 days of diﬀerentiation there was a signiﬁcant change from
neuronal to more oligodendrocytic diﬀerentiation (Figure 5.53). Taken together,
Brg1 seems to be important for neural stem cell maintenance and neuronal diﬀer-
entiation both in vitro and in vivo. When Brg1 was deleted cells were not able
to proliferate in a normal frequence. During neuronal diﬀerentiation a switch from
the neurogenic to the gliogenic pathway occurred. Besides the importance of Brg1
containing complexes with speciﬁc subunit presence in either neural stem cells or
more diﬀerentiated neurons [Lessard et al., 2007], so far little is known about the
function of Brg1 in a complex mechanism such as adult neurogenesis. This study
shed some light on the importance of Brg1 in this regard but further examinations
will be carried out to address the functions more precisely.
6.5 HDAC2 and Brg1 - comparison
When linking the function of HDAC2 to that of Brg1 it appears that Brg1 plays sev-
eral important roles in neurogenesis both in embryonic stages as well as in adulthood.
The two proteins can act together on the same genes [Narlikar et al., 2002] and it
was shown for HDAC2 as well as for Brg1 that they are recruited to REST-mediated
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repression. Brg1 activity increases the stability of REST-RE1 interactions with chro-
matin [Ooi et al., 2006]. Moreover, Brg1 can aﬀect transcription in both a positive
and a negative manner, while the negative eﬀect is achieved conjointly with HDACs
[Sif et al., 2001]. Along these lines, Brg1 also revealed to interact with the proneural
bHLH proteins Neurogenin and NeuroD and mediates their transcriptional activi-
ties for neurogenesis in Xenopus laevis [Seo et al., 2005b]. Various sequence-speciﬁc
transcription factors are regulated by the SWI/SNF complex together with HATs
or HDACs to either activate or repress transcription and presumably also proneural
bHLH transcription factors [Kadam and Emerson, 2003]. This possibly oﬀers the
best explanation for the switch from neuronal to glial cell fate after the deletion of
Brg1. Furthermore, it was demonstrated that Brg1 also interacts with Pax6 [Yang
et al., 2006], a potent regulator of neurogenesis, which is conducive to the neuronal
diﬀerentiation into adult TH+ glomerular neurons [Brill et al., 2008]. Therefore, it
is likely that Pax6 can only fully achieve its potent function by interaction with Brg1.
Not only HDACs alone are recruited by SWI/SNF complexes but, most prominently,
also the mammalian repressor complex mSin3 containing HDAC2 as a subunit [Xu
et al., 2006] then acting together in an orchestratic manner. In the CNS, HDAC2
and Brg1 show an overlapping expression pattern in almost all cells except the mul-
tipotent stem cells, which suggests that functions regarding neuronal diﬀerentiation
can be achieved conjointly, whereas the function of Brg1 in stem cell maintenance
might possibly be addressed together with other HDACs. This is also reﬂected in the
mutants for either HDAC2 or Brg1 analyzed in this study, given that both mutants
show a neuronal diﬀerentiation phenotype. In the HDAC2 def mice the defect in
neuronal maturation leads to apoptosis, whereas after Brg1 deletion, a switch from
neuronal to NG2-glial cell fate occurs. Hence, it might be interesting to understand
the causes of Brg1 and HDAC2 loss in adult neural stem cell diﬀerentiation and, on
the other hand, to examine the function of each protein in a mutant background of
the other. Moreover, the interaction of Brg1 and also HDAC2 with important neu-
rogenic regulators such as Pax6 is a highly interesting study that should be designed
in the future.
This study identiﬁed for the ﬁrst time a speciﬁc role of two epigenetic factors in the
CNS, namely HDAC2 and Brg1. HDAC2 steers the regulation of neuronal matura-
tion in the adult, but not the embryonic brain. Conversely, Brg1 regulates neural
stem cell maintenance and neuronal cell fate in both embryonic and adult neuro-
genesis in which both proteins might act together. Thus, the functions of HDAC2
146
6 Discussion
and Brg1 reveal the speciﬁcity by which epigenetic mechanisms aﬀect key features
in adult neurogenesis and therefore regulate the ﬁnal maturation and integration of
new neurons into preexisting neuronal networks in the adult brain.
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